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vAbstract
The aim of this thesis was to examine the ability of metal organic frameworks (MOFs)
to store and controllably release biologically significant amounts of nitric oxide (NO).
Initial work involved the synthesis of a series of isostructural MOFs, known as M-
CPO-27, which display coordinatively unsaturated metal sites (CUSs) when fully
activated (guest solvent molecules both coordinated and uncoordinated to the metal
atom are removed). Two of these frameworks (Ni and Co CPO-27) displayed
exceptional performance over the entire cycle of activation, storage and delivery
showing the largest storage and release of NO of any known porous material (up to 7
mmolg-1). These frameworks would therefore be considered for initial research into
the formulation of MOFs, for possible use in medical applications. It was shown that
they still release large amounts of NO even when placed inside porous paper bags,
creams or hydrocolloids. The other versions of M-CPO-27 also displayed significant
adsorption of NO however they show poor total NO release. It was also shown that it
is possible to synthesise both Ni and Co CPO-27 using microwave synthesis without
any detrimental effect to the porous structure.
Several iron-based MOFs were also investigated for NO storage and release. The
results showed that Fe MIL-88 based structures adsorb good amounts of NO but only
release a small amount of the irreversibly adsorbed NO. Two successfully amine
grafted giant pore MOFs were then investigated to attempt to improve the NO
adsorption and release. This result was not observed however, due to the poor total
amine grafting coverage and pore blockage resulting from the amines. In-situ IR
studies reveal that when exposed to NO, activated Fe MIL-100 forms a chemical bond
vi
with the NO. The studies also displayed that when water is then allowed to attempt to
replace the NO that only a small amount of NO is actually released, the majority of the
NO either remains chemically bonded to the Fe atom or forms N2O in conjunction
with a Fe-OH group.
Other MOFs were also successfully synthesised and characterised for NO storage and
release. Both Ni succinate and Ni STA-12 display good adsorption and excellent
release of NO. This indicates that Ni based MOFs show the best results for NO
adsorption and release.
In the conclusion of the thesis I am able to categorise the NO release ability of MOFs
based on composition and formulate a theory as to why this happens.
vii
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1 Introduction
1.1 Metal-organic frameworks
1.1.1 Introduction
Over the last 15 years or so there has been an intensification of interest in the field of
porous materials research after the discovery of a class of compounds known as
metal-organic frameworks or MOFs1-3. Previously, porous materials research had
been dominated by zeolites and activated carbons4. Since the late 1990s however, the
emphasis has very much shifted towards MOFs. This can be easily seen in the
number of publications produced per year (see figure 1.1). There are several names
that have been used to describe these structures, including porous coordination
polymers (PCP), however as the field grew the more general term MOFs was
adopted. Even today there are derivations of the term MOF such as metal organic
polyhedra (MOP), isoreticular MOF (IRMOF), zeolitic imidazolate framework (ZIF)
and microporous metal-organic framework (MMOF). MOFs are constructed from
metal ions which act as connectors, and these are combined with organic ligands
which act as linkers. This combination leads to structures with ranging
dimensionality (mostly 3D) but linked exclusively with strong bonds. One of the
factors influencing the explosion in MOF research is the properties they have been
shown to exhibit, including high surface area and permanent porosity.
Chapter 1 Introduction
2
Figure 1.1 Chart showing the number of publications concerning metal-organic frameworks
(red) and coordination polymers (blue) versus year.
In fact certain MOFs have shown extremely high surface areas; MOF-55, HKUST-16,
MIL-1017 and MOF-1778 are prime examples. Indeed, until very recently a MOF
known as UMCM-2 had the highest surface area of any known porous material9
(Langmuir surface area of 6060 m2g-1). This has since been superseded by a porous
aromatic framework9 (PAF) which has a Langmuir surface area of 7100 m2g-1.
Figure 1.2 Examples of MOFs (from left to right), the world famous MOF-5, MIL-101 and
HKUST-1 structures. Reproduced with kind permission from Nature and the Royal Society of
Chemistry.
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MOFs also have several advantages over zeolites. For example, during synthesis the
solvent acts as the template for MOF formation with the result that the majority of
MOFs are neutrally charged. This is not the case for zeolites where a charged
template is required. However this can also be an advantage for zeolites as negatively
charged frameworks present more functionality then neutral ones. The biggest
advantage for MOFs however, is the almost limitless possibilities for structure types.
Beginning with the cations, zeolites are for the most part, based on aluminium and
silicon with a number of exceptions. MOFs can be constructed from almost any
cation, certainly all the di, tri (including the rare-earth elements) and tetravalent
transition metals. This represents an extremely large number of framework
possibilities. This number is then increased vastly when the number of organic
linkers which could be utilised is taken into account. Linkers fall primarily into two
categories: O donors and N donors. The vast majority of O donor MOFs have been
constructed using either mono or poly carboxylates. There have, however, also been
many MOFs constructed using phosphonates and to a lesser extent sulfonates10. The
most commonly used N donors are cyanides, pyridine and imidizoles, which attach
directly to the cation. This leads to a huge number of possible frameworks. This
number can be increased again as post synthetic modification can be carried out on
MOFs to functionalise organic parts, tailoring them for specific applications11.
However there are certain scientific constrictions which reduce this number. For
example, certain metals form particular clusters that appear again and again. These
are known as secondary building units (SBUs)1,12. Three of the most common
examples of SBUs can be seen in figure 1.3.
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Figure 1.3 Three of the most common SBUs. (a) The paddlewheel MO5 dimer. (b) The MO4
tetrahedron and (c) The planer trimer containing MO6 octahedra with a central oxygen atom.
Figure 1.3(a) shows the “paddlewheel” SBU which is produced by a number of
metals, most notably Cu2+ but also others such as Zn2+ and Fe2+. Figure 1.3(c) shows
the trimer SBU, which can be produced by a number of metals including Fe3+ and
Cr3+. Using these SBUs an entire series of MOFs can be produced that have the same
topology but utilise different linkers in synthesis. The best example of this is the
isoreticular MOFs (IRMOFs) produced by Yaghi and co-workers. By using the same
zinc SBU (figure 1.3(b)), but using different organic linkers, they were able to
synthesise an entire range of MOFs (see figure 1.4) differing in surface area and
functionality, but with the same cubic topology13. The most famous of this set is
MOF-5 (figure 1.2)5, which has been one of the most studied MOFs to date.
a) b) c)
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Figure 1.4 The series of iso-reticular MOFs produced by Yaghi and co-workers14, showing the
same SBU (cubic topology) but with differing linker length and functionality. (Reprinted from
reference 14, Copyright (2004), with permission from Elsevier).
1.1.2 Synthesis of MOFs
The original method for producing MOFs involved slow coupling of the coordinating
species. This method was time consuming and therefore other synthetic procedures
were adopted. Solvothermal synthesis very quickly took over and has proved to be
the dominant synthesis procedure used to produce MOFs. In a typical synthesis the
precursor reactants are diluted into solutions using polar solvents such as water,
alcohols, dialkyl formamides or less commonly acetone. These solutions are
combined in a Teflon-lined autoclave (figure 1.5) and then heated to the required
temperature (somewhere between room temperature and 250°C). Once the reaction
has finished (ranging from a few hours to several days) the autoclave is removed
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from the oven and cooled to room temperature. The resulting solid is filtered, washed
with the parent solvent and then dried. The crystallinity of the sample produced is
then checked using powder X-ray diffraction. The results can be compared with a
database of known materials to see if the phase has been synthesised before or to
confirm that your phase is exactly what is required.
Figure 1.5 A diagram showing a Teflon lined Parr bomb15 (autoclave)
which relieves excess pressure safely.
1.1.3 New methods of producing MOFs
In recent years there have been numerous efforts at producing frameworks using
different synthesis techniques. The first of these is so-called Ionothermal synthesis.
This involves using an ionic liquid as both the solvent and template in the reaction.
This method has been pioneered by Morris and co-workers16-18. They have shown
that it is possible to make several types of frameworks using ionic liquids in the
reaction. It is still a technique in its infancy, however, as there are only very few
examples of frameworks being produced using ionic liquids.
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The next technique being pioneered to produce MOFs involves using microwave
synthesis. This method has already been used to form dense solids and seems very
promising for the production of MOFs. The advantages of microwave synthesis are
much shorter crystallisation times compared with conventional techniques and
control over morphology. Indeed Chang and co-workers have shown recently that
microwave synthesis is an extremely efficient way of producing certain MOFs. They
have synthesised the giant pore structures of chromium trimesate and terephthalate
(MIL-100 and MIL-101 respectively) in less than 1 hour19 which is 60 times faster
than the conventional hydrothermal route. Chang and co-workers have also produced
the famous MOF-5 structure20 and Choi and co-workers have synthesised MOF-5
and shown which factors are important for higher quality material to be produced21.
Another example of efficient microwave heating is the Ni glutarate system. Whereas
the conventional method takes many hours, the microwave method can produce both
the original MIL-77 [Ni20(C5H6O4)20(H2O)8·40H2O] and also the formation of a
different phase, [Ni22(C5H6O4)20(OH)4(H2O)10]·38H2O, within a few minutes22.
Morris and co-workers have also shown that it is possible to synthesise MOFs using
microwave ionothermal synthesis. Indeed they produced the same frameworks both
ionothermally and using microwave synthesis and concluded that the microwave
samples were purer and had higher crystallinity23.
All these examples show that there are definite steps towards commercialisation in
the production of MOFs. This commercialisation has already begun as it is now
possible to purchase several MOF structures from Aldrich. These are produced by
BASF and one of them uses the third of the new synthetic techniques. This involves
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electrochemical production of MOFs24. The best and only example of this is the
structure known as HKUST-1, which is a copper 1,3,5 benzenetricarboxylate MOF.
BASF produce this MOF (see figure 1.3) using copper plates as both anode and
cathode and have the organic linker dissolved in a solution of methanol. After 2 ½
hours (12-19V, 3A) of reaction time a greenish-blue precipitate is formed. The
HKUST-1 formed from the electrochemical route has also proved to be of a higher
quality24 and give increased surface areas compared with the conventional
solvothermal synthesis sample.
The final method now being employed for the creation of MOFs is the production
through high throughput synthesis25-31. This method has four main stages: design of
experiment, synthesis, characterisation and data evaluation. A tremendous amount of
data can be produced in a very short space of time, but in order to be efficient it is the
design of the experimental stage which is the most important. A typical experiment
includes 48 mini autoclaves and so entire combinations and variance can be tested in
only a few days. Bein, Stock and co-workers have pioneered this technique and have
shown that it is possible to find new phases of materials26. They have proved that
water content and pH play a very important role in reaction trends and they also have
optimised the production of MOFs with this particular synthesis method30-31.
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1.1.4 Applications for MOFs
It is no surprise that given the surface areas and pore volumes available within MOFs
that they have major potential for a large number of applications32. Due to the
aforementioned properties it is in the areas of catalysis and the separation and storage
of gases that have received the most attention for research. However, there are other
areas of research for which MOFs are considered potential candidates for use
including light-emission and magnetism. Finally, the area in which this thesis
concentrates is in the emerging field of biomedical research using MOFs.
1.1.5 Catalysis using MOFs
MOFs have been looked at for possible catalytic applications32-34, although hydrogen
(H2) and carbon dioxide (CO2) storage remain the most heavily researched areas. For
catalytic applications it is in the area of heterogeneous catalysis where nanoporous
materials are of significant interest. This is not only due to the high surface areas
available but also to the lack of “dead volume” (inaccessible volume) these materials
possess. There are three main approaches to the utilisation of MOFs in catalysis, the
first involves using the porous material as the carrier for the active mass. An example
of a MOF being used for this process is MOF-5, and both silver and platinum are
catalytically active when encapsulated by MOF-535-36. A further example is produced
by the Fischer group in Germany who have achieved different catalytic properties
using MOF-5 loaded with gold, palladium and copper37. The second method involves
fixing catalytically active species within the framework. This has been done by
modifying previously known catalysts, so that they are capable of forming MOFs.
Hupp and co-workers have shown that a MOF constructed using manganese salen
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struts has only a slightly lower reaction rate for olefin epoxidations than the
homogenous alternative,38 proving that the reaction takes place inside the pores of
the MOF. The final approach employed is the generation of coordinated species in
the framework which are also stabilised by the framework. Two recent examples of
such an approach are from Rosseinsky and co-workers39 and Wenbin Lin’s group40.
The Rosseinsky group managed to protonate a chiral MOF and use it efficiently as a
catalyst in the enantioselective methanolysis of cis-2,3-epoxybutane. The Lin group
constructed a homochiral MOF which was extremely useful in forming chiral
secondary alcohols via addition of diethylzinc to aromatic aldehydes. Finally the
most recent method for producing catalytic MOFs used post-synthetic modification.
The most noteworthy example of this class of approach is the modification of MIL-
101 with ethylenediamine41. Hwang and co-workers have managed to achieve the
Knoevenagel condensation of benzenealdehyde and ethyl cyanoacetate with a
selectivity of 99.3% towards the product. This high selectivity has also been shown
to be due to the MOF and the structural features contained within the framework.
1.1.6 Light emitting and magnetic MOFs
Light emission by MOFs has received a great deal of attention and there have been
over 200 papers and several reviews published regarding the luminescent properties
of MOF systems42-45. Indeed there is a comprehensive review of luminescence in
MOFs published recently by Allendorf et al46. The reasons for utilising MOFs for
light emission are threefold. Firstly, the organic linkers present in MOFs have their
own inherent luminescent properties. Secondly, by combining these organics with
metal clusters the thermal stability is greatly increased compared with the free
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organic molecules, increasing the likelihood of applications. Finally this combination
of metal and linker could improve the luminescent properties of the linkers.
Examples of MOFs improving luminescent properties compared with the free
organic linker are Zn(C6N2O2H5)2(H2O)4.5 and Cd(C8O4H4)(py),where both show a
vast improvement compared with the free linkers (urocanate and terephthalate)47-48.
The urocanate ligand shows almost no luminescence at room temperature in the solid
state but when placed in the MOF it displays an intense blue47. A similar effect is
noted in the second structure where a 100 fold improvement in the blue fluorescence
is seen48. The majority of light emitting MOFs are constructed using metals from the
transition elements (especially the d10 configured cations Zn2+ and Cd2+). However,
the rare earth metals have also been used. Song and co-workers created some
frameworks consisting of lanthanide oxalates with phosphate decoration which
displayed blue, red and near IR luminescence49. The Férey group doped Eu, Tb and
Dy into the Y1-xEnx(C9O6H3) (x~0.024) complex which then showed blue, green and
red emissions respectively50.
Research has also been carried out into the magnetic properties of MOFs, and several
reviews have now been written concerning this area42,51-53. The majority of magnetic
MOFs contain paramagnetic metal centres such as those in the first row of the
transition metal series (V, Cr, Mn, Fe, Co, Ni, and Cu). Using MOFs with magnetism
could lead to new applications such as molecular sensors42. One of the major
discoveries concerning magnetic MOFs are solvatomagnetic effects. That is changes
in magnetic ordering, when a MOF has been desolvated or if the structure has
collapsed. These effects were first reported by Ohkoshi and co-workers in their
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CoII1.5[CrIII(CN)6].7.5(H2O) framework which when it was exposed to ethanol, it
changed from peach coloured to blue. This effect was attributed to a change from 6
coordination to 4 coordination at the CoII centre54. Another notable example of a
magnetic MOF is the highly flexible nanoporous magnet
Cu3(PTMTC)2(py)6(CH3CH2OH)2(H2O) produced by Veciana and co-workers55.
This structure expands/shrinks by 30% depending on ethanol sorption and also
displays subtle solvatomagnetic properties.
1.1.7 Gas adsorption, storage and release by MOFs
Due to the extremely large surface areas and porosities that MOFs possess, it is no
surprise that the majority of application research has focused on gas storage or
separation using MOFs56. Indeed in the current climate of trying to reduce carbon
footprints and cut carbon emissions, it is energy and environmental applications
which receive the largest amount of attention regarding gas storage. It could be either
storing H2 for a hydrogen fuelled car, or using MOFs to capture carbon dioxide
(CO2) to reduce greenhouse gases. However there is an emerging area of storage
application which uses MOFs for medicinal applications.
1.1.8 Storage of gas for energy applications
Due to concerns regarding carbon dioxide emissions from the usage of petrol and
diesel causing irreparable damage to the earth’s eco-system, alternative fuels and
energy sources are now required. Battery and fuel-cell powered modes of transport
are likely candidates to replace petrol engines, as is utilising hydrogen as a fuel.
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Hydrogen is attractive as a replacement fuel as it is abundantly available (from
water) and is carbon free. The US Department of Energy (DOE) has produced
stringent targets for the storage of H2 for use in mobile applications. They are as
follows: 6.0 wt% and 45 gL-1 of H2 capacity, a refuelling time of less than 10
minutes, a lifetime of 1000 refuelling cycles and an ability to operate within -30°C
and 50°C by 201057-58. MOFs are attractive for the storage of hydrogen as they have
extremely high surface areas and low densities. Therefore a vast amount of research
has centred on hydrogen adsorption of different MOFs. The MOF with the highest
volumetric storage density is MOF-5 which takes up 66g L-1, corresponding to 10
wt% at 100 bar59. This is achieved with a sample which has been fully activated and
not exposed to air (displaying an optimal BET surface area of 3800 m2g-1). It has also
been demonstrated that MOF-5 can adsorb that amount of hydrogen within 2 minutes
and can desorb and re-adsorb for at least 24 cycles without loss of capacity.
Hydrogen storage performance on over 150 MOFs has now been carried out in an
effort to increase and improve the results on MOF-560-62. A MOF which has closely
matched the results on MOF-5 is MOF-177 (Zn4O(BTB)2) which has equalled MOF-
5 in terms of excess H2 adsorption at 77K8,63-64, however due to its larger pores, has a
lower volumetric density. The best performing MOFs have been validated by BASF
and have been compared with compressing hydrogen in an empty container. The
results can be seen in figure 1.6.
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Figure 1.6. A graph displaying H2 capacities for different MOFs and comparing them with a
zeolite and an empty tank32. Reproduced with permission from the Royal Society of Chemistry.
One of the main strategies used to improve H2 uptake in MOFs is using the
coordinatively unsaturated sites (CUS) or open metal sites present in some
frameworks. Many synthesised MOFs have exposed metal sites available for binding
when guest molecules (solvents) have been thermally removed. Some good examples
of such frameworks are the M-CPO-27 series (M2(DHTP))65-67 and HKUST-1
(Cu(BTC)2)68-69. The concept of using open metal sites is that the H2 will bind to the
exposed site. Indeed HKUST-1 has been shown to bind H2 at the metal site using
both infrared spectroscopy and neutron powder difraction70-71. HKUST-1 has the
common paddlewheel SBU and this allows one solvent molecule to be removed to
leave an open metal site. HKUST-1 has been shown to have a hydrogen uptake of
2.27% at 77K and 1bar72. Other Cu paddlewheel based structures include the PCN
series of MOFs from the Zhou group which have shown good uptakes of hydrogen
notably PCN-11 which adsorbs 2.55% at 77K and 1bar73. The Long group have
produced some very interesting research concerning hydrogen storage in MOFs and
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have synthesised two MOFs with open metal sites, Mn BTT and Cu BTT
(M3[(M4Cl)3(BTT)8]2) which adsorb 2.25% and 2.42% of hydrogen at 77K and 900
torr respectively74-75. The M-CPO-27 series of MOFs has been tested and has proved
to be of significant interest as comparisons between different metals and their
binding energy with H2 can be measured76. It was shown that Ni has the highest
initial isosteric heat of adsorption, which means that the Ni version binds the H2
strongest compared with the others. Several reviews have been written concerning
the use of MOFs for hydrogen storage and the challenge of finding a material with
the right set of properties is being widely undertaken60-62. Indeed there seems to be a
consensus that surface area and the amount of hydrogen adsorbed are related61. This
can be seen clearly in figure 1.7.
Figure 1.7. Graph showing the relationship between surface areas and hydrogen uptakes in
MOFs61 (red: Langmuir method, blue: BET method and black shows a theoretical carbon H2
adsorption). Reproduced with kind permission from the Royal Society of Chemistry
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Another potential alternative fuel is methane gas (CH4) and unlike hydrogen it is
easier to store at room temperature in appreciable amounts. For a MOF to be even
considered a candidate for industrial methane storage it must compete with
compressed natural gas (CNG) and exceed a DOE target which requires storage of
about 35 wt% or 180 cm3(STP)cm3 at 298K and 35 bar77. There have been many
studies carried out on MOFs for methane storage starting back in the late 1990s with
the Kitagawa group. They produced a MOF ({[M2(4,4’-bpy)3(NO3)4].xH2O}n)
(M=Co, Ni and Zn) which showed a methane uptake of 2.3 mmol CH4 per gram of
MOF material at 30 atm78. Following this initial success many groups have matched
and indeed improved on this result. The Yaghi group have run CH4 adsorption on
many of their MOFs and IRMOF-6 has shown an exceptionally high uptake of 155
cm3 (STP)cm3 CH4 at room temperature and at 36 atm13. The most recent
publications concerning methane storage in MOFs show great promise for industrial
applications. Hong Cai Zhou’s group have synthesised a MOF known as PCN-14
which illustrates extremely high CH4 uptake79, indeed it is 28% above the DOE
target for methane storage. The M-CPO-27 series of frameworks have been
investigated for methane storage80 and it has been shown that methane binds initially
at the open metal sites, followed by secondary binding again at the metal site. In
addition it was shown that the nickel version of this MOF has the highest adsorption
of CH4 of this series (200 cm3 (STP)/cm3) and exceeds the DOE target (180 cm3
(STP)/cm3) at room temperature and 35 bar.
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1.1.9 Storage of gas for environmental applications
The world is now very aware of some of the effects of climate change and almost
everyone knows about “carbon footprints” and the effect that carbon dioxide (CO2)
has on our environment. Therefore there is much interest in trying to remove or
separate CO2 from industrial processes and also to try and cut down on the amount of
CO2 produced by vehicles. MOFs have the ability to be used as materials to capture
environmentally toxic gases such as CO2, sulphur dioxide (SO2) and ammonia (NH3).
MOFs are also being used to separate CO2 from flue gases to try and limit the
amount of CO2 released.
There have been numerous studies conducted on MOFs for both the storage
(removal) of CO2 and separation of CO2 from other exhaust gases. The first MOF to
be tested for CO2 adsorption was MOF-2, a Zn paddlewheel based
benzenedicarboxylate MOF81. It had a modest uptake of about 2 mmolg-1 at 1 atm
and 195K. Since then, Yaghi and co-workers have tested many MOFs for CO2
adsorption and have had some outstanding results including MOF-177 which adsorbs
33.5 mmolg-1 of CO282 at room temperature and 42 bar. Again the M-CPO-27 series
has been investigated for CO2 storage and it was shown that the magnesium version
adsorbs the largest amount of CO2 (35 wt%) at 1 atm83. The nickel version has been
thoroughly investigated and the CO2 molecule has been shown to bind directly to the
open metal site through an oxygen atom. Some of the most interesting results
regarding CO2 storage in MOFs are from the “breathing” MIL-n MOFs synthesised
by Férey and co-workers84. The “breathing” phenomenon occurs in only a few
examples such as MIL-5385-86 and MIL-8887-88 and is observed when guest molecules
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are removed from the structure, altering the shape of the structure considerably and
having a very pronounced effect on the adsorption/desorption properties of these
materials. For example MIL-53, has a distinct adsorption isotherm for CO289.
Initially it shows a modest uptake of CO2 (3 mmolg-1 at 5 bar), however under
increased pressure it shows a step and adsorbs a large amount of CO2 (8 mmolg-1 at
20 bar), as can be seen in figure 1.8.
Figure 1.8 a) Structure of MIL-53 and its ability to breathe and b) the adsorption/desorption
curve for CO2 on hydrated MIL-5356. The methane adsorption isotherm is also included for
comparison. (Reproduced with kind permission from Wiley Interscience)
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Research into storage or removal of sulphur dioxide (SO2) and ammonia (NH3) is
still in its infancy as far as MOFs are concerned, however there are a few
publications highlighting MOFs as potential materials for the capture of these toxic
gases. Yaghi and co-workers have released a paper showing the adsorption isotherms
for six famous MOFs and their affinity towards eight harmful gases including SO2
and NH390. These results showed that MOFs outperform a Calgon activated carbon
material in the storage of most gases, therefore making MOFs very attractive for use
as harmful gas adsorbers. The results also highlighted the importance of open metal
sites or linker functionality and their impact on the adsorption of different gases.
1.1.10 Prospective biomedical applications of MOFs
An area of research concerning MOFs which up until recently, had remained
unexplored, is the use of MOFs for medicinal applications and therapies. It is only in
the last few years that papers have been published regarding applications for MOFs
in biology or medicine. However, there are now a number of research groups within
the porous materials community who are interested in the idea of using MOFs for
biomedical applications. This area can be broadly split into two categories. The first
concerns using MOFs themselves as active materials and the second involves
utilising the properties of large surface area and open metal sites for the delivery of
different therapeutic remedies based on the requirements of the individual patient.
The first category using MOFs as active materials in medicine has been pioneered by
Wenbin Lin’s group in the United States. They have produced MOFs that have been
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shown to be useful as contrast agents in magnetic resonance imaging (MRI) scans.
They first produced a Gd3+ based nanoscale MOF (nanoMOF) as Gd3+ is highly
paramagnetic (a requirement for useful MRI contrast agents). Using this nanoMOF
they were able to show large relaxivities orders of magnitude higher than those of
other Gd3+ based MRI contrast agents91-92. However, the toxicity of the nanoMOF
would be too large for clinical use. They then produced a Mn2+ based nanoMOF as
Mn2+ is much less toxic than its Gd3+ counterpart93. The relaxivities observed this
time were modest, but they proved that site-specific imaging would be a possibility
using a silica based coating on nanoMOFs to delay the leaching of metal ions until
they reached the specific site. They have also produced nanoMOFs that show
potential as anti-cancer drug delivery vehicles via decomposition of the platinum
based linker94. Finally their most recent research has yielded the first nanoscale
production of MIL-10195. To achieve this they used post-synthetic modification to
produce a nanoMOF with a fluorophore and an anti-cancer drug, which could be
used for optical imaging and as an anti-cancer therapy respectively.
Meanwhile there has been a lot of initial research investigating the use of MOFs as
storage and delivery vehicles for a number of different therapies. These include
biologically active gases, such as nitric oxide (NO), carbon monoxide (CO),
hydrogen sulphide (H2S) and pharmaceuticals. Nitric oxide will be discussed in
much greater detail in section 1.2. However, it is necessary to give a brief statement
of why it is beneficial to store and release nitric oxide. Using nitric oxide as a therapy
would enable wound-healing times on chronic wounds (such as diabetic ulcers) to be
reduced by several days96. It could also be used to coat medical instruments to
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prevent clotting after invasive surgery97. Other NO releasing therapies being
investigated have their disadvantages98-99, whereas there would be no side-effects
from NO being released from porous materials as it would be in the form of pure NO
gas. Morris et al began storing and releasing NO in zeolites100-101. Zeolite-A shows a
good adsorption capacity of NO and this can be tailored depending on the metal ion
present in the framework and the amount of exchanged metal present100,102-103. They
also carried out thrombus studies proving that the NO-containing zeolite prevents
aggregation of platelets (thrombus formation). Subsequent publications have shown
that trials on human skin were successful and the NO-releasing zeolite causes no
harm to the skin whereas the acidified cream (a competing NO-releasing therapy)
actually causes quite severe damage to the skin104. Following NO storage in zeolites
the Morris group then tried storing NO in HKUST-172. Due to the larger surface area
and big pores, HKUST-1 displays a higher uptake of NO compared with the zeolites
previously investigated. However the release of NO from HKUST-1 is 2 orders of
magnitude less than the amount actually adsorbed. Despite this, NO-loaded HKUST-
1 completely inhibits platelet aggregation, showing that the small amount of NO
released is still of biological significance. Included in this thesis are the most recent
publications from the Morris group regarding NO storage in MOFs. The MOF family
of M-CPO-27 (M = Ni, Co, Zn, Mn and Mg) are shown to be of interest in NO
storage particularly the Ni and Co versions as they display almost perfect storage and
release of NO103,105-106. Indeed M-CPO-27 (M=Ni and Co) has shown the highest
reported uptakes of NO of any porous material. A comparison between MOFs and
zeolites and their NO storage abilities can be seen in figure 1.9. Clearly toxicology
could be a problem and that is addressed within this thesis also. Recent testing of
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iron carboxylate MOFs (Fe MIL-88) could help as there are already therapies
(though not NO related) on the market containing iron carboxylates, (FerrettsTM has
the same composition as Fe MIL-88-A). So their toxicology would not be
problematical compared with those composed of Ni and Co CPO-27. The most
recent publication regarding NO storage and release in MOFs comes from the
Rosseinsky group107. They have carried out post-synthetic modification on the open
copper sites of HKUST-1 with a secondary amine, which, when reacted with NO
produces an N-diazeniumdiolate (NONOate) inside the pores of the framework. This
should allow NO to be released upon exposure to moisture. Unfortunately the
majority of the NO attached to the open copper sites that had not been successfully
grafted with amine. However this route of grafting of amines to improve NO storage
and release is of interest and will also be covered in this thesis.
Figure 1.9 Graphs showing the comparison between zeolite Zn-LTA and 3 different MOFs (Ni,
Co CPO-27 and HKUST-1) and their NO adsorption capacity, all conducted at 298K.
Carbon monoxide (CO), like NO, is mostly known for its toxicity, however it is also
potentially useful in biological and medical applications. Indeed there is considerable
literature regarding carbon monoxide releasing molecules (CORMs) and their ability
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to release CO gas in a biological setting108. There is, however, very little research on
CO storage in porous materials. The storage and delivery systems of CO gas will
essentially be the same as for NO. There are a few papers that have looked into CO
storage in MOFs, but not from a biological point of view90,109. They are more
concerned with separation of CO from H2, or as a trap from other systems109. Results
for CO adsorption from a selection of MOFs proved that there is no improvement in
adsorption when compared with the current technology of activated carbon90.
However, these are just initial results and the lack of research in this area might be
partially due to the discovery of CO as a signalling molecule after NO and therefore
biological studies on CO are still fifteen years behind those of NO.
Hydrogen sulfide (H2S) has also been identified as a potential therapeutic agent as it
has been linked with several biological functions and its targeted release could be
beneficial in numerous areas including vasodilation110 and neuroprotection111. In
addition it is capable of producing a suspended animation type state in mice112. A
theory has been put forward that suggests organ preservation could be improved with
its use and it could also have benefits during surgical procedures113-114. There is only
one example of MOFs being used to adsorb H2S so far and this came from the Férey
group115. Their main aim was to purify natural gas, however the adsorption results
are obviously still of interest. It showed that MILs 101,100, 53 and 47 can certainly
be used for the storage of H2S, however, selecting the correct metal and structure
type is very important as H2S can destroy some structures and be irreversibly
adsorbed in others.
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Of course MOFs are not just being used to store gases which could be used for
therapies. The Férey group have investigated the storage and release of ibuprofen116-
117 using several of their MOFs. Great efforts are being employed in finding new
methods for storing and controlling the release of drugs. Using MOFs is a suggested
solution as they contain large porosity and organic groups within their frameworks
which could hold the key to both high storage capacity and controlled release of
drugs. The MOFs studied so far for ibuprofen storage and delivery are MIL-53 and
the giant-pore MIL-100 and MIL-101. Initial testing was carried out on MIL-100 and
MIL-101116. The results were extremely encouraging as MIL-101 showed four times
the capacity for ibuprofen compared with MCM-41. It also took 6 days to completely
release its store of the drug. Following these initial results, ibuprofen loading was
carried out on Fe MIL-53117. The MIL-53 structure is of significant interest as it
“breathes” (undergoes a reversible cell expansion) when dehydrated. MIL-53
delivers about the same amount of ibuprofen as MCM-41, however it is delivered
over a period of 20 days compared to just 2 for MCM-41. A graph showing these
release values can be seen in figure 1.10. Very recently the Férey group have studied
many of their iron-based MOFs for the storage and delivery of both anti-cancer and
anti-AIDS based therapies118. They have shown that several of their MOFs exhibit
storage and release capacities that greatly exceed the current technology for delivery
of these pharmaceuticals. Further to these results they have also proved that these
MOFs are non-toxic in vivo and would present no problem for use as nanocarriers of
drugs. These initial results show great potential in using MOFs as delivery vehicles
for medical therapies both internally and externally.
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Figure 1.10 Graphs displaying the ibuprofen release from a selection of frameworks.
(Reprinted from reference 117, Copyright (2008), with permission from ACS journals)
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1.2 Nitric oxide
1.2.1 Background
The gaseous diatomic nitric oxide (NO) molecule was until 1986 perceived only as
one of the toxic gases produced from car exhausts. Its chemistry was fully explored
by the oil companies in an effort to reduce NO levels produced from the internal
combustion engine. Since 1986, this small free radical has been named ‘molecule of
the year’ in 1992 in science119. Subsequently in 1998 three American scientists (F.
Murad, R. Furchgott and L. Ignarro) won the Nobel Prize in physiology for
discovering its uses in the human body and in particular its action as a muscle
relaxant. A family of enzymes are now known to produce NO in the body,
collectively called Nitric Oxide Synthase (NOS). The chemistry of this interesting
molecule, its reactivity, its roles in the body and prospective applications of NO will
all be examined.
1.2.2 Nomenclature, structure, properties and reactions of NO
Nitric oxide is the common name for the molecule that is being introduced however,
IUPAC gives it the name nitrogen monoxide. NO has an unpaired electron in its
valence shell and this means it is classed as a radical. For this reason it is a reactive
species. The molecular orbital diagram of NO shown in figure 1.11 illustrates this
unpaired electron and its position in the * (anti-bonding) orbital. As can be seen NO
contains eleven valence electrons, five come from the nitrogen atom and six from the
oxygen atom. This means that there are three electrons in anti-bonding orbitals and
eight in bonding orbitals. Consequently, there is an excess of five bonding electrons
(2.5 bonding pairs or bond order) and this gives the bond a partially double, partially
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triple nature120. As a result, the bond length in NO is 1.15Å, which is in between the
triply bonded NO+ (1.06Å) and the length of an O2 double bond (1.2Å). As already
explained due to its unpaired electron NO is a radical and would normally be
expected to dimerise. This would eliminate the unpaired electrons by forming a N-N
bond, however this process involves a loss of entropy and does not occur. However,
it should be noted that in its liquid and solid state dimerisation does occur, although
they are joined side on rather than end to end. It has been shown that the unpaired
electron is only near the nitrogen atom 60% of the time and this delocalisation
contributes to the lack of reactivity in NO.
Figure 1.11 Ground state molecular orbital diagram of NO.
This lower than expected reactivity does not, however, mean that NO does not
spontaneously react. For example, the Gibbs free energy of the decomposition
reactions of NO are all negative. This does not take into account the activation
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energy which is high and the rate of reaction which is slow for these reactions and
therefore a cylinder of NO could stand alone for weeks before any of these reactions
would occur. However, if left for long enough contamination with N2, O2, N2O and
NO2 would result.
1.2.3 The oxides of nitrogen and chemical reactivity
NO reacts readily with oxygen to form the brown gas known as nitrogen dioxide
(NO2). This means that when NO forms in the atmosphere it is a mixture of NO and
NO2. The formation of NO in our environment occurs mostly from combustion
engines, but also a small percentage comes from lightning strikes. From these
sources a mixture is produced (mentioned above) known as NOx. It is this mixture
which is directly responsible for the photochemical smog that famously appeared
above Los Angeles in the 1950s. Measures were then taken to remove the NOx
emissions from exhausts using catalytic converters. Another problem caused by the
NOx mixture occurs when it reacts with water in the atmosphere to form nitrous and
nitric acids which contribute to the “acid” rain that damages buildings and can harm
the wildlife in lakes and rivers. There is a whole series of oxides defined by the
increasing valency of the nitrogen. These vary from the well known N2O (also
known as laughing gas) used in anaesthetics, to the unstable NO3 (or N2O6). Some of
these oxides react with water to form acids (the oxides are the anhydrides of acids)
i.e. N2O5 is the anhydride of nitric acid and N2O3 is the anhydride of the weaker
nitrous acid. Thus it would be sensible to assume an acid – anhydride relationship for
NO. It was thought that NO might be the anhydride of the weak acid H2N2O3,
however no relationship exists. This relationship was also thought to exist with the
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rare hydronitrous acid (H2NO2) because, in theory it could be formed from the
reaction of NO and water. Studies have shown, however, that nitric oxide undergoes
no hydrolysis in an aqueous environment. This lack of reaction with water is
essential for the use of NO in the body. It can be generated in a cell, released into the
aqueous environment between the cells and diffuse unchanged until it reaches a cell
membrane, provided there is no oxygen present. Membranes of cells are constructed
from non-polar lipids which allow the small hydrophobic NO molecule through to
interact with the enzymes in a neighbouring cell. The sparing solubility of NO in
water (1.7 x 10-3 mol L-1 in normal conditions) is comparable with that of oxygen
and nitrogen as they do not have the large dipole moment required for solution in a
polar substrate like water. In an aqueous environment, NO readily reacts with oxygen
to form nitrites, which are then easily oxidised to nitrates. One of the reasons why
NO is so useful is its ability to be both easily oxidised and easily reduced. For
example, if its unpaired electron is removed the nitrosonium ion (NO+) is formed.
NO+ is isoelectronic with carbon monoxide (CO) and also involves the same strong
triple bond that is present in CO. The nitrosonium ion is useful in forming ionic salts
like NO+BF4-, which in water are rapidly hydrolysed to form nitrous acid. A more
interesting use for the nitrosonium ion is in biologically important reactions
involving the transfer of an NO+ group from a nitrosothiol to a secondary thiol (see
equation 1.1).
RSNO + R’S- RS- + R’SNO (1.1)
Where R and R’ are organic groups.
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A single electron reduction of NO gives the nitroxide ion NO-. Studies have shown
that there is yet no known biological role for the nitroxide ion in the body. However,
it is used in reactions that seem to be biologically significant, for example in altering
thiols and also binding to iron in haemoglobin. NO very rapidly reacts with natural
compounds which make detecting it in aqueous biological media very difficult. For
example, our immune system produces both NO and superoxide (O2-). These two
molecules react together to give peroxynitrites (equation 1.2) which are toxic and can
lead to cell death and this is how NO kills bacteria. Other examples include NO
binding to metal centres in complexes etc (i.e. the iron in the sodium nitroprusside
complex Na2[Fe(CN)5NO] which is useful in the treatment of cardiovascular
dysfunction121). As mentioned previously, it can form nitrosothiols from thiols and
these can be used as a storage facility for NO in the body. They may also be used in
drugs specifically for the production of NO in the body for patients whose own
natural production is low122-124. However, research for this is still in the preliminary
stages.
NO + O2- O=N-O-O- (1.2)
The natural production of NO in mammals involves the conversion of L-arginine to
L-citrulline using enzymes known as Nitric Oxide Synthase (NOS).
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1.2.4 NO in the body and NOS
Enzymes are responsible for nearly all chemical reactions occurring in living things.
They are used to increase the rate of reaction to a significant level, however in
general they only ever catalyse one reaction and their substrate selectivity is very
high. As stated above the family of enzymes responsible for the natural production of
NO in the body are the NOSs. The production of NO requires two substrates. The
nitrogen providing substrate is L-arginine (a natural amino acid) and the oxygen
donating substrate is oxygen gas. An overview of the reaction is shown in figure
1.12. A more detailed mechanism will be illustrated later in this chapter. There are
three main family members of NOS, which are eNOS, iNOS and nNOS: again more
detail of each synthase will be given later. It is noticeable though that the enzymes
are self sufficient as they do not need any other enzymes to be able to produce NO.
Figure 1.12 An overview of the production of NO from arginine and oxygen
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The conversion of L-arginine to L-citrulline is a complex one and requires the use of
several cofactors, Nicotinamide Adenine Dinucleotide Phosphate (NADPH), Flavin
Mononucleotide (FMN), Flavin Adenine Dinucleotide (FAD) and
tetrahydrobiopterin (BH4). An understanding of the structure of NOS is required
before a more detailed look at the mechanism of the conversion is undertaken. The
NOS enzyme is split into two domains. The oxygenase domain contains the cofactors
BH4 and an iron protoporphyrin IX (PPIX, haem) and receives the electrons to
permit the change of arginine and oxygen into citrulline and NO. The reductase
domain contains the other cofactors FMN and FAD. Once electrons have been
donated from the transformation of NADPH into NADP+ and H+, they then are
passed on to the haem cofactor in the oxygenase domain. The domains are linked via
a sequence involving Calmodulin (Ca2+), which allows the transport of electrons
between them and also FAD and FMN without which it would be impossible to
produce NO in the body125. The NOS structure has been compared to a baseball
catcher’s glove126 with the iron haem component being the part where your palm sits.
The hydrophobic regions are folded which creates a tunnel through which the BH4
can access and bind to the haem part of the oxygenase domain.
Following discussion of the structure of NOS, it is easier to describe the mechanism
in which NO is produced from L-arginine. When required, NO is produced in the
following way. NADPH found in the reductase domain of NOS is oxidised to form
NADP+ and H+. This means that there are two free electrons which react with the
flavins (FMN and FAD). The responsibility of these flavins is to separate the two
electrons for transfer to the oxygenase domain at the appropriate time. This is where
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the Calmodulin (CaM) is used to improve the flow of these electrons. As there is a
flow of electrons from one NOS monomer in one domain to another NOS monomer
in the other domain there is a requirement for dimerization of the enzyme to ensure
full NOS activity127. One of these free electrons then reacts with the iron haem
centre, which causes a valence charge on the iron cation. Following this, molecular
oxygen reacts with the ferrous haem centre. Another electron then attacks, and the
combination of these two attacks leaves a very reactive species which then itself
attacks the L-arginine. This produces hydroxyarginine and a molecule of water
leaving the iron centre ferric again and thus completing the first of two
monooxygenations128 required to produce NO. For the second monooxygenation,
another electron attacks the ferric centre and molecular oxygen to form a tetrahedral
intermediate which is unstable and quickly collapses to form the L-citrulline and
produces NO and water. BH4 is required for this second step in order to maintain the
dimer structure. A more detailed mechanism is shown in figure 1.13.
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Figure 1.13 A more detailed look at the mechanism for the conversion of L-arginine into
L-citrulline and NO9.
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1.2.5 Different types of NOS
As mentioned previously, there are three different types of NOS. These are detailed
below, the name refers to where they are most commonly found in the body.
 eNOS (endothelial NOS) is responsible for generating NO in the endothelium.
The endothelium is the layer of cells which line the walls of blood vessels. eNOS
can however also be found in the kidneys, heart and brain. It is the principle NOS
used for regulating the vascular function.
 iNOS (inducible NOS) is part of macrophage cells (scavenger cells that make up
part of the immune system, and guard against unfriendly microbes). It is also
found in the cardiovascular system.
 nNOS (neural NOS) is found in brain cell responsible for cell communication
and has a role in forming memory and learning. There is also an nNOS variant
called mitochondrial NOS (mtNOS) which is calcium dependent and has been
identified to play an important role in respiration function.
As mentioned before, the structures of all three synthases are very similar. The main
differences are in their responses to the concentration of calcium ions (Ca2+) within
the cell. eNOS and nNOS differ from iNOS in that when calcium ion levels rise
nNOS and eNOS are activated. iNOS appears to be insensitive to calcium levels.
Calmodulin is associated with all three forms of NOS and is a calcium binding
protein, linking both domains in the NOS and allowing the flow of electrons between
the two. A calcium ion rise allows the Ca2+/calmodulin complex to bind strongly to
eNOS and nNOS, activates the enzyme and so NO is produced. However, in iNOS,
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the calmodulin complex is already strongly bound and therefore does not depend on
the calcium ion levels for activation. The activation for iNOS occurs when an
unfriendly agent invades the body and NO is required to eliminate any threat. The
gene for the production of iNOS is activated and once the agents are destroyed the
iNOS disappears. This is different to eNOS and nNOS again, as at any point in time
there is a large quantity of each lying dormant in the endothelial and neuronal tissue
respectively, whereas there is very little iNOS until it is required.
1.2.6 An overview of the biological roles of NO in the body
As NO is a very small highly reactive species, it can diffuse very easily in the body.
Its impact on the body is therefore dependent upon the concentration of NO produced
and where its production occurs. It is also true to say that the NO requirement is a
delicate balance as too little or too much can lead to life threatening diseases and can
even be fatal. A table illustrating some of these diseases relative to the NO
concentration can be seen in figure 1.14.
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Figure 1.14 Diseases related to insufficient or excess NO in the body.
NO is very useful in the brain as it helps in memory function129, however too much is
very dangerous. A stroke occurs when there is a restriction in blood flow to the brain,
possibly due to a blood clot or atherosclerosis (when arteries fur up). Initial damage
to the brain is caused by the release of excessive amounts of glutamate (a
neurotransmitter) and not by oxygen starvation. This excess results in over
stimulation of NDMA and produces a large flow of calcium ions into the
postsynaptic neurone, and as already stated, calcium ions stimulate the arginine
conversion into citrulline producing NO. Oxygen will finally arrive again in the brain
once the blockage has been removed, however this leads to the production of radicals
such as superoxide which is readily oxidised to destructive peroxynitrite. This means
neural damage can result from both a stroke and reoxygeneration.
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1.2.7 The role of NO in the cardiovascular system.
Before discussing the skin and NO it is necessary to give an overview of blood
vessels. The vessels that carry blood around the body have the ability to enlarge or
contract, depending on how much blood is required for different tissues or organs.
Blood vessels have three main parts. (figure 1.15). The lumen is where the blood
flows, on the inside of the lumen is a layer of cells known as the endothelium and
finally the wall of the vessel consists mainly of smooth muscle. When the smooth
muscle relaxes the lumen enlarges and allows more blood to flow and vice versa.
Figure 1.15 Diagram illustrating the main components of a human blood vessel.
When a blood vessel is damaged there is an extremely efficient repair mechanism in
place to help and if it were not for this a person would simply bleed to death. The
mechanism employed depends on the size of the vessel that is affected. A very small
arterial wound is readily dealt with using a sheath of smooth muscle to close the
lumen and restrict blood flow to the affected area. This results in opposing
muscle layer
endothelium
lumen
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endothelial surfaces being pressed together and sticking to each other sealing off the
vessel permanently. Obviously with larger vessels permanent closure is not viable
and loss of blood is stopped with a mechanism involving platelets. Platelets are
fragments of cells that circulate around in blood, they are 2 µm in diameter and in
healthy blood there are 250 million platelets in each millilitre. When the
endothelium is damaged these blood platelets adhere to the exposed surface and
facilitate the production of more platelets and this process (termed platelet
aggregation) continues until a platelet plug is formed. This obviously prevents
bleeding, however if platelet aggregation were to continue then a clot or thrombus
would form. This can be dangerous and sometimes fatal and so there is a chemical
agent called prostaglandin I2 (PGI2) responsible for removing the plug. The first part
of the NO story was its discovery as the EDRF (endothelium-derived relaxing
factor)130 which allows the vascular muscle to relax permitting arterial dilation and
preventing platelet aggregation. NO prevents platelet aggregation in a similar way to
smooth muscle relaxation as platelets contain guanylate cyclase and NO activates
this enzyme to form cGMP from GTP which inhibits platelet aggregation. Therefore
if a clot or thrombus occurs when it is not required, new drugs containing NO may be
administered. When the endothelium is damaged macrophages also move to the
affected site and die after ingesting the oxidised lipids available. A lipid core is then
left on the inside of the lumen. This is one step in the complex process called stenosis
which, if it continues, can cause a severe narrowing of the artery. NO also prevents
stenosis by removing oxygen based radicals, forming nitrates instead, and also
prevents macrophages adhering to the affected site. Nonetheless, stenosis does occur
mostly in the arteries close to the heart and one treatment is the use of a stent which
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enlarges the artery, but can sometimes damage the endothelium resulting in thrombus
formation. There is currently research into coating stents and other medical devices
with NO releasing materials to prevent thrombus formation. More will be discussed
about this below.
1.2.8 NO in the skin
The skin is the largest organ in the human body. It gives protection from extremes of
temperature along with UV radiation from the sun and is the first defence against
germs. It consists of two layers; the outer dermis and the inner dermis (figure 1.16).
Keratinocytes form at the base of the epidermis and gradually make their way to the
surface over two weeks before becoming dehydrated and flattened, and eventually
shed altogether. Also located at the base of the epidermis are the melanocytes which
produce the pigment melanin which protects the keratinocytes. Also, part of the
dermis, although not shown in figure 1.16, are fibroblasts, structural protein
(collagen), blood vessels, nerves, sweat glands, hair roots and muscles. When
stimulated, keratinocytes produce NO and hydrogen peroxide. Both are useful in
limiting the numbers of bacteria present on the skin’s surface and trying to enter the
body via a cut or abrasion. It should come as no surprise that the skin protects as it
contains sources of NO. The skin could really be considered part of the immune
system and therefore when attacked it is iNOS that produces the required NO.
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Figure 1.16 A section of the epidermis in human skin3.
1.2.9 Drugs and therapies that utilise NO
Doctors have been prescribing drugs that utilise nitric oxide for years, although it
was not until 1987 when NO’s full biological significance was discovered. The best
example still remains glyceryl trinitrate (GTN, figure 1.17). The use of GTN as a
treatment for the symptoms of angina pectoris was finally confirmed by William
Murrell in 1879131, however people had already experienced the effects of GTN
before this. Indeed GTN is still to this day the most effective treatment of angina.
The mechanism for the production of NO from GTN is still unclear but it involves an
enzyme metabolism. GTN also has uses in treating thrombosis. This class of organic-
nitrates do however have their drawbacks and side-effects reported include
headaches and dizziness132.
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Figure 1.17 Glyceryl trinitrate.
There are also therapies available that spontaneously produce NO in the body. The
use of NO gas is still used only rarely because of the obvious danger of its toxicity. It
does however have use in the treatment of infants with respiratory failure, though
with mixed and contradictory results133-135. A family of compounds known as
diazeniumdiolates also produce NO spontaneously97,136-138. Also called NONOates
because of their structure (R1R2NN(O)=NOR3), they are produced using secondary
amines. There are a number of ways in which diazeniumdiolates can be used to
release NO. All of which involve the use of polymers to encase the diazeniumdiolate
and allow them to release NO without also releasing dangerous precursors that can
lead to carcinogens being formed in the body. NONOates can be used as vascular
grafts, clinical sensors or even have use in the procedure known as Extracorpeal
membrane oxygenation circuits (ECMO). This is where the patient’s lungs are not
functioning properly and their blood has to be pumped through an oxygenation
chamber.
S-nitrosothiols when used as NO donor drugs break down to form NO and,
depending on the nature of the S-nitrosothiol, a disulphide may also result (see
equation 1.3)138. Some nitrosothiols occur naturally in the body while others have
been made in the laboratory. It is believed that S-nitrosothiols in the body act as a
ONO2
ONO2
ONO2
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storage facility for NO and allow it to be released when necessary. However, it is still
not known how S-nitrosothiols are formed in vivo (as the reaction of NO with a thiol
doesn’t produce a S-nitrosothiol) or how NO is released when necessary.
2RSNO RSSR + 2NO (1.3)
It is the presence of copper that decomposes S-nitrosothiols, especially the use of
Cu+ ions which are formed by the reduction of Cu2+ ions by thiols. There are two
other methods used to release NO from S-nitrosothiols, firstly using an ascorbate
with the nitrosothiol to release NO. The other method involves the use of light in a
homolytic reaction to remove NO. S-nitrosothiols are potentially useful as medical
coatings to aid in the prevention of restenosis and angioplasty along with the
inhibition of platelet aggregation. Research into the use of medical coatings involved
the use of both diazemiumdiolates and nitrosothiols being inserted into polymers139-
143.
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1.2.10 Wound healing and current research involving NO
After an injury wound healing is required to keep the integrity of the body intact. It is
a complicated process involving a sequential number of events. Figure 1.18 shows
the concentration of NO in the area affected by the injury over time144. In the early
part of wound healing iNOS is synthesised by inflammatory cells (macrophages).
NO (released through iNOS) regulates the formation of collagen and wound
contraction and therefore is essential in wound repair.
Figure 1.18 Concentration of NO in affected area over time, showing the huge increase in NO
after initial clotting to ensure no infection occurs. Image adapted from reference 141.
It has also been shown that NO has a functional role in wound healing. For example,
feeding humans on an arginine (the precursor to NO) enriched diet improves wound
healing (measured by collagen deposition) and when rats are fed an arginine free diet
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their wound repair is impaired145-147. Therefore, there is current research into utilising
NO releasing materials to aid in wound healing. This takes a several forms and one
idea is using NO gas topically applied to the skin. Another is to use NO releasing
creams on the skin, and the final idea is to use dressings or plasters that will release
NO in a controlled manner. Before discussing new NO releasing materials, mention
must be made of other current wound healing promoters. The best example is the
recent use of silver compounds in dressing which have improved wound repair times.
Wright, Lam and Burrel148 have reported the use of silver in a variety of delivery
methods and found that the use of silver in dressings reduces the number of wound
impairing bacteria on the skin during wound repair. However, the effects of silver on
wounds are disputed and have been shown to cause delayed wound healing and even
harm by Burd et al149.
Using NO gas topically applied to the body is an idea used by Miller et al150 in
treating non-healing leg ulcers with success in their case study, though they admit
more research is required. Also the use of gaseous NO has been applied to wounds
on rats by Shekter et al96. Indeed “Plason” gas has been used to good effect in the
treatment of many different types of wounds96,151. However, as with gaseous NO in
the treatment of infants care must be taken to ensure the gas is extremely pure
otherwise NO2 could be administered instead. Another drawback is the difficulty in
handling gaseous NO.
The second method of NO delivery to wounds is by using a cream. Weller et al152
have demonstrated the use of an acidified nitrate cream in the treatment of tinea
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pedis with success and again Weller and Finnen have demonstrated that an acidified
nitrate cream improves wound healing time in normal and diabetic mice153. However,
there is also evidence available which shows that using acified nitrate creams
produces inflammation and scarring. Omerod et al99 have shown that the use of such
creams increases cytotoxic effects along with producing inflammation of the skin.
The final method of delivery of NO to an exposed wound is by using dressings or
plasters within which a framework containing NO is present. There are many such
frameworks that are currently being investigated. As mentioned previously,
Wheatley et al100 have successfully synthesised zeolite-A and investigated its NO
storage capacity and its release. MOFs have already been found to give pores large
enough to accommodate NO. Xiao et al72 have investigated both the NO and
hydrogen storage and releaseability of HKUST-1, a copper benzene tricarboxylate
MOF. The area of storage and release of NO from MOFs is of significant interest for
a number of possible applications.
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2 Aims of this Project
The overall objective of this thesis was to investigate the storage and release of nitric
oxide (NO) from a series of porous materials known as metal-organic frameworks
(MOFs). As NO has been shown to play a significant role in the human anatomy, in
particular its beneficial effects in wound healing were of interest1-7. Currently there
are no known NO donor materials that controllably release pure NO when triggered
except the recently developed NO releasing zeolites8-11. The aim of this project was
to synthesise MOFs which could store and release biologically significant amounts of
NO for possible use in medicinal applications.
The first major objective was the synthesis of MOF materials containing
coordinatively unsaturated metal sites (CUSs) once activated. Following successful
synthesis, characterisation techniques would be employed to show that the material
produced matched the expected MOF.
The next major objective was to study the amount of NO that different MOFs can
adsorb, and more importantly, controllably release with time. MOFs were chosen on
the basis that comparisons could be made between different metals and their affinity
for NO. Also different structure types were investigated to see if surface area has a
bearing on NO adsorption. Further experiments were carried out using samples
kindly donated from different sources, including some that contained diamines which
had been grafted onto the CUSs present in the framework hoping to achieve higher
adsorption and release of NO.
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Finally, the MOFs that did show promise for NO adsorption and release were tested
in a variety of formulations for potential use in medicinal applications. If a good NO
donor MOF has been found, it would be considered for commercialisation.
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3 Experimental Techniques
3.1 Hydrothermal Synthesis
The vast majority of MOFs are synthesised using hydrothermal synthesis. This
technique involves calculated amounts of reactants being combined with appropriate
solvents and homogenised. This reaction mixture is then placed in a
polytetrafluoroethylene (Teflon) lined acid digestion bomb (autoclave) and heated
for a pre-determined period of time. The product is then recovered from the liner,
vacuum filtered and washed with parent solvent before being dried. The nature of the
material obtained can depend on many variables such as concentration, solvent,
temperature and even the reaction vessel itself. Indeed it is sometimes difficult to
reproduce products and high throughput studies are required to show what the
conditions required for production of certain phases are, even although these
methods can suffer from inconsistent results1-2.
3.2 Microwave Synthesis
Microwave-assisted synthesis is a field of synthesis which has only really come to
the fore in the last 20 years or so. It allows reactions that would normally take hours
or even days to be run in a matter of minutes or seconds. The first reported use of
microwave assisted synthesis was in 19863-4. However since then there have been
huge advances in the field and as of 2007 there are now well over 3500 publications
describing the use of microwave synthesis. The majority of these publications
concern organic synthesis and the term microwave assisted organic synthesis
(MAOS) is now well known. However, in recent years there have been a number of
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publications concerning the microwave production of MOFs5-11. Most of these
publications report shortened reaction times for the production of MOFs, synthesis of
more crystalline versions of MOFs or in some cases the production of entirely new
phases. Reactions can also be optimised by using microwave initiators which are
now fitted with the ability to control the many variables of a reaction, such as time,
temperature and pressure. So both yields and reaction conditions can be optimised as
well as the ability to scale reactions up. Microwave synthesis can also remove
unwanted side effects that are sometimes observed with conventional solvothermal
synthesis, with uncertainty over exact reaction temperature and pressure. Factors
which, as already stated can be easily controlled by modern initiators, such as the
Biotage Initiator Eight12 pictured (figure 3.1) and used in all microwave experiments
reported in this thesis.
Figure 3.1 The Biotage Initiator Eight12 used for all microwave experiments mentioned.
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3.3 X-ray Diffraction
3.3.1 Background and theory
In a perfect crystalline solid, identical motifs are arranged in repeating units which
produce a highly ordered structure. The regular repeating motif present in such
systems is known as the unit cell of the structure. When X-ray diffraction is
employed it allows chemists to understand the structural properties of the material in
question. For example, inter and intra molecular distances and the arrangement of
atoms in the unit cell can be deduced as well as the unit cell parameters. Diffraction
of the X-rays by the crystal only takes place if the radiation wavelength is of the
same magnitude as the object separation. This means that X-rays are well suited for
the investigation of atom positions as the wavelength of X-rays (~1Å) and the
interatomic distances are very similar. This diffraction is described by Bragg’s Law
(3.1).
 sin2dn  (3.1)
This law gives the conditions by which a diffracted beam can be observed. Bragg’s
law can be easily derived using figure 3.2.
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Figure 3.2 Derivation of Bragg’s law showing the reflection of X-rays from two lattice planes.
When the in-phase X-rays strike the top layer, the top beam is diffracted by the atom
on the top layer, the second beam continues through to the bottom layer and is
diffracted by the atom on the bottom layer. The second beam has travelled the extra
distance AB+BC = 2dsinθ if the two beams are to continue travelling in parallel. This 
extra distance is known as the path difference. The path difference must be equal to
an integral multiple (n) of the wavelength (λ) for both beams to be the same. This 
results in Bragg’s law being satisfied for constructive interference. When X-rays
enter the crystal the lattice planes diffract the incoming X-rays only producing
constructive interference if Bragg’s law is satisfied. These planes can be described by
Miller indices (or planes) and are represented by three integers (hkl). Examples of
Miller planes can be seen in figure 3.3.
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Figure 3.3 Examples of Miller planes. The orange line represents the (010) plane where the b
axis is intercepted once but both the a and c axis are never crossed. The blue line represents the
(110) plane where the a and b axis are intercepted once but never intercepts the c axis.
3.3.2 Powder X-ray diffraction
Powder X-ray diffraction is a very powerful tool in the characterisation of solids. It
examines the bulk material and can be used to very quickly establish the crystallinity
of a sample. Where single crystal X-ray diffraction gives single diffraction spots,
powder X-ray diffraction gives thousands of diffraction spots forming a ring as can
be seen in figure 3.3. This is due to the varying orientations of the crystals in the bulk
sample being examined. The blue line through the circle represents what would be
observed in a powder X-ray diffraction pattern, where the detector cuts through the
rings as shown.
a
b
a
b
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Figure 3.3 Examples showing the difference between single crystal (left) and powder X-ray
diffraction (right). The large number of random orientations form rings and a normal
experimental X-ray powder diffraction can be viewed by slicing the rings (blue line). 2θ is 
increasing from the centre of the rings outwards.
3.3.3 Phase identification using X-ray diffraction
In this work powder X-ray diffraction has been used as a characterisation tool for
checking that the materials produced match those already published in the literature.
This has been carried out by comparing the X-ray powder diffraction patterns with
theoretical patterns produced using the Diamond 3 crystal visualisation software13.
The unit cell parameters, space group and atomic coordinates of the published
structure are input into the program which then produces a theoretical pattern which
can then be compared with the experimental data. This process can also be carried
out using an existing cif file as an input. An example can be seen below for Co CPO-
27.
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Figure 3.4 Experimental X-ray powder pattern (top) compared with the theoretical one
(bottom) for Co CPO-27.
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3.3.4 Equipment used for powder X-ray diffraction
In this thesis powder X-ray measurements were carried out using either a STOE
STADIP diffractometer using monochromated Cu Kα1 radiation or on a Phillips
XPERT data collector. Although both produce very similar outputs the machinery
works in a different manner. The STOE diffractometer consists of an X-ray source, a
moveable sample platform, an X-ray detector and associated computer software and
electronics. A sample is placed in a sample holder (a sample can either be in a
capillary that is spun or can be in a pre-prepared disc). The sample holder is then
spun to ensure that all orientations of the crystals in the powder are examined. The
beam of X-rays is fixed and the platform rotates at an angle theta with respect to the
beam. The detector rotates at twice the rate of the sample being analysed and
therefore is at an angle of 2θ with respect to the X-ray beam. This is known as 
transmission mode. The Phillips diffractometer works in reflection mode and has the
sample on a plate with the detector on a moving arm and the plate remaining
stationary. The X-rays are reflected off the surface. Photos of the powder X-ray
equipment can be seen below (figure 3.5).
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Figure 3.5 The powder X-ray diffractometer setups used in this work; (a) shows the capillary
(transmission) setup with appropriate labels and (b) displays the flat plate (reflection) setup
with appropriate labels. The red arrow in each case illustrates the direction of the X-ray beam.
3.3.5 Rietveld refinements
As a structural model for all of the MOFs synthesised in this thesis is available, it is
possible to refine a structural model against an observed experimental powder pattern
using a Rietveld refinement. The refining process uses the GSAS program suite14.
The refinement is carried out by minimising the residual Rwp using a least squares
procedure, where yio and yic are the observed and calculated intensities and setting wi
is set to be equal to a suitable weight at the ith step giving equation 3.2.
2
  icioiwp yywR (3.2)
Using this least squares method, the difference between yobs and ycalc is minimised.
Firstly the diffractometer zero point, background shape and peak shape are refined.
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Once a reasonable model is established then other parameters are refined such as the
unit cell, x,y,z coordinates and site occupancies. The quality of the refinement model
can then be seen from the use of weighted residual factors Rwp (3.3) and goodness of
fit χ2 (3.4). A powder pattern is then expressed in terms of yobs and the intensity is
compared with ycalc at a set 2θ.  
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The quality of the data can be measured and is represented by Rexp using equation
(3.5) which uses the number of profile points (N) and refined parameters (P).
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If a good refinement has been carried out the value of Rwp should approach that of
Rexp and this can be seen from the goodness of fit value represented by χ2.
Rietveld refinements have been used on powder diffraction data in this thesis to
establish the exact location of the NO molecule in the pores of M-CPO-27. An
example of the output from GSAS can be seen in figure 3.6.
Figure 3.6 An example GSAS output illustrating the differences between the calculated pattern
and the experimental one. The red graph shows the measured pattern, the black graph is the
calculated pattern and the blue line shows the differences between the two (Rwp).
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3.4 Surface area and porosity measurements
3.3.1 Introduction
One of the most crucial parts in the characterisation of MOFs is surface area analysis.
This technique has been thrust into the limelight in recent years due to the increasing
advancement of MOFs, and indeed MOFs have recently been synthesised with
surface areas exceeding 6000 m2g-1. Gas adsorption in all porous solids is a very
complex phenomenon. It involves mass and energy interaction and possible phase
changes. There are many theories concerned with describing the behaviour of
interactions between gas and solid and the most commonly used theories will be
discussed later in this section. It is now common practice to measure the surface area
of any newly produced MOF (or any porous material). Not only can surface areas of
porous materials be measured, it is also possible to calculate pore volume and pore
size distribution. Gas adsorption is always carried out at a constant temperature with
the pressure being variable. There are two methods by which gas adsorption
isotherms are measured. The first involves volumetric adsorption. Pressure
measurements are taken before and after the data point in question. The difference
forms the adsorption isotherm. This method is used in all N2 adsorption isotherms.
The second type of adsorption is gravimetric adsorption. In this type the sample’s
mass is constantly monitored and the adsorbate pressure is gradually increased, with
increases in mass being used to form the adsorption isotherm of sample mass versus
pressure. This is the method used in the NO adsorption isotherms as discussed later
in this chapter.
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Adsorption isotherms are plotted as an equivalent volume at standard pressure (either
as a true volume, mass or moles per gram of material) against the equilibrium
pressure (P/P0) at constant temperature. There are six types of adsorption isotherm
that are known for porous materials (see figure 3.7) from IUPAC definitions. Types 1
to 5 were originally assigned by Brunauer15, whereas type 6 is a relatively recent
addition16.
Figure 3.7 The six basic types of adsorption according to the Brunauer classification. The red
lines indicate the desorption arm of the isotherm.
Type I isotherms (also known as Langmuir isotherms) are typically seen with
microporous solids and are noted for the rapid rise in the volume adsorbed at low
pressure. This initial rise indicates monolayer deposition of molecules in the pores.
The long plateau section is governed by the total pore volume and is interpreted as
gradual filling of the micropores. Occasionally there is a rise at high partial pressure,
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which can be attributed to multilayer coverage of the external surface of the pores
(see figure 3.8).
Figure 3.8 - Experimental N2 adsorption isotherm carried out at 77K for Ni CPO-27 (a
microporous MOF), showing type I isotherm shape and a second rise indicative of multilayer
coverage of external surfaces.
Type II and IV isotherms are characteristic of either nonporous materials or porous
materials with relatively large pores (a good example is mesoporous materials). Type
III and V isotherms arise when the adsorptive molecules have more affinity for each
other than they do for the solid. Type VI isotherms are encountered very rarely and
indicate a nonporous material with an almost completely uniform surface16-17.
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3.3.2 Determination of surface area and porosity
There are now several theories which can be used to determine the surface area of a
material. For microporous materials, the two most commonly used are the BET
equation and the Langmuir equation.
3.3.2.1 Langmuir Theory
Langmuir developed his theory of adsorption and surface area between 1916 and
191818-20. It should be stated that the Langmuir theory more correctly applies to
chemisorption situations and not physical adsorption, due to the fact that its first
assumption states that gases will only form one monolayer on a material. The
collision of a gas molecule with the surface is assumed to be inelastic (meaning that
the gas molecule remains in contact with the surface for a time before returning to
the gas phase). It is this delay in time which is responsible for adsorption. The initial
equation (3.6) relates the rate at which molecules strike the surface to the rate at
which they leave.
bP
bPVV ma


1 (3.6)
Here Va is the quantity of gas adsorbed at a pressure P. Vm is the quantity of gas
adsorbed to produce monolayer coverage of the solid and b is a constant. If this
equation is re-arranged to the linear form (see equation 3.7) and values of P/Va are
plotted against P, a straight line should be observed. In fact when using liquid
nitrogen temperatures and using nitrogen as the gas to be adsorbed, some sets of data
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plot straight lines only in certain regions. This still allows b and Vm to be calculated
from the slope and intercept.
mma V
P
bVV
P

1
(3.7)
Therefore the specific surface area s of the material (the area contained in 1g) can be
calculated from Vm using equation 3.8.
o
Am
mV
NVs 
(3.8)
Here σ is the surface area occupied by a single adsorbed gas molecule (for nitrogen
σ = 16.2 Å2 or 16.2 x 10 -20 m2), NA is the Avogadro constant (6.023 x 1023
molecules/mole), m is the mass of the adsorbing sample and Vo the molar volume of
the gas (22414 cm3). As all the surface measurements used N2 as the adsorptive gas
the surface area can be calculated using equation 3.8 arranged as follows.
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3.3.2.2 BET Theory
Brunauer, Emmett and Teller produced an improved version of Langmuir’s theory by
incorporating the concept of multilayer adsorption. It is now known as the BET
theory taken from the surnames of the founders21. The main assumption is that the
forces responsible for the condensation of gases are also active in the binding energy
in multimolecular adsorption. Therefore by equating the rate of the condensation of
gas onto an already covered surface to the rate of evaporation from that layer and
then summing for an infinite number of layers, equation 3.10 can be derived.




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


0
0 )1(1)( P
PCPP
CPVV ma (3.10)
Here C is a constant, P0 is the saturation pressure of the gas and all the other terms
are the same as stated previously. The value of the constant C is as follows:
RT
qqC L 1exp (3.11)
Where q1 is the heat of adsorption of the first layer of gas molecules, qL is the heat of
the liquefaction of N2, R represents the gas constant and T the absolute temperature.
Again, equation 3.10 can be re-arranged into the linear form to give 3.12.
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From this it should be possible to plot P/[Va (P0-P)] vs. P/P0. A straight line should
be observed with intercept 1/VmC and slope (C-1)/VmC. The values of Vm and C can
then be calculated. Following calculation of the volume, the surface area may now be
calculated using the area occupied by a single adsorbed molecule. This can be
determined from an assumption of close packing at the surface given by the
following formula:
3/2
2/1)2(4
)866.0)(4( 








AN
M
(3.13)
σ is the mean area per molecule, M is the molecular weight, NA is Avogadro’s
number and ρ is the density of the liquid adsorbate. 
This model is best applied to multilayer adsorption in Type II adsorption isotherms
and low pressure regions of type IV isotherms. However due to the high number of
assumptions, it has been shown that BET theory is not the best at estimating surface
areas in microporous materials. For example, there are no lateral interactions
between the adsorbed species and the heats of adsorption are the same for all the
layers adsorbed. Indeed these assumptions lead the BET equation away from the
ideal Langmuir adsorption isotherm.
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3.3.2.3 Chemical adsorption (Chemisorption)
There is a distinction to be made between physical adsorption (physisorption) and
chemisorption. Physical adsorption is the result of a relatively weak interaction
between a material and the gas, and usually such interactions are formed from weak
van der Waals forces and have low heats of adsorption (not exceeding 80 kJ/mole).
During the desorption part of an experiment usually all the gas (and therefore the
interaction) is removed by vacuum. Chemisorption is a much stronger interaction,
sometimes with extremely high heats of adsorption. During the adsorption process
the adsorbing molecule forms a chemical bond with the adsorption site (in the case of
dehydrated MOFs the coordinatively unsaturated metal site (CUS)). This bond
involves the sharing of electrons and it is therefore very difficult to reverse the
desorption under vacuum. However, it is not uncommon for both chemisorption and
physisorption to occur at the same time. It is possible that once all of the available
metal sites have been used that a layer of physisorbed molecules may form on top, or
may occur at the non-active sites present in the material. Indeed as will be shown
later, in order to be useful for the stated applications, NO requires an active metal site
to bind to, otherwise poor adsorption is observed at room temperature.
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3.3.2.4 Equipment used for surface area determinations
For all nitrogen adsorption experiments (physical adsorption) a Micromeritics ASAP
2020 surface area and porosity analyser was used (see figure 3.9). Samples of mass
~100 mg were placed into pre-weighed glass sample tubes and sealed using a seal-
frit, a piece of equipment that prevents exposure to the atmosphere between the
degas and analysis steps. The sample tube is then inserted into the degas port of the
analyser, and the sample is degassed (under vacuum and exposure to temperatures
varying between 120 and 250°C for a certain time period). Once fully desolvated the
sample tube is transferred to the analysis port and the analysis part of the experiment
can begin. All experiments are carried out at 77K using a liquid nitrogen bath.
Figure 3.9 A Micromeritics ASAP 2020 Surface Area and Porosity Analyser. Degas ports are on
the left complete with heating manifolds. The analysis port is on the right with a liquid N2 bath
directly below.
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3.4 NO gas adsorption and desorption measurements
3.4.1 Adsorption/desorption experiments
Much of the research in this thesis involved the adsorption and desorption of NO.
The adsorption of NO gas was an integral part of this work and was carried out using
a gravimetric adsorption system (see figure 3.10). A CI instruments microbalance
was thermally stabilized to eliminate the effect from the external environment. The
microbalance has a sensitivity of 0.1 μg and a reproducibility of 0.01% of the load. 
The pressure of the adsorption system was monitored by two BOC Edwards Active
gauges in the ranges of 1 × 10-8 to 1 × 10-2 and 1 × 10-4 to 1 × 103 mbar, respectively.
The sample (~30 mg) was initially degassed at the required temperature (depending
on the sample’s activation temperature and stability) under 1 × 10-4 mbar, until no
further weight loss was observed. The sample temperature was then decreased to
25°C and kept constant by a circulation water bath with temperature accuracy ±0.02
K. The counterbalance temperature was kept the same as that of the sample to
minimize the influence of temperature difference on weight readings. The sample
temperature was monitored using a K type of thermocouple, located close to the
sample bucket (<5 mm). The variation in sample temperature was minimal (<0.1 K)
throughout the experiment. NO gas was introduced into the adsorption system until
the desired pressure was achieved, and the mass uptake of the sample was measured
as a function of time until the adsorption equilibrium was achieved. In this manner an
adsorption isotherm was collected by incrementally increasing the pressure and
noting the mass gain of the sample after equilibrium was reached. The desorption of
the NO gas adsorbed in the samples was performed by gradually decreasing the
system pressure to a desired value (until 2 × 10-2 mbar).
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Figure 3.10 Photograph showing the NO gravimetric adsorption system. Relevant parts of the
system are labelled appropriately.
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3.4.2 Measurement of NO release by chemiluminescence
It is possible to see from the adsorption experiments how much NO various MOFs
would adsorb both physically and chemically. However to quantify the amount of
NO that could be recovered from samples, a NO analyser was used (see figure 3.11).
The Sievers NOA 280i chemiluminescence Nitric Oxide Analyser uses a high-
sensitivity detector for measuring NO based on a gas-phase chemiluminescent
reaction between NO and ozone (O3) (see equations 1 and 2).
NO + O3 NO2* + O2 (1)
NO2* NO2 + h (2)
The emission from the excited nitrogen dioxide is in the near-infrared end of the
spectrum and is detected by a red-sensitive photomultiplier tube. The instrument was
calibrated by first passing air through a zero filter (Sievers, <1 ppb NO) and then
89.48 parts per million (PPM) NO gas (Air Products, balance nitrogen). The flow
rate was set to 200 mL/min with a cell pressure of 8.5 torr and an oxygen pressure of
6.1 psig. To measure NO release from different samples, nitrogen gas of known
humidity was passed over the powders. The resultant gas was directed into the
analyser and the concentration of NO in PPM or parts per billion (PPB) was
recorded. For the liquid-based experiments a sample vial was connected to the
instrument using tubes with needles and with the sample already inside, a pre-
determined amount of liquid was then injected into the vial and the sample stirred to
ensure good mixing.
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Figure 3.11 The Sievers NOA 280i chemiluminescence Nitric Oxide Analyser. Picture showing
the sample holder and the output from the analyser. Relevant parts are labelled appropriately
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3.5 Thermogravimetric analysis
Thermogravimetric analysis (TGA) is useful as it quantifies the loss of mass in
microporous materials with increasing temperature. The procedure involves pre-
weighing and zeroing an alumina crucible, before a small sample of material is
transferred into the crucible, which is then re-weighed. The experiment involves
heating the crucible in a controlled manner under a gaseous atmosphere (usually
nitrogen or laser air). The changes in mass are recorded and can be used to give
information about the stability of the material at certain temperatures and also when
guest solvent molecules are lost. It can also give clues about molecular formula. All
samples were analysed using a Netzsch TG 209 analyser under an air atmosphere.
An example of an experimental TGA curve can be seen in figure 3.12.
Figure 3.12 Experimental TGA curve for Ni CPO-27 (a metal organic framework) showing two
distinct mass losses. The first (50-175°C) can be attributed to solvent in the pores (in this case
water) and the second (~250°C) signals the collapse of the framework as the organic linker
decomposes.
0 100 200 300 400 500 600
20
30
40
50
60
70
80
90
100
M
as
s
(%
)
Temperature (oC)
Ni CPO-27
Chapter 3 Experimental Techniques
86
3.6 Elemental analysis
C,H,N elemental analysis gives the percentage amount of each of the aforementioned
elements found in the sample. It can yield useful data regarding organic molecules
present within frameworks. It can also be used to quantify successful solvent
exchange in a MOF. Elemental analysis was carried out using a Carlo Erba 1106
CHN elemental analyser.
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4 M-CPO-27: an isostructural series of MOFs
4.1 Background
In 2005 Dietzel and co-workers synthesised a highly crystalline MOF1 with the
formula [Co2(C8H2O6)(H2O)2]·8H2O. Dietzel was interested in running in-situ single
crystal X-ray diffraction to see if the long range order in such frameworks is
maintained even after guest solvent molecules are removed (activation). This
phenomenon is known as permanent porosity and is key for porous materials to be
useful for gas storage. The in-situ single crystal X-ray diffraction experiments
showed that the dehydrated form of this compound has an open metal site which
originally had a solvent molecule bound to it. Since this initial discovery, several
isostructural analogues have been produced including Ni2, Zn3-5, Mg6-7, Mn8 and
very recently Fe9. This MOF is also known as MOF-74 which was originally
designated to the zinc version by Yaghi and co-workers who first synthesised it.
However, to avoid confusion throughout this thesis the name M-CPO-27 will be
adopted.
4.2 Aims of chapter 4
The main aim in this chapter was to synthesise an isostructural set of MOFs which
contain coordinatively unsaturated metal sites (when activated), which it is believed
are a key requirement in the storage and delivery of significant quantities of NO.
Following successful synthesis and characterisation of the materials, NO storage and
release measurements would be undertaken. M-CPO-27 was chosen to be
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synthesised due to the isostructural nature of the frameworks, allowing comparisons
to be made between different metals and their affinity for NO.
4.3 Synthesis of M-CPO-27
In order for a complete investigation to be carried out and for comparative purposes
all the analogues of this MOF were produced for NO investigation using the
literature based synthetic methods1-2,4,6-8,10. However, an iron analogue of this
structure was produced very recently and therefore is not covered in this thesis9. M-
CPO-27 is produced in autoclaves using hydrothermal synthesis, however individual
versions use slightly different procedures. Figure 4.1 displays the various methods
which can be employed to successfully synthesise the isostructural frameworks. The
linker utilised in each case is 2,5-dihydroxyterephthalic acid (DHTP). Dietzel and co-
workers have produced almost all of the compounds using the solvent
tetrahydrofuran (THF) combined with some water. Once the heating of the
autoclaves is finished they are cooled and the resulting powder is filtered and washed
with the parent solvent and air dried. For certain analogues, solvent exchange is
required to allow enhanced activation. In the reactions involving dimethylformamide
(DMF) and ethanol, the DMF is solvent-exchanged with a solvent which has a lower
boiling point, such as methanol to allow the framework to be evacuated fully and
without destroying the pores.
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24135°Cn/aDMF/ethanol/waterMnCl2 ·4H2OMn CPO-278
24125°Cn/aDMF/ethanol/waterMg(NO3)2·6H2OMg CPO-277
72110°C1mol NaOHwater/THFMg(NO3)2·6H2OMg CPO-276
72110°C1mol NaOHwater/THFZn(NO3)2·6 H2OZn CPO-275
24100°Cn/aDMF/waterZn(NO3)2·6 H2OZn CPO-274
72110°Cn/awater/THFNi(CH3COO)2·4H2ONi CPO-272
72110°Cn/awater/THFCo(CH3COO)2·4H2OCo CPO-271
Time
(hours)
Temp
(oC)
Additional
reagents
Solvent usedMetal sourceMOFRef
Figure 4.1 Table showing the various synthetic procedures employed to form M-CPO-27.
4.4 Structure of M-CPO-27
The structure of M-CPO-27 is three dimensional and consists of one dimensional
channels, giving a honeycomb-like appearance (see figure 4.2). The metal atom is
coordinated by six oxygen atoms in a distorted octahedron. Five of the atoms
originate from the fully deprotonated organic linker and the one remaining oxygen
atom comes from a solvent molecule. In the Co, Ni, Zn and Mg versions produced by
Dietzel and co-workers this is a water molecule.
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Figure 4.2 A diagram of a section of M-CPO-27 viewed down the c-axis showing the honeycomb
appearance. It also illustrates the vacant pores and the coordinatively unsaturated metal sites
(CUSs) available once the MOF is activated.
The pores of M-CPO-27 are ~11Å wide and are filled with guest solvent molecules
(in the Co and Ni versions it is water, in others it can be a mixture of water, DMF
and ethanol). However, activation of these frameworks can yield a fully evacuated
MOF with accessible metal sites to which gases can bind. This activation process
again is different for the various analogues as some of the structures are less
thermally robust compared with the others. Figure 4.3 shows a table listing the
activation conditions used for each of the versions of M-CPO-27. The empty
channels of the partially dehydrated structure occupy 49% of the total structure. This
figure rises to 60% once all coordinated solvent molecules are also removed. The
coordination environment around the metal atom changes from a distorted
octahedron to a coordinatively unsaturated square pyramid.
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Figure 4.3 A table showing the procedures required for full activation of the different analogues
of M-CPO-27.
4.5 Characterisation of Co and Ni CPO-27
The Co and Ni versions were the first to be synthesised for this chapter. Powder X-
ray diffraction was used initially to characterise these materials and to check for
phase purity. The Phillips diffractometer was used for this process. It also allowed
the Co version to be examined using Cu radiation. On the STOE diffractometer a
large fluorescence was observed due to the differing mode of collection (reflection
versus transmission). Figure 4.4 shows the experimental powder X-ray patterns for
both Ni and Co versions of M-CPO-27. As can be observed they match very well to
each other and also the XRD patterns found in the literature. Importantly they also
match the theoretical powder X-ray pattern produced using the Co CPO-27 cif file
and Diamond 3.0 software package (see figure 4.5).
1102 (BET)solvent exchange then vacuum + 250oCMn CPO-278, 16
1905solvent exchange then vacuum + 250oCMg CPO-277
varying 150 - 1030vacuum + 250oCMg CPO-276
not reportedsolvent exchange then vacuum + 250oCZn CPO-275
245, 1132solvent exchange then vacuum + 270oCZn CPO-273, 4
1083vacuum + 150oCNi CPO-272
not reportedvacuum + 150oCCo CPO-271
Reported Langmuir
surface area (m2g-1)
Activation conditionsCompoundRef
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Figure 4.4 An experimental powder X-ray diffraction pattern for both Co and Ni CPO-27.
Figure 4.5 The theoretical powder XRD pattern for Co CPO-27, produced using the Diamond
3.0 software package.
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Following successful powder X-ray diffraction studies, thermogravimetric (TGA)
experiments were run on both Ni and Co CPO-27. The TGA curves matched the
appropriate literature very well (figure 4.6). The drop in mass observed initially
between 50 and 150°C is indicative of the removal of both the water trapped in the
pores and also the water coordinated to the metal and matches very well to the
expected value of 36% (29% uncoordinated and 7% coordinated water). This leaves
the fully dehydrated porous structure. Decomposition then occurs at 250°C.
Figure 4.6 Experimental TGA curve showing mass losses for both Co and Ni CPO-27. Both
samples lose all water trapped in the pores and attached to the metal, after heating to 150°C.
One of the fundamental characterisation techniques of MOFs is nitrogen (N2)
physisorption, as it is used to determine the porosity. This includes both surface area
measurements and determination of pore volume. There have been many
publications concerning M-CPO-27 and its gas storage properties2,7-8,11-15. The
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characterisation of the series in each case has led to differing surface area
measurement values. Ni and Co CPO-27 presented no problems with regard to their
activation and their adsorption isotherms are comparable with those stated in the
literature1-2. As can be seen in figure 4.7 both show almost ideal Langmuir behaviour
at 77K. Co CPO-27 showed a measured Langmuir surface area of 1060 m2g-1 and a
pore volume of 0.39 cm3g-1, while Ni CPO-27 showed a Langmuir surface area
measurement of 1055 m2g-1 and a pore volume of 0.40 cm3g-1. In the original paper,2
Dietzel stated that Ni CPO-27 shows a Langmuir surface area of 1083 m2g-1 and a
pore volume of 0.41 cm3g-1. These values match extremely well to the synthesised
compounds.
Figure 4.7 Experimental N2 adsorption isotherm at 77K for Co and Ni CPO-27. Both samples
show almost identical Langmuir (Type I) isotherm profiles.
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Using the above mentioned characterisation methods it can be deduced that high
quality Ni and Co CPO-27 have been successfully synthesised.
4.6 NO adsorption and release using Co and Ni CPO-27
Since originally synthesised, the CPO-27 series of MOFs have attracted significant
interest for gas storage not only due to the CUSs available when the framework is
activated but also due to their isostructural nature2,7-8,11-15. This allows comparisons
to be made between different metals and their affinity towards certain gases. As
stated in chapter 2, the main goal of this project is to investigate the affinity which
MOFs have for NO and their ability to store and release biologically significant
amounts of this gas for possible use in medical applications. Using the NO
adsorption apparatus available, several NO adsorption isotherms were measured. The
MOFs were activated, initially under high vacuum, then using a thermal treatment at
150°C. The initial vacuum activation step removes the guest molecules in the pores,
which account for a mass loss of ~29%. The thermal treatment subsequently removes
two water molecules per formula unit (a further 7% mass loss) leaving a theoretical
0.0064 mol CUSs per gram of activated material. During this activation process,
there is a noticeable and distinct colour change observable for these materials (both
turn much darker colours). The materials were then cooled to room temperature and
a water bath was used to maintain a constant temperature of 25°C. The activated
MOF sample was then exposed to NO. The results for Ni and Co CPO-27 were
remarkable. Previous NO studies on MOFs had shown HKUST-116 (a porous
benzenetricarboxylate-based MOF with open copper sites upon activation) had a NO
uptake of 3 mmolg-1. Both Ni and Co CPO-27 show NO capacities of between 6 and
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7 mmol per gram of activated MOF. This is twice as much as the previous MOF
studied and ~5 times greater than the best performing zeolite17-19. As can also be seen
from the isotherm, the desorption arm shows a very distinct hysteresis, which is
indicative of the NO binding strongly to the CUSs. The amount of NO adsorbed is
~1 NO molecule per available CUS. Therefore the maximum adsorption capacity
should be 6.4 mmolg-1 of NO, however there are extra NO molecules weakly
adsorbed (physisorbed) onto the pore walls of the MOF. The actual amount of NO
chemisorbed is 4.99 mmolg-1 for Co CPO-27 and 5.99 mmolg-1 for Ni CPO-27 which
is very close to the theoretical maximum of 6.4 mmolg-1.
Figure 4.8 NO adsorption/desorption isotherm for Ni and Co CPO-27 at 298K showing the
exceptional NO uptake of these MOFs.
This large capacity of NO storage is extremely significant, however it is only useful
for potential applications if the gas which has been stored can be recovered. In this
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case a very simple trigger is used to start the release of NO from the samples. Water
or moisture has a greater affinity for the metal in the MOF and therefore when
triggered, the NO gas should be released from the metal and replaced with water
molecules.
To investigate the releaseability of NO from pre-loaded MOFs a NO analyser was
used. The Ni and Co CPO-27 samples were placed into sealable vials, before being
activated in the same manner as mentioned above. This time a Schlenk line and
Buchi glass oven were used to produce the necessary vacuum and thermal treatments
required to fully activate the compounds. Once activated the samples were cooled to
room temperature before being exposed to 2 atmospheres (atms) of NO gas. The
activated materials show a distinct colour change when exposed to the NO. The Co
CPO-27 (already a much darker colour from the activation step) turns almost black
and Ni CPO-27 turns from yellow to a very dark green. In figure 4.9 these colour
changes can be seen. This colour change is indicative of the NO interacting with the
available CUSs.
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Figure 4.9 Photos of Ni CPO-27 (always on left) and Co CPO-27 (always on right) showing the
colour changes when samples are dehydrated and NO-loaded.
Once loaded the vials containing the NO-loaded samples are then flame sealed under
an argon atmosphere to ensure no contamination occurs. The experimental set-up for
the NO analyser has already been explained in chapter 3. Samples were exposed to a
“wet nitrogen” atmosphere (11% relative humidity) and the amount of NO released
was recorded. Release profiles for both Ni and Co CPO-27 can be seen in figure
4.10. As shown below the total amount of NO released is ~7 mmolg-1, indicating that
the entire store of NO has been released. This occurs over ~20 hours. This
observation is further evidenced by the fact that the samples placed in the analyser
sample holder gradually returned to their original hydrated colours (red for Co CPO-
27 and yellow for Ni CPO-27). This release behaviour is in complete contrast to that
which occurs in HKUST-1 where only 2 μmolg-1 is released16.
Hydrated Dehydrated NO-loaded
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Figure 4.10 Graphs showing the amount of NO released by Ni and Co CPO-27 and the time
taken.
The amount of NO released from these materials did not diminish over storage time.
Figure 4.11 shows NO release profiles for Co and Ni CPO-27 over several weeks. In
each case the amount of NO released is still between 5.75 and 7 mmolg-1. In addition
to this it is also possible to re-cycle the samples and load them again with NO. This
means there is a complete cycle of activation, storage and delivery (see figure 4.12).
This is essential for a successful gas storage material. The storage and release of NO
from Co and Ni CPO-27 is extremely significant and represents a milestone for the
use of MOFs as possible delivery vehicles of biologically active gases for medicinal
applications.
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Figure 4.11 Graph showing the release profiles of NO over several weeks of storage for Ni and
Co CPO-27.
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Figure 4.12 The required cycle of activation, loading, storage and delivery for a prospective
candidate material suitable for gas storage. The activation stage is extremely important as great
care must be taken to ensure all guest solvent molecules are removed to allow all CUSs available
for NO binding. Colour key: cyan, Ni/Co; red, oxygen; grey, carbon; pink, oxygen of
coordinated water molecules. The hydrogen atoms and uncoordinated water molecules have
been omitted for clarity.
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4.7 Rietveld refinement of NO-loaded M-CPO-27
In order to confirm that the NO gas was indeed chemically binding to the free metal
site, powder X-ray diffraction was carried out on the as-synthesised (hydrated),
dehydrated and NO-loaded Ni CPO-27. Confirmation of the NO binding to the
available metal site has also been confirmed using in-situ IR studies20. Initially, the
Co CPO-27 analogue crystal structure had been solved by Dr David Wragg using the
dehydrated structure as a base model14. The NO atoms were located using Fourier
maps and included in the refinement. The final refinement converged to Rwp =
0.0784, Rp = 0.0582 and R(F2) = 0.2166. Figure 4.13 shows a pore with the NO
loaded onto the cobalt atom. The atom positions, bond lengths and the NO binding to
the Co atoms can be seen in the enlarged view on the right. The NO is bound in a
bent fashion, a phenomenon which has already been observed in NO-loaded cobalt
zeolites21.
Figure 4.13 A view of the pore of Co CPO-27 with the NO loaded onto the free Co CUSs. On the
right is an enlarged view showing the bent nature of the NO molecule together with the bond
angle and lengths.
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Using the NO-loaded Co CPO-27 model, further calculations were carried out on Ni
CPO-27 to prove that the NO binds in a bent fashion to the nickel atom of this
framework. The NO-loaded version of Ni CPO-27 was sealed in a capillary and run
overnight on the STOE diffractometer. Following a successful run, the pattern
produced was used in the refinement process and compared with the Co analogue
result. The atom positions were kept fixed and the final refinement pattern can be
seen in figure 4.14. The NO-loaded version had values of Rwp = 0.2199, R(F2) =
0.1944 and Rp = 0.1573. The final parameters can be viewed in figure 4.15. These
values are consistent with the NO molecule binding to the open metal site in a bent
fashion as already noted in Co zeolites21 and Co-CPO-2714 and this can be seen in
figure 4.16. The quality of the diffraction is not the highest and further work is
required using a synchrotron source (single crystal diffraction) to be more definitive.
To show that the NO binds in a bent fashion, the oxygen atom was moved to form a
linear M-NO bond and the final values were as follows Rwp = 0.2759, R(F2) = 0.2815
and Rp = 0.1920 showing that the bent NO binding is most likely. To fully confirm
this, the refinement was carried out without the NO atoms and the final values were
Rwp = 0.3717, R(F2) = 0.4121 and Rp = 0.2863.
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Figure 4.14 The final Rietveld patterns for the NO-loaded version of Ni CPO-27. Top shows the
overall pattern. Bottom figure shows an enlargement of the 20° to 50° degree region.
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Figure 4.15 Table of final parameters for the NO-loaded Ni CPO-27.
Figure 4.16 A view of the Ni CPO-27 pore. On the right is an enlarged view of the coordination
of the NO to the Ni metal which is the same as in the Co version.
space group: R-3
a = b = 25.8063 (19) c = 6.7188 (13)
α = β = 90o γ = 120o
Fractional coordinates
atom x y z
Ni1 0.36687 0.04968 1.01840
C1 0.24600 -0.07060 1.07670
C2 0.20720 -0.11990 1.21360
C3 0.22180 -0.12260 1.41560
C4 0.15350 -0.16390 1.13840
H3 0.14520 -0.16180 1.00490
O1 0.29400 -0.02700 1.14750
O2 0.22830 -0.06510 0.91810
O3 0.27620 -0.08820 1.50230
N1 0.44530 0.13430 0.93000
O1N 0.50740 0.15880 0.88610
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4.8 Results on Zn, Mg and Mn CPO-27
Following the significant results obtained from Ni and Co CPO-27 showing their
exceptional storage and release properties for NO, other versions of M-CPO-27 were
subsequently synthesised. This was particularly prompted as one of the major
drawbacks of Ni and Co CPO-27 for use as delivery vehicles is that cobalt and nickel
toxicology is well known and not beneficial. However, Zn, Mg and even Mn are
much less toxic metals for humans and so a MOF composed of such metals would be
of great interest if they could perform to the same standard. The materials were
synthesised according to the methods described in the literature. In the case of Zn
and Mg CPO-27, two hydrothermal methods were used for each4-7. One required
solvent exchange of the materials prior to any porosity experiments being carried
out4,7 but the second did not require this step5,6. The materials were successfully
synthesised and characterised using powder XRD, TGA, N2 and NO adsorption and
release measurements. All XRD patterns were carried out on the STOE
diffractometer with the exception of Mn CPO-27 which displayed a large
fluorescence. In this case the Phillips diffractometer was employed.
Chapter 4 M-CPO-27: an isostructural series of MOFs
108
4.8.1 Zn CPO-27
Zn CPO-27 was originally synthesised by Yaghi and co-workers using
dimethylformamide (DMF) as the solvent in the reaction3-4. It was then solvent
exchanged with methanol (a solvent with a lower boiling point) to aid in the
activation process. Dietzel and co-workers managed to synthesise this phase, using a
similar method to that utilised in the formation of the Co and Ni analogues, only
adding base (NaOH 1 molL-1) to ensure deprotonation of the linker. A sample of this
was kindly donated by the Sintef group in Norway for investigation. Figure 4.17
shows the XRD patterns for the solvent exchanged Zn CPO-27 and as-synthesised
Sintef Zn CPO-27 (Dietzel’s sample).
Figure 4.17 Powder XRD patterns of solvent-exchanged Zn CPO-27 and
as-synthesised Sintef Zn CPO-27.
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However the TGA curves for the Zn CPO-27 samples show distinct differences
(figure 4.18). With the Sintef sample the solvent located in the pores is water,
whereas with the Zn CPO-27 it is initially DMF. This explains why the TGA curve
shows only a small drop in mass between 50 and 150°C.
Figure 4.18 TGA curves for the various versions of Zn CPO-27. The DMF version shows no
large initial drop in mass and even after solvent exchange it still does not lose the appropriate
mass of solvent.
Even after solvent exchange procedures have been carried out using methanol, it still
only shows a small drop in mass at the appropriate region. This shows that the Zn
CPO-27 sample is extremely difficult to fully solvent exchange and even harder to
activate. This was highlighted by Yaghi in his initial paper concerning Zn CPO-273.
The Sintef version of Zn CPO-27 has also been shown to have problems with
activation as it goes through several structural transformations before being fully
evacuated5 and this puts great strain on the structure. Therefore, it is not unexpected
that the N2 adsorption results were much lower than the theoretical surface areas. The
surface area obtained by Yaghi initially, when solvent exchanging with water3, was
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245 m2g-1. This was subsequently improved to 1132 m2g-1 using methanol and a
higher temperature for activation4. The N2 results obtained on the samples showed
varied and low surface areas. Surface area measurements were carried out on the
solvent exchanged Zn CPO-27 only. One batch produced a Langmuir surface area of
379 m2g-1 and another 548 m2g-1. There are obviously problems with the activation
of this compound in the N2 adsorption equipment.
Despite these problems, NO measurements were still taken. Figure 4.19 shows the
NO adsorption isotherms for both solvent-exchanged Zn CPO-27 and Sintef Zn
CPO-27. As can be observed, there is no sharp initial uptake as seen with the Ni and
Co versions, however both still show remarkable NO capacity, particularly the
solvent-exchanged Zn CPO-27 which displays an uptake of ~6 mmolg-1. Both
samples still exhibit a large hysteresis indicating that CUSs were available to bind to
and so the materials must have been at least partially activated.
Figure 4.19 NO adsorption isotherm at 298K for both samples of Zn CPO-27. There is
obviously still chemisorption occurring, however they do not show the huge initial uptake
behaviour exhibited by Ni and Co CPO-27.
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The next logical step was to carry out release measurements on both samples of Zn
CPO-27. The total release of NO from both zinc compounds is poor in comparison
with the Ni and Co versions. The amount released from the Sintef Zn CPO-27 only
averaged 0.12 mmolg-1 and the Zn CPO-27 only averaged 0.18 mmolg-1 (both
averaged over 4 samples). These results can be seen in figure 4.20.
Figure 4.20 NO release curves for both samples of Zn CPO-27 showing that only a small amount
of the total NO adsorbed is released.
Both samples however, are still releasing biologically significant amounts of NO up
to 20 hours after starting the experiment. The amount of NO required to be
considered biologically significant varies depending upon which application and
indeed which organ of the body is to be targeted. Indeed, HKUST-1 only releases 2
μmolg-1, but this is still considered to be of biological significance, as it was shown
that platelet aggregation is prevented using only this small amount of NO16.
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Due to the low NO release values obtained, methods were used to try and improve
the total NO released by Zn CPO-27. It was thought that an increase in temperature
would result in more of the adsorbed NO being released. Therefore a water circulator
system was used in combination with a sample holder utilising a water bath function.
Two elevated temperatures were adopted (50°C and 80°C), as well as a comparison
with the room temperature release.
Figure 4.21 Comparison of the hot water bath experiments with the room temperature release
of NO from Zn CPO-27.
As can be seen, there is a slight increase in total NO released, however all the
experiments run to completion after about 4 hours. This is not unexpected, as an
increase in temperature should promote the replacement of NO with water quicker
than at room temperature. Another method employed involved using a UV lamp
pointed directly at the sample holder during the experiment. It was thought that UV
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light might act as a catalyst for cleaving the M-NO bond. However there was no
noticeable difference in the release data acquired. The results demonstrate that Zn
CPO-27 does not act in the almost ideal fashion that Ni and Co CPO-27 perform.
However, due to the minimal toxicological effects of Zn compared to the two
aforementioned metals, it is still of interest for potential biological applications.
4.8.2 Mg CPO-27
The Mg form of CPO-27 was also synthesised in two different ways. For
comparative purposes both Mg versions were synthesised. To clarify, Sintef Mg
CPO-27 is the version made using Dietzel’s method6 and Mg CPO-27 is produced
using the method of Caskey and co-workers7. The first method (from the work of
Sintef6) was similar to those used for the Ni and Co versions (utilising THF as the
solvent and 110°C as the reaction temperature). Some base was added to ensure full
deprotonation of the linker6. The second procedure combined a solvent mixture of
DMF, ethanol, and water in a 15:1:1 ratio and a reaction temperature of 125°C.
Following initial synthesis, solvent exchange procedures were then used to exchange
the DMF molecules for methanol7. Powder XRD patterns for both versions (Sintef
and the solvent-exchanged Mg CPO-27) can be seen in figure 4.22 and show that
both match the theoretical XRD pattern extremely well.
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Figure 4.22 Normalised powder XRD pattern for both synthesised samples of Mg CPO-27.
Observation shows that they are almost identical, indicating that both synthetic
methods produce highly crystalline Mg CPO-27. Following the solvent exchange
process TGA measurements were taken on both the Sintef Mg CPO-27 and the
solvent exchanged Mg CPO-27. Figure 4.23 shows the TGA curves for both samples.
Interestingly both of the graphs are very similar indicating that the solvent exchange
process was much more successful compared with that on Zn CPO-27. Both show
large drops in mass (~30%) up to the activation temperature for this version (250°C)
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Figure 4.23 TGA curves of both types of Mg CPO-27 including the pre and post solvent
exchanged samples.
Once again there are problems with regard to full activation of these MOFs. Dietzel
and co-workers obtained Langmuir surface areas ranging from 150-1030 m2g-1. They
tried a series of different pre-treatments and activation temperatures and could only
make some generalisations regarding the activation of the material. These were
firstly that a higher activation temperature is required for the Mg analogue compared
with the Ni and Co versions (up to 250°C compared with just 110-150°C for the Ni
and Co structures). Secondly that pre-treatment of this compound is required to give
even mediocre surface areas. In the case of the Caskey synthesis, no mention is made
of problems regarding activation of their Mg CPO-27, although solvent exchange
methods have already been shown to be unreliable3. N2 adsorption isotherms were
carried out on both versions of Mg CPO-27. Mg CPO-27 shows a Langmuir surface
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area of 203 m2g-1, which is much lower than the reported 1905 m2g-1. The Sintef Mg
CPO-27 showed a surface area of only 138 m2g-1. Both these values are very low
compared with those published. However, in the paper the Sintef version which
performed best had to be kept under an inert atmosphere for two weeks and included
a solvent exchange before the measurements were carried out. It is believed that the
ineffective activation of these compounds is responsible for the resulting low surface
areas. However in the NO adsorption apparatus, the results were much more
promising.
The theoretical adsorption of NO by the Mg version of CPO-27 is 8.2 mmolg-1,
assuming that one NO molecule attaches to one available CUS. The results for NO
adsorption of both versions of Mg CPO-27 can be viewed in figure 4.24.
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Figure 4.24 NO adsorption isotherm for different versions of the Mg CPO-27 analogue carried
out at 298K. The Sintef version almost reaches the theoretical adsorption for NO.
It is noteworthy that the Sintef Mg CPO-27 almost reaches the theoretical amount,
indicating that the vast majority of the CUSs must have been available to bind to. It
also displays a much higher uptake at low pressures of NO compared with the Zn
CPO-27 versions mentioned previously. These high NO adsorption results are in
contrast with the low N2 adsorption results which showed poor adsorption. The
Caskey synthesised Mg CPO-27 adsorbs ~5 mmolg-1 of NO which, is less than
theoretically expected. This could be explained by ineffective solvent exchange or
improper activation procedures. Nonetheless the Sintef Mg CPO-27 shows the
highest NO adsorption of any porous material tested to date. The NO release results
were comparable with those of the Zn analogues, whereby only a fraction of the NO
adsorbed was actually quantifiably released. The release curves can be seen in figure
4.25.
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Figure 4.25 NO release curves for both versions of the Mg CPO-27 analogue. Both show much
lower amounts released than initially adsorbed.
The Sintef analogue showed a much more promising total NO release compared with
the Mg CPO-27, however both were still releasing significant amounts of NO up to
20 hours after the experiment began.
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4.8.3 Mn CPO-27
The final analogue synthesised was the Mn version. So far there has only been one
synthetic procedure published for creating this analogue of the CPO-27 series. It
follows a similar method to the Mg CPO-27, utilising a 15:1:1 ratio of DMF, ethanol
and water and a slightly higher reaction temperature of 135°C. Once again, solvent
exchange with methanol is required to enable this MOF to be used for porosity
measurements. The MOF was successfully synthesised and characterised using
powder XRD and TGA measurements. Figure 4.26 shows both the experimental
XRD pattern and TGA curve obtained for Mn CPO-27.
Figure 4.26 Experimental powder XRD and TGA curves for Mn CPO-27. The XRD pattern
matches very well with the literature based synthesis. Note the difference between the TGA
curves before and after solvent exchange with methanol.
The TGA curves show distinct differences. This can be attributed to the solvent
exchange process. DMF molecules are exchanged with methanol over the course of
several days, with the removal and addition of fresh methanol every day. Methanol
has a lower boiling point and therefore is removed very easily from the pores
Chapter 4 M-CPO-27: an isostructural series of MOFs
120
compared with DMF. The main difference is noticeable in the first mass drop
between 50 and 200°C, where the solvent exchanged sample shows a mass loss of
25% compared with just 12% for the as-synthesised sample.
Despite the encouraging results from the TGA curve, the Mn CPO-27 illustrates no
noticeable adsorption of N2 which again is in contrast with the results stated in the
literature16. This apparent lack of available porosity can be attributed to the solvent
exchange process. It could be possible that during the exchange process, some of the
pore walls are destroyed by the removal of DMF and the insertion of methanol.
Finally the NO results were once again undertaken despite the lack of apparent
surface area. Figure 4.27 shows the NO adsorption isotherm for Mn CPO-27.
Figure 4.27 NO adsorption isotherm for Mn CPO-27 carried out at 298K.
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This is very similar to the Zn CPO-27 graphs where there is no immediate uptake of
NO and the amount adsorbed is not as high as the Ni and Co analogues. However,
over 3 mmolg-1 is adsorbed and again is a significant amount and comparable with
that of HKUST-117. The NO release profiles once again follow the same pattern as
the Zn and Mg analogues where only a small percentage of the amount of NO
actually adsorbed is fully released. Figure 4.28 displays the release profiles for Mn
CPO-27.
Figure 4.28 NO release profiles for Mn CPO-27. Biologically significant amounts of NO are still
being released after 20 hours, but the total released is only a fraction of the amount actually
adsorbed.
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4.9 Alternative synthetic routes to produce M-CPO-27
Following the important results shown by the M-CPO-27 series and their NO
adsorption and release, efforts were made at alternative synthetic methods to produce
these frameworks. For any application, a synthesis which requires 72 hours heating
time in an oven before usage is inefficient. As explained in chapter 1 microwave
synthesis has recently come to the forefront as a method of creating MOF phases in
exceedingly quick times and has even been shown to produce materials that are more
crystalline than their solvothermal counterparts22. Further to this, being able to
produce MOFs at room temperature by simply mixing reactants together and stirring
would be much easier and less harmful to the environment, depending on the
solvents employed.
4.9.1 Microwave synthesis of Ni and Co CPO-27
The utilisation of microwave synthesis has so far yielded several world famous
MOFs including MOF-523-24 and MILs-100 and 10125-27. The method employed here
was to use the existing reagent concentrations, but instead of solvothermally heating
for 72 hours, microwaves would be employed. The table shown in figure 4.29 details
the concentrations of the various reagents and the conditions used in the microwave
synthesis.
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Figure 4.29 Table detailing the reaction conditions used in the microwave synthesis of Ni and Co
CPO-27.
The procedure from the most recent synthesis of Ni CPO-27 was utilised11. Using
calculated amounts of reactants each phase formed with no impurities. This is the
first time that this framework has been formed using microwave synthesis. Initial
experiments lasted 1 hour and the powder XRD patterns proved that both Ni and Co
CPO-27 were successfully synthesised. Following this initial success, it was decided
to see how quickly the Ni CPO-27 compound could be produced. The results were
very impressive. It is possible to form the Ni CPO-27 framework after only 1 minute
of microwave heating at 110°C. Figure 4.30 shows the 1 hour micro Ni CPO-27 and
the 1 min micro Ni CPO-27 experimental powder XRD patterns. The TGA curves
for each MOF are also shown. These match extremely well to the hydrothermally
synthesised versions. A comparison is also made with the hydrothermally produced
version. It is noticeable from the XRD results, however, that the full width at half
maximum (FWHM) value is much larger for the microwave synthesised compounds
indicating that the particle size is smaller. Using the Scherrer equation28 (4.1) the
particle size (τ) for each Ni CPO-27 version was estimated.  
1 hour at
110°C
10 mins at
60°C2:10.1490.3846mlCo CPO-27
1 hour at
110°C
10 mins at
60°C2:10.1490.37336mlNi CPO-27 1 hour
1 min at
110°C
5 mins at
60°C2:10.1490.37336mlNi CPO-27 1 min
main reactionpretreatment
Metal:ligand
ratio
DHTP
used
(g)
M
acetate
used (g)
Vial
size
MOF
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The particle size is calculated using a constant K, wavelength (λ) and uses the full 
width at half maximum (β) and the Bragg angle (θ) in radians. Using this equation 
the particle size for the hydrothermally synthesised version was estimated to be at
least 1123 nm and 353 nm for the microwave synthesised version.
This result is not unexpected as it has been observed before in microwave
synthesised MOFs25. Following this, scanning electron microscopy (SEM) images
were taken of both the hydrothermally synthesised Ni CPO-27 and the microwave
synthesised version. From these it can be seen that the hydrothermal synthesis gives
particle sizes of about 4μm whereas the microwave synthesis yields particles of about 
1μm. The SEM images are shown in figure 4.31. 
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Figure 4.30 Top left, experimental XRD curves for both microwave synthesised versions of Ni
CPO-27. Top right, a comparison with the hydrothermally produced Ni CPO-27 shows broader
peaks indicative of smaller particle size. Bottom picture shows the TGA curves of both
microwave versions and a comparison with the hydrothermally produced Ni CPO-27.
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Figure 4.31 SEM images of both versions of Ni CPO-27. On the left is the hydrothermal version
showing a particle size of ~4μm and the right shows the 1 min micro version with particle size of 
~1μm. 
Comparisons between the hydrothermally produced MOF and the microwave
synthesised framework were then made. Initially the N2 adsorption capacity and
surface area measurements for each Ni version were taken. Figure 4.32 shows the
adsorption isotherms for each of the three materials; the hydrothermal Ni CPO-27,
the 1 hour microwave synthesised Ni CPO-27 and the 1 minute microwave
synthesised Ni CPO-27.
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Figure 4.32 N2 adsorption isotherms comparing the microwave synthesised Ni CPO-27 with the
traditional hydrothermally produced Ni CPO-27. All experiments were carried out at 77K.
As can be seen there are slight differences between the microwave synthesised
samples and the hydrothermally produced Ni CPO-27 although the microwave
samples still show high Langmuir surface areas. This proves that the porosity of the
framework is of the same standard as that produced using hydrothermal methods.
There is a slight drop in surface area in the 1 min micro Ni-CPO-27 sample, which
could be due to poorly formed pores. The difference is minimal and the surface area
measurement matches that of the originally synthesised Ni CPO-272. To further
confirm this, NO adsorption investigations were carried out and compared with the
hydrothermal sample. The results can be seen in figure 4.33.
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Figure 4.33 NO adsorption isotherms for the three different samples of Ni CPO-27. All three
experiments were carried out at 298K.
As shown the variations in the amount of NO actually adsorbed are very low. There
is a slightly lower amount of NO actually chemisorbed by the microwave samples.
However, it is still storing an extremely large amount of NO. Finally, to see if the
samples still have the exceptional performance over the storage and delivery cycle,
NO release measurements were also carried out. The results can be seen in figure
4.34.
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Figure 4.34 Total NO released by the 3 different types of Ni CPO-27.
As can be seen the amount of NO released by the microwave synthesised samples is
a little lower than for the standard hydrothermally-produced Ni CPO-27. This might
arise from the slightly lower surface areas measured by N2 adsorption. However, the
microwave samples are still releasing the NO in the same controlled manner as the
hydrothermal version and the total NO released is still remarkably high. The
microwave synthesised Co analogue was also tested for NO adsorption and the
results can be seen in figure 4.35.
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Figure 4.35 NO adsorption graphs carried out at 298K, comparing the microwave synthesised
Co CPO-27 with the hydrothermal Co CPO-27.
As can be observed, there is almost no difference in the total NO that is chemisorbed
onto the CUS in the pores of both Co CPO-27 samples. However, the total NO
adsorbed including the physisorbed NO shows a small difference. These results are
extremely encouraging. This means that bulk quantities of these materials can be
produced in minutes compared with the 72 hours required for the hydrothermally
produced M-CPO-27. The materials obtained match very well to those produced
using hydrothermal synthesis with only slight differences in the total NO release
properties.
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4.9.2 Room temperature synthesis of Zn CPO-27
A recent paper from Yaghi and co-workers illustrated the possibility of synthesising
several famous MOFs at room temperature29, one of which is Zn CPO-27. To
compare this with the hydrothermally synthesised Zn CPO-27, the experimental
procedure from the literature was followed and the room temperature version of Zn
CPO-27 was successfully produced. Initially zinc acetate and DHTP are dissolved in
two separate portions of DMF (20ml). The dissolved acid solution is then added drop
wise over 10 minutes to the dissolved metal salt while stirring. The mixture is then
left stirring overnight. The next day the resulting powder is separated from the parent
solvent by centrifugation. The powder is then solvent exchanged by immersion in
methanol for three days, replacing the methanol everyday after centrifugation.
Powder XRD and TGA curves match very well to the theoretical patterns found in
the literature (figure 4.36).
Figure 4.36 XRD and TGA patterns for room temperature synthesised Zn CPO-27.
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The RT Zn CPO-27 (room temperature Zn CPO-27) is then activated at elevated
temperature (250°C), under vacuum. Once again, however, the N2 adsorption
isotherm was not an ideal match with the surface area described in the literature. A
Langmuir surface area of 860 m2g-1 was found and this is slightly lower than the
1187 m2g-1 for the RT Zn CPO-27 mentioned in the paper. However it is a significant
improvement on the surface area measured for the hydrothermal Zn CPO-27
discussed earlier. The discrepancy in these values can be attributed to either
incomplete activation or ineffective solvent exchange.
The NO adsorption results, however, compare well with the Zn CPO-27 already
described. Indeed there are actually improvements noted in the uptake of NO. Figure
4.37 shows both NO isotherms.
Figure 4.37 NO adsorption at 298K of RT Zn CPO-27 compared with that of the
hydrothermally produced Zn CPO-27.
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There is a pronounced difference in total NO adsorbed, and indeed in the actual
amount of NO chemisorbed. The RT Zn CPO-27 has chemisorbed 7.36 mmolg-1,
whereas the hydrothermally produced Zn CPO-27 has only 4.72 mmolg-1 attached to
the CUSs after desorption. It would be expected that an increase in the amount of NO
released by this MOF would be observed when these samples are exposed to the
“wet nitrogen” of the NO analyser. As can be seen from figure 4.38 there is no
increase noticeable from the RT Zn CPO-27.
Figure 4.38 NO release curves for the two versions of Zn CPO-27. Even though the
RT Zn CPO-27 adsorbs more NO, it releases marginally less than the
hydrothermally produced Zn CPO-27.
RT Zn CPO-27 releases marginally less than its hydrothermally produced analogue.
From the inset in the concentration curve one can see that it has released almost all
the biologically significant NO after only 10 hours, which is in much less time than
the hydrothermally produced samples took.
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4.10 Summary and discussions from chapter 4
It has been shown that MOFs can store and release large amounts of NO. In
particular the M-CPO-27 series have shown a remarkable affinity for NO gas. The Ni
and Co versions display an exceptional activation, loading and delivery cycle and as
such have shown important potential for investigation into various biological
applications. The other versions however, have problems possibly arising from poor
activation or due to the fact they have to be synthesised with DMF and then solvent-
exchanged prior to use. Even though some still show excellent adsorption isotherms
for NO, the amount released is poor in comparison, although still enough for many
biological applications. Figure 4.39 shows the theoretical chemical adsorption
compared with the actual chemical adsorption of NO. It also details the total NO
released and the percentage of NO released compared with the amount originally
chemisorbed.
Figure 4.39 Table displaying theoretical adsorption of NO compared with actual experimental
results. Also shown is the percentage of NO released compared with the amount adsorbed.
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The values for Ni and Co CPO-27 show almost perfect releaseablity. The reason for
the release percentage being over 100 is due to the aforementioned physisorbed NO,
which is not accounted for in the calculations. This value can vary due to the
unknown amount of NO which is physisorbed. The physisorbed NO is also the first
to be released as it is not chemically bonded to the metal. This discrepancy in the
percentages may also be due to the NO-loading procedure being carried out under
slightly different conditions to the adsorption measurement. It is interesting to note
that the release percentages from all the other analogues of CPO-27 are all between 2
and 5%. There are several reasons that could explain this. Several processes occur
during the activation, loading and release steps and careful analysis of these steps
might yield an answer as to why several of the analogues show good adsorption but
poor release of NO. The steps involved in the various processes can be seen in figure
4.40. The stability of the dehydrated structure will determine whether or not the NO-
loaded MOF will transfer back to the hydrated state. The reaction that occurs during
the replacement of NO with H2O (NO release) will involve a reaction mechanism,
and here are two possible mechanistic processes. These are illustrated in figure 4.40.
Mechanism 1 would suggest that the incoming water molecule and the exiting NO
molecule are both attached to the metal before the NO departs. Mechanism 2
suggests that the NO dissociates from the metal before the water reattaches itself
suggesting that there is an intermediate of similar structure to the dehydrated MOF.
Mechanism 2 would be the most logical as mechanism 1 would be sterically hindered
as the combination of both a water molecule and an NO molecule would be too bulky
around the one metal atom. Indeed a seven coordinated metal is unlikely to form is
such a constrained space. In the Ni and Co versions the dehydrated structure clearly
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must display good stability as it is much easier to activate these materials compared
with the others. If the dehydrated structure is easy to form, then changing the species
attached to the activated version should also be straightforward. It therefore follows
that if it is difficult to achieve the fully activated structure, then replacing any species
attached to the activated structure will be very difficult.
Figure 4.40 Diagram depicting the reactions involved at the metal in the activation and loading
and release of NO in MOFs. Also illustrated are the 2 possible mechanisms for NO release from
a loaded MOF. Mechanism 2 is the most likely process as steric hindrance would prevent
mechanism 1 from occurring. Metal atoms are shown in light blue, oxygen in red, hydrogen in
yellow and nitrogen in dark blue.
Therefore in the Zn, Mg and Mn analogues, the dehydrated structure must not be as
stable and this might lead to the NO not being replaced by the water molecule. This
situation would lead to the NO-loaded structure being more favourable compared
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with the dehydrated intermediate, which is required before the water can attach itself
back to the metal. Another factor influencing the NO release is the strength of the M-
NO bond that is formed when the activated material is exposed to NO. It is possible
that the M-NO bond is much stronger for Zn, Mg and Mn than Ni and Co. This
would explain why such low NO release percentages are found. Microcalorimetry
experiments could be carried out to investigate this further. The IR measurements
carried out in the next chapter give an explanation of what is occurring at an iron
atom in MIL-100 during NO loading and release. Obviously different MOFs will
react differently with NO, however some of the main points may offer another reason
as to why the NO release is poor for certain analogues of M-CPO-27.
In conclusion it has been shown that there is significant potential in using the M-
CPO-27 MOFs to store and release NO for medicinal applications. The initial results
of which can be found in chapter 7.
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5 NO storage and release from various MIL
frameworks
5.1 Background
One of the most prominent research teams in the area of MOF chemistry has been the
Férey group based in France. They have synthesised many of the most famous MOF
structures and have written a large number of high profile publications. As
mentioned in chapter 1, MOF structures have evolved several acronyms. Here at the
University of St Andrews two examples are STA (St Andrews porous material) and
STAM (St Andrews MOF). One of the most used acronyms is MIL, meaning
Materials of Institut Lavoisier, and any framework with a MIL name was originally
synthesised by this group. Over recent times they have synthesised MOFs with wide-
ranging properties, including MILs 100, and 101 which have some of the largest
surface areas of any MOFs and MILs 53 and 88 which show a fascinating breathing
phenomenon. The Russell Morris group work closely with the Férey group and part
of this project was to investigate the NO adsorption and release properties of several
of the MILs synthesised in France.
5.2 Aims of chapter 5
The main aim in chapter 5 is to investigate a variety of iron-based carboxylate MOFs
for NO storage and release. An investigation into structures with similar morphology
but using different linkers is presented. Another comparison was made between
MOFs which are amine grafted and those with CUSs present to bind NO. Finally in
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collaboration with the Férey group based in France, an in-situ IR investigation is
presented. This gives interesting results, which explain the adsorption and release
results for NO in Fe based frameworks.
5.3 NO adsorption and release from MIL-88 structures
Following synthesis in France several samples of MIL-88 based structures were sent
over to the University of St Andrews where NO adsorption and release experiments
were carried out.
5.3.1 Introduction to the structures investigated
In 2002 Serre and co-workers synthesised MIL-53 using terephthalic acid and
chromium metal1-2. The structure displayed a remarkable breathing effect upon
dehydration, whereby the structure expanded and the pore size was greatly increased.
This discovery was then followed by the creation of another breathing framework
MIL-883-5. They successfully used Fe3+ together with differing linkers to produce a
set of structures which were very similar with variation in the linker, comparable
with the isoreticular series of MOFs created by Yaghi6. Their approach uses a
“Controlled Secondary Binding unit (SBU)”, which means that the metal cluster is
formed before being introduced into the reaction with the organic species to form the
MOF. In this case the trimeric iron acetate is prepared and then added to various
organic moieties (see figure 5.1). Fe MIL-88-A and Fe MIL-88-B have already been
reported in the literature3-5, however samples of two new forms of Fe MIL-88-B
were also donated very kindly by the Férey group for NO investigation. Using
nitroterephthalic acid and 2,5-dihydroxyterephthalic acid (DHTP) as linkers,
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structures similar to Fe MIL-88-B are formed with extra functional groups present
on the aromatic ring. Fe MIL-88-A is a three dimensional framework constructed
from iron (III) trimers and fumaric acid with the formula FeIII3O(CH3OH)3{-O2C-
C2H2-CO2-}3.{-O2C-CH3}.4.5CH3OH (see figure 5.2(a)). The framework is made up
of cages together with channels running along the c-axis. Fe MIL-88-B is of the same
topology as Fe MIL-88-A, however the fumaric acid has been replaced by
terephthalic acid (figure 5.2(b)). The material is unique in that its cell volume
undergoes a reversible expansion from the closed (dehydrated) to the open (fully
hydrated) form. This increase (85% for Fe MIL-88-A) is the largest known for any
MOF and is completed without any phase transition or bond breaking.
Figure 5.1 A scheme showing the iron acetate trimer and the various different linkers used in
forming the set of Fe MIL-88 structures.
O
OH
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Figure 5.2 (a) Cage of Fe MIL-88-A, clearly showing the iron trimer connected to the fumaric
acid linker and (b) similar view of the cage structure in Fe MIL-88-B except using terephthalic
acid as the organic linker.
As mentioned in chapter 1, MOFs have great potential for use in healthcare
applications. Indeed initial toxicology studies have already been carried out on iron
carboxylate based MOFs resulting in no detrimental effects observed from acute and
semi-chronic exposure7. Further to this, iron carboxylates (including MIL-88) have
recently been shown to be of great interest for drug delivery and imaging7. The
compositions of the Fe MIL-88 structures are very favourable in terms of toxicology
as they contain iron as the metal source, which is substantially less toxic when
compared with the other metals in MOFs studied for NO applications so far (Ni, Co
and Cu)8-9. Indeed some current prescribed medicines have the same chemical
composition as MOFs and have been approved for medical use. For example, iron
fumarate (same composition as Fe MIL-88-A) has been approved as an oral iron
supplement10 (trade name FerrettsTM).
(a) (b)
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5.3.2 NO adsorption results on Fe MIL-88
Figure 5.2 clearly shows the cage structure of both Fe MIL-88-A and Fe MIL-88-B
(excluding guest solvent molecules). The iron trimer can be clearly seen and it is at
the iron atoms that the NO would be expected to attach during NO adsorption
studies. Thermal activation at 150°C (with the exception of Fe MIL-88-B-2OH for
which 80°C was used) removed guest water molecules and the coordinated water
leaving the dehydrated structure and coordinatively unsaturated metal sites (CUSs)
which the NO can bind to. The Fe MIL-88 compounds were first subjected to
gravimetric adsorption measurements. Fe MIL-88-A shows a 20% drop in mass after
thermal activation before exposure to NO, which correlates well with the
thermogravimetric analysis (TGA) carried out (figure 5.3), indicating that all guest
solvent molecules (including bound ones) are removed. All the other Fe MIL-88
compounds show similar behaviour indicating that all solvent molecules were
removed prior to NO adsorption.
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Figure 5.3 TGA curve for Fe MIL-88-A.
NO adsorption isotherms can be seen in figure 5.4. Fe MIL-88-A adsorbed the
largest amount of NO, 2.5 mmolg-1. The desorption curve showed some irreversible
adsorption with 1.61 mmolg-1 of NO probably chemically bonded to the iron atoms.
Fe MIL-88-B showed an uptake of 1.8 mmolg-1 with 1.31 mmolg-1 irreversibly
adsorbed. The other Fe MIL-88s both exhibited smaller uptakes of NO (~1 mmolg-1)
with Fe MIL-88-B-NO2 irreversibly adsorbing 0.84 mmolg-1 and the 2OH version
just 0.66 mmolg-1.
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Figure 5.4 The NO isotherms for all Fe MIL-88 structures investigated. Fe MIL-88-A shows the
highest uptake with the Fe MIL-88-B structures displaying similar uptakes of about 1 mmolg-1.
All results obtained at 298K.
However, all the adsorption values are significantly lower when compared with the
theoretical values of adsorption (see figure 5.5). Assuming that all three of the iron
atoms in the trimer are unsaturated prior to NO exposure, Fe MIL-88-A should
chemisorb 5.7 mmolg-1 of NO. This value is unrealistic however, as removal of so
many oxygen atoms would put too much strain on the iron trimer. It is therefore
more likely that only one of the iron centres is coordinatively unsaturated and
therefore available for chemical binding.
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Figure 5.5 Graph displaying the theoretical adsorption of each Fe MIL-88 depending on the
number of sites available on each trimer and comparing it with the actual NO adsorption
observed.
From figure 5.5 it is clear that there is less than one site available per Fe trimer for
adsorbing NO molecules. This corresponds well with the assumption that there could
only be one of the three possible sites available. Additionally all of the adsorption
isotherms show compounds that are not fully saturated with NO (the equipment only
measures to two atmospheres of NO for safety reasons), which would also explain
why the actual adsorption values are lower than the theoretical ones. These two
effects explain the lower than expected adsorption of NO for all the Fe MIL-88
materials. In the curves for MIL-88-A and B a step can be observed between 50 and
100 mmHg. This could be due to a “gate opening” effect11 which has been observed
before in other MOFs. Initially the structure is in the closed form when dehydrated
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and as NO is adsorbed into the structure it expands into the open form and thereby
allows more NO into the pores. Mention must also be made of the fact that a very
small amount of weakly adsorbed (physisorbed) NO will also be present in the pores
of the framework at 298K, however upon desorption this should be removed. The
desorption arm of the isotherm shows a large hysteresis which is consistent with
previous NO studies and shows that the NO has bound to open iron sites. The
amount of NO adsorbed is less than that of the exceptional storage and release
capacity of the CPO-27 materials8, however, it is still comparable with that of Zn
zeolite-A which adsorbs ~ 1.5 mmolg-1 of NO12. The extra functional groups added
to the MIL-88-B could be responsible for lowering the amount of NO adsorbed as
they will partially block access to the open metal sites located within the pores. This
would explain the lower values of NO adsorption for the newer Fe MIL-88-B
structures.
5.3.3 NO release measurements on Fe MIL-88 structures
As mentioned in the previous chapter the amount of gas adsorbed is vital for
particular biological applications relating to NO. However of much greater
importance is the amount of NO released and over what period of time which will
determine if individual MOFs are suitable for further investigation. Release
experiments were carried out on the Fe MIL-88 compounds to see if the NO stored in
the framework could all be released using moisture as a trigger as demonstrated
previously. Following the same activation procedure the NO-loaded samples were
stored under a dry atmosphere before being placed in the sample holder. Once
exposed to the “flowing wet gas” of the apparatus the water molecule should replace
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the NO on the Fe atom. The NO should then be released and quantifiably calculated
using the intensity of chemiluminescence on reaction of NO with ozone. The
concentration release profile and the total amount of NO released from the Fe MIL-
88 compounds can be seen in figure 5.6.
Figure 5.6 NO release profiles for the Fe MIL-88 structures. Top left shows the total amount
released. The concentration curves for three of the structures are also shown. Fe MIL-88-B is
omitted due to the extremely poor NO quantity released.
These graphs illustrate that the vast majority of the total NO released is liberated
within the first hour of the experiment for most of the compounds. However, this is
Chapter 5 NO storage and release from various MIL frameworks
151
not a major concern as the compounds are still releasing biologically significant
quantities of NO (10 parts per billion (PPB)) up to 16 hours after starting the
experiment, as in the case of Fe MIL-88-A. As noted, the compounds are releasing
values of NO which are significantly less than the amount initially adsorbed. Fe
MIL-88-A releases only about 5% of the total amount adsorbed, Fe MIL-88-B-NO2
and Fe MIL-88-B-2OH both release about 14% of the total they adsorbed. This
behaviour has been observed before in the previous chapter with Zn, Mg and Mn
CPO-27 and in the literature with HKUST-1 (a Cu-based MOF) which adsorbed 3
mmolg-1 of NO but only released 2 μmolg-1 of NO 9.
Overall the NO adsorption and release from the Fe MIL-88 structures is similar to
the release from the Zn, Mg and Mn CPO-27 compounds. Again the release
percentages from these compounds are not as high as would be expected and further
discussions regarding these results can be found later in this chapter. Further
investigation of how many CUSs are available following activation and the bond
strength between iron and NO is required to fully understand the poor release of NO
from these compounds. Nonetheless the amount of NO produced is still significant
and merits further investigation for possible biological applications.
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5.4 NO adsorption and release from MIL-101 and MIL-
100 based structures
5.4.1 Introduction to structures
In 2005, Férey and co-workers synthesised structures known as MIL-100 and MIL-
10113-14. They once again used the metal trimer, with two different carboxylic acids
(trimesic and terephthalic acid). However, the structures produced had some of the
largest unit cells ever reported for MOFs and huge surface areas. The MIL-101
structure used terephthalic acid and MIL-100 used trimesic acid in combination with
Cr metal initially, however since then the Fe version of MIL-100 has been reported15.
The structures are built from supertetrahedra which then form two different types of
cages and can be seen in figure 5.7. By using the metal trimer in the synthesis it
allows both structures to have CUSs upon desolvation of the framework. This
combined with the huge available surface areas has led to many investigations into
their gas storage properties16-17. Indeed drug storage and release has also been
performed on these frameworks18. In 2008, however, there was a paper published
which demonstrated the use of grafting amines onto the CUSs available in MIL-101
to improve certain catalytic reactions19. The MIL-101 structure was first dehydrated
then the amine was successfully grafted onto the available CUS. It was thought that
by using samples of amine grafted MIL-101 it would be possible to improve the
amount of NO that the structure could adsorb. The reason for this is based on another
set of NO releasing compounds known as diazeniumdiolates (NONOates)20-21.
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Figure 5.7 Structures of MIL-100 and MIL-101. (Left) A trimer of Cr octahedra and linkers
(trimesic acid for MIL-100 and terephthalic acid for MIL-101). (Centre) Hybrid
supertetrahedra. (Right) Cages of MIL- 100 and MIL-101. Picture adapted from reference 17.
As mentioned briefly in the introductory chapter, NONOates have the general
structure illustrated in figure 5.8. Also shown is the spontaneous release of NO from
this family of compounds when placed in aqueous media.
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Figure 5.8 NO release from NONOates adapted from reference 20.
As can be observed, 2 molar equivalents of NO are released from the structure upon
decomposition. By grafting an amine onto a CUS in a MOF, the possibility for
creating the NONOate group is realised. Following successful grafting and
subsequent activation (insuring that the secondary amine is not removed or
decomposed) NO could be attached to the N atom creating the NONOate group.
When exposed to the moisture from the wet gas the decomposition of the NONOate
inside the pores should lead to 2 molar equivalents of NO being released from each
metal site. On the other hand, if it is simply the open metal site that is chemically
binding to NO only 1 molar equivalent of NO will be released. The two proposed
mechanisms can be seen in figure 5.9 (using N-methylethylenediamine as an
example). The use of amine grafting offers the possibility of doubling the NO
adsorption capacity and release values for individual MOFs. This approach to the
Chapter 5 NO storage and release from various MIL frameworks
155
loading and release of NO has been successfully shown in the HKUST-1 framework
by Rosseinsky and co-workers22. Using the unsaturated Cu sites available after
activation, they successfully grafted 4-(methylamino)pyridine and exposed this to
NO gas. This formed the diazeniumdiolate group which, when triggered with water,
released the 2 molecules of NO bound to the amine. The one major drawback to this
technique, however, is firstly the assumption that all the metal centres are fully
activated before grafting of the amine. Secondly it is assumed that the amine grafts
successfully to the all the metal sites available. This second assumption was proven
to be problematic, as when the amine-grafted samples of HKUST-1 were exposed to
NO some of the NO bound directly to the Cu CUSs, indicating that full amine
grafting is not guaranteed22.
Figure 5.9 Two proposed mechanisms for NO-loading and release. Mechanism 1 shows the
standard method of activation followed by exposure to NO, and before the NO is released via
moisture. Mechanism 2 utilises the amine-grafted MOFs. Here the amine can bind 2 molar
equivalents of NO forming a NONOate before releasing the NO in the same manner as above.
mechanism 1
mechanism 2
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The NO adsorption isotherms for Fe MIL-100 and Cr MIL-101 have previously been
carried out by another member of the Russell Morris group. The Férey group in
France again kindly provided two samples of amine grafted MOFs for initial NO
experimentation. One was a sample of Cr MIL-101 with N-methylethylenediamine
grafted onto the metal (see figure 5.8). The other sample was Fe MIL-100 with a
semicarbazide attached to the Fe atoms (see figure 5.8).
Figure 5.8 The diamine molecules grafted onto the metal sites to improve NO storage in Cr
MIL-101 and Fe MIL-100.
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5.4.2 NO results from amine grafted MIL frameworks
NO adsorption isotherms were undertaken for both amine grafted samples and then
compared with the results of the bare frameworks (kindly provided by Dr Paul
Wheatley and Dr Bo Xiao). The activation temperature used for each framework was
150°C which is the same as was used for the bare frameworks (except for the MIL-
100 sample which is degassed at 250°C). Figure 5.9 shows the NO adsorption graph
for the amine grafted MIL-101. MEDA stands for N-methylethylenediamine.
Figure 5.9 NO adsorption isotherm carried out at 298K comparing the amine grafted Cr MIL-
101 with the bare Cr MIL-101 framework.
The amount of NO chemisorbed by the two samples is very similar, both showing
chemical adsorption of 1.75 mmolg-1 of NO. However, there is significantly more
NO adsorbed by the bare framework of Cr MIL-101. The adsorption of NO by the Fe
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MIL-100 samples can be viewed in figure 5.10. The sample designated Fe MIL-100
250°C was activated at 250°C instead of the standard 150°C. This was carried out at
the suggestion of the Férey group. It can be seen that the Fe MIL-100 activated at
150°C adsorbs much less NO than when activated at 250°C, suggesting that not all
the solvent molecules are removed by activation at 150°C. In the case of the
semicarbazide Fe MIL-100, it is not possible to heat beyond 150°C as the
semicarbazide molecule would be destroyed. This proves that despite only being
treated at 150°C prior to the experiment the semicarbazide grafted sample shows a
much higher uptake of NO compared with the standard bare framework degassed at
150°C. This suggests that the NO is binding to the amine group in the expected way.
Figure 5.10 Comparison of Fe MIL-100 structures obtained at 298K. The graphs show that
activation conditions play an important role in determining the NO adsorption of a material.
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Comparing the amounts of NO adsorbed with the theoretical amount shows that in
theory the bare framework should chemically adsorb 4.17 mmolg-1 of NO. However,
once again because the framework utilises the metal acetate trimer, this theoretical
value is based on all three CUSs being available. This is unrealistic as if all three
sites were unsaturated it would cause a great strain to the structure. Figure 5.11
details the theoretical amounts of NO that should be adsorbed depending on the
number of available metal sites per trimer. It is then compared with the actual
amount of NO chemisorbed using the gravimetric adsorption equipment.
Figure 5.11 Graph showing the theoretical adsorption values for the bare frameworks of MILs
101 and 100 and the amine-grafted versions. These are compared with the actual amount of NO
chemisorbed.
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In the case of MIL-100 using the elevated thermal activation temperature brings the
actual amount of NO adsorbed to almost 3.5 mmolg-1, which shows that more than 2
CUSs per trimer are available for binding. This also indicates that the framework is
evacuated to a better degree than if treated at 150°C. Thermal activation at 150°C
gives adsorption values indicative of having 1 available CUS per metal trimer and
this is evident in both Cr MIL-101 and Fe MIL-100.
Due to the larger theoretical NO adsorption value for the amine-grafted MOFs, It
would then be anticipated that the amount of NO released from the amine-grafted
samples should be greater than for the bare framework. The results can be seen in
figure 5.12 together with a table in figure 5.13 summarising the NO release
measurements for the bare frameworks and the amine grafted ones. The NO release
results for the bare frameworks were once again kindly provided by Dr Paul
Wheatley.
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Figure 5.12 NO release curves for the amine-grafted samples of Fe MIL-100 and Cr MIL-101.
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Figure 5.13 Table summarising the NO adsorption and release from all forms of MIL-101 and
MIL-100.
From figures 5.12 and 5.13 it is clear that neither of the amine-grafted MILs show
higher NO release values than the parent framework. Indeed the values from the
MEDA grafted MIL-101 are particularly low. Further analysis reveals that the poorly
activated Fe MIL-100 shows a higher release of NO than the semicarbazide loaded
version. As mentioned previously, it is very difficult to fully load the CUSs available
with secondary amine. This result has been shown already22. An explanation might
be that only a certain number of the metal sites are bound with amine. The loading of
the amine onto the metal sites blocks the pores slightly and therefore when exposed
to NO only a certain percentage of NO can access the pores and attach either directly
to the metal or to the amine (forming the NONOate). When this is then exposed to
moisture the NO adsorbed is released, however as seen previously only a small
percentage of the NO bound to the metal will actually be released. Therefore smaller
total NO release values are obtained.
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5.5 In-situ IR investigation of NO on Fe MIL-100
As mentioned previously the Morris group collaborate closely with the Férey group
in France on certain aspects of MOF chemistry and in particular the NO adsorption
and release from various MIL frameworks. Initial results from iron carboxylate-
based MOFs show lower than expected release of NO. In-situ IR measurements
were then carried out on Fe MIL-100 to try to understand the processes involved in
loading and release of NO from the framework. These experiments were all carried
out at the in-situ IR facility located in Caen France. Several experiments were
undertaken and the results give an insight as to why the release of NO is lower than
expected.
5.5.1 Fe MIL-100 exposed to NO
Fe MIL-100 was activated at 250°C for 12 hours. An IR spectrum was taken of the
activated MOF and used as a comparison with the NO-loaded spectra. Before being
exposed to NO there are peaks observable at 1913 cm-1 and 1896 cm-1 which are
most likely due to C-H stretches associated with the para-substituted benzene ring
present in Fe MIL-100. When exposed to NO, an immediate change is noticeable in
the IR spectra. Peaks appear at 1822 cm-1 and 1809 cm-1 which correspond to NO
adsorbing at Fe2+ sites (FeII(NO)). These changes can be seen in figure 5.14. What
can be seen from this result is the definite interaction between Fe2+ and NO, and that
there is little interaction observed between Fe3+ and NO although there may be
unsaturated Fe3+ sites in the framework. The hydrated structure contains only Fe3+
iron and so it is strange that interactions with are more prevalent with Fe2+. This
“self-reduction” of Fe3+ to Fe2+ has been explained (in the case of zeolites) as a
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hypothetical hydrolysis reaction23-24 (5.1). There are observable interactions between
Fe3+ and NO at low temperatures (77K) where a sharp peak appears at 1895 cm-1
signifying this interaction and indeed showing that there are unsaturated Fe3+ sites
even after activation. However as the temperature is increased this peak disappears
indicating that the interaction between Fe3+ and NO is weak and more likely to be
physisorbing than chemisorbing. The peak also appears at high loadings of NO
however as we are interested in the chemisorbed NO, small loadings of NO were
used (~10 torr) for all further experiments, so the Fe3+-NO peak is generally absent.
2[Fe3+OH-] = 2[Fe2+] + H2O + ½O2 (5.1)
Figure 5.14. IR spectra of Fe MIL-100 activated at 250°C/12h upon exposure to NO at RT. The
purple line shows Fe MIL-100 under vacuum after activation at 250°C for 12 h. The blue line
shows Fe MIL-100 upon initial exposure to NO. Peaks are observable for FeII(NO).
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5.5.2 Fe MIL-100 under prolonged exposure to NO
In order to study the stability of NO on the Fe2+ sites, a sample of Fe MIL-100 was
exposed to 10 torr of NO for a prolonged period of time (~14 hours). During this
time IR measurements were taken. As can be seen in figure 5.15 it appears that the
NO peaks associated with FeII(NO) decrease in intensity. Indeed the peak that
appears at 1822 cm-1, when first exposed to NO almost disappears completely. In
combination with this loss of the FeII(NO) peak intensity there is an increase of water
observed. This could be due to the evolution of water as a result of an interaction
between NO and the Fe-OH groups25. The peak at 3674 cm-1 may indicate the
presence of Fe3+-OH groups. This peak can be seen in figure 5.16.
Figure 5.15. IR spectra of Fe MIL-100 comparing NO adsorption on FeII sites under prolonged
exposure to NO, spectra taken at 298K: (A) 816 min; shoulder at 1822 cm
-1
has almost
completely disappeared, and peak at 1805 cm
-1
has shifted to 1799. (B) 722 min. (C) 628 min. (D)
440 min. (E) 346 min. (F) 227 min; peak at 1897 cm
-1
disappears, and peak at 1822 cm
-1
becomes
shoulder. (G) 31 min; peaks at 1897, 1876 (NO gas), 1822, and 1805 cm
-1
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Figure 5.16. IR spectra of Fe MIL-100 comparing NO adsorption on FeII sites under prolonged
exposure to NO, spectra taken at 298K: (A) 31 min; peaks observable at 3676, 3601, and 3087
cm-1. (B) 227 min. (C) 346 min. (D) 440 min. (E) 628 min. (F) 722 min. (G) 816 min; peaks at
3676, 3601, and 3087 cm-1 have continued to increase in intensity, along with a broad
background intensity increase.
This result suggests that unless completely sealed off, the amount of NO available
for release will gradually decrease and the amount of water present in the framework
will increase.
5.5.3 Spectra of NO-loaded Fe MIL-100 exposed to water
In the release experiments the NO is replaced with water. However the Fe MIL
frameworks display minimal release of NO and therefore presumably water does not
displace NO. To understand the competitive effect of H2O and NO at the Fe2+ centre,
experiments were carried out exposing an NO-loaded sample of Fe MIL-100 to water
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vapour. Figure 5.17 shows the changes in the IR spectra for Fe MIL-100 at different
stages. Initially no peaks are observed as this is the dehydrated sample prior to NO
exposure. However, when NO is allowed into the sample the expected peaks at 1822
and 1809 cm-1 appear. The NO is then evacuated and the FeII(NO) peaks remain,
indicating that a chemical bond has formed between the iron atoms and the NO
molecules. This is perfectly consistent with the conclusions regarding chemisorption
from the adsorption isotherms. Following this, water vapour is then fed into the
sample. An immediate reduction in the peak located at 1822 cm-1 is seen. It very
quickly disappears and a new peak at 1770 cm-1 is observed. This peak also
disappears over time (90 minutes). Scans were also taken of the gas phase during this
experiment and an interesting result was that the peak associated with N2O species
(2224 cm-1) increased over time with the addition of water vapour. It is therefore
theorised that the peak at 1770 cm-1 is the result of the introduction of water either
causing the formation of a dinitrosyl species at the Fe2+, NO dimerisation or possibly
as the result of an interaction between H2O and NO (for example hydrogen bonding).
It is thought that the probable explanation for this is the formation of a dimer at the
Fe2+ site, with the antisymmetric NONO dimer [υ(-O=N)] on the Fe2+ centres. This
peak should be observed at 1778 cm-1 and correlates well with the observed IR
spectra26. This could lead to the formation of N2O as has been observed before27.
This theory is reinforced by the fact that after exposure to H2O, the gas phase shows
the peak attributed to N2O increasing (see figure 5.18 and 5.19). Further evidenced
by the fact that the amount of N2O does not increase when placed in an empty cell,
meaning that the Fe2+ site is required to produce the N2O.
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A number of conclusions from this initial result can be drawn. It is clear that after
evacuation the FeII(NO) remain, and this is a strong indication of a chemical bond
being formed between the Fe2+ and the NO molecule. Another observation is that
when initially exposed to water vapour the peak at 1822 cm-1 disappears, indicating
that some of the bound NO has been liberated. The released NO will be the less
strongly bound NO and could be liberated depending on the coordination
environment of the surrounding trimer. In one case the FeII(NO) might be surrounded
by two FeIII-OH environments or it might have another FeII(NO) and one FeIII-OH.
Although as can also be seen the water does not displace all the NO indicating that
some of the NO remains bound to the iron metal. This explains why there is poor
release of NO observed from Fe-based frameworks. Finally the introduction of a new
peak at 1770 cm-1 combined with the increase in N2O is consistent with the
formation of a NONO dimer at the Fe2+ leading to the evolution of N2O gas25-26.
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Figure 5.17. Fe MIL-100 activated at 250°C/12h upon exposure to NO followed by H2O, spectra
taken at 298K: IR spectra: cyan sample prior to NO; peaks observable at 1913 and 1896 cm-1.
Red line shows initial NO exposure and new peaks appear at 1822 and 1809 cm-1. Blue line after
rapid evacuation peaks at 1822 and 1809 cm-1 remain showing chemisorption of NO. Dark blue
line, after initial H2O exposure peak at 1822 cm-1 disappears, peak at 1809 cm-1 decreases in
intensity and a new peak emerges at 1770 cm-1. Pink line shows peak at 1770 cm-1 decreasing in
intensity. Green line shows peak at 1770 cm-1 decreasing drastically. Gold line shows peak at
1770 cm-1 is practically gone and peak at 1809 cm-1 has decreased significantly. Finally grey line
shows peak at 1809 cm-1 beginning to intensify.
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Figure 5.18. Left, IR spectra of gas phase of Fe MIL-100 activated at 250°C/12h upon exposure
to NO followed by H2O, spectra taken at 298K: Spectra showing the evolution of gas phase N2O
(2224 cm-1) and gas phase NO (1876 cm-1) peaks over time. (A) 99 min; peaks are observed at
2236, 2216, and 2203 cm-1 (centred at 2224 cm-1). (B) 133 min. (C) 159 min. (D) 361 min. (E) 410
min. Right shows a close up of the N2O peak region.
Figure 5.19. Graph of N2O evolution in the gas phase of Fe MIL-100 activated at 250°C/12h
upon exposure to NO followed by H2O, spectra taken at 298K: There is a general increasing
trend in the N2O peak area over time.
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These results show that certain MOFs (certainly those containing iron) do not exhibit
the perfect activation, storage and release of NO that has been observed for Ni and
Co CPO-27. Indeed once loaded it seems difficult to retrieve all the NO from the iron
CUSs. This explains why the release results from the iron-based MOFs are so poor
when compared with the amount of NO adsorbed. This could also explain some of
the poor release results from certain versions of M-CPO-27, although further
experiments would have to be carried out to prove this. It is clear from these results
that there is an extremely complex process occurring when activating and loading
MOFs with NO. The results shown here correlate well with the theory put forward in
chapter 4, explaining that the stability of the dehydrated structure will determine how
well the NO-loaded material will release its store of NO when exposed to water
vapour.
Chapter 5 NO storage and release from various MIL frameworks
172
5.6 Summary of chapter 5
As has been shown, MIL frameworks adsorb and deliver amounts of NO which are
considered to be of interest for possible biological applications. The fact that the
majority of these frameworks contain iron as the metal source is a significant
advantage over other frameworks as iron has limited toxicity for humans.
Unfortunately the iron frameworks (whether amine-grafted or not) do not show the
almost ideal NO release behaviour associated with Ni and Co CPO-27. This has been
explained using in-situ IR experiments and the results have shown the complex
process which occurs in iron based MOFs when loading and releasing NO. These
results give an insight into the key factors required when considering MOFs for NO
storage and the results that can be obtained from them. Despite the relatively poor
release of NO obtained from certain Fe MOFs studied here, there is still great
potential for the storage and release of NO for medical applications using Fe-based
MOFs.
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6 Other MOFs for NO storage and delivery
6.1 Introduction
The majority of this thesis thus far has focused on the M-CPO-27 series of materials
and iron-based MIL frameworks. However, other MOFs were also synthesised and
characterised using NO adsorption and release measurements. All the MOFs were
chosen as a comparison with either M-CPO-27 or another MOF already investigated
for NO storage and release. The MOFs chosen were Ni succinate, Ni STA-12 and
finally Mn and Cu BTT.
6.2 Aims of chapter 6
The overall aim in chapter 6 was to show the NO adsorption and release results
obtained from different MOFs and compare them with those already reported. It was
also an opportunity to compare different metal centres to see if any effect on the
storage and release of NO from different MOFs was observed. Ni succinate and Mn,
Cu BTT MOFs were synthesised and the sample of Ni STA-12 was very kindly
donated from the Wright group at the University of St Andrews.
6.3 Ni succinate
Paul Forster and Anthony Cheetham synthesised the Ni succinate MOF in 20021, and
there are numerous different MOF structures utilising different metals with succinic
acid as the organic linker2-5. Indeed, high-throughput analysis has shown that
reaction conditions play a decisive role in the framework produced from the same
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metal and succinic acid6 reactants. The Ni succinate that Forster and Cheetham
produced was the first porous succinate structure and also the first hybrid to display
full 3D metal-oxygen-metal connectivity. The structure of Ni succinate can be seen
in figure 6.1. It shows a framework similar to the honeycomb of M-CPO-27. This Ni
succinate material also contains coordinatively unsaturated metal sites (CUS) when
fully activated, and should therefore provide an interesting comparison with the M-
CPO-27 series of structures.
Figure 6.1 A portion of the Ni succinate structure, viewed down the c-axis. Hydrogen atoms are
removed for clarity.
Using the method described in the literature1, Ni succinate was successfully
synthesised using Ni acetate and succinic acid mixed in water in the ratio 1:2:50. The
mixture was then placed in autoclaves for 3 days at 150°C. Following synthesis,
characterisation methods were employed to confirm that the powder obtained was
indeed Ni succinate. Comparing both the experimental and theoretical powder
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patterns it can be seen that the pattern produced matches very closely with the
theoretical one (figure 6.2).
Figure 6.2 Experimental powder XRD pattern of Ni succinate (top) and theoretical powder
pattern of Ni succinate produced with Diamond 3.0 software (bottom).
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XRD analysis was then followed by TGA measurements. The graph obtained can be
seen below (figure 6.3). This closely matches the literature, and two distinct mass
losses are obtained. The first gradual mass loss between 50 and 250°C corresponds to
both the coordinated and uncoordinated water molecules being removed (~6%). The
second loss occurs at ~300°C and corresponds to pyrolysis of the succinic acid and
destruction of the framework (~50%).
Figure 6.3 An experimental TGA curve performed under air atmosphere of Ni succinate
showing the two distinct mass losses.
The results from both the XRD and TGA confirm that the required Ni succinate
phase has been obtained. Following dehydration procedures (240°C under vacuum)
the Ni succinate was exposed to NO for both adsorption and release measurements.
One key observation is that the Ni succinate samples change colour when activated,
from blue-green to a much lighter green. This is one of the indicators of CUSs being
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present in the structure. NO adsorption measurements on the framework were then
carried out. The NO adsorption/desorption isotherm can be observed in figure 6.4.
Figure 6.4 NO adsorption isotherm carried out at 298K for Ni succinate.
As can be seen both the total NO adsorbed and the amount of NO chemisorbed are
much lower compared with the Ni CPO-27 structure. However this is not surprising
as the pores in Ni succinate are congested with methylene groups from the succinic
acid and so there is much less space available in the structure for NO to occupy. The
theoretical chemisorption of NO for Ni succinate is 1.75 mmolg-1 based on 1 NO per
metal atom. The actual amount irreversibly adsorbed experimentally is 1.4 mmolg-1,
which is very close to the theoretical adsorption. This implies that there may be some
CUSs that are not fully unsaturated or that there may be some pore blockage which
does not allow NO into the pores as they are only ~4Å wide and NO has a kinetic
diameter of 3.1Å. Measurement of NO release from 4 samples showed an average
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release of ~1.1 mmolg-1 of NO and the samples released biologically significant
amounts of NO for about 12 hours. The graphs of release measurements can be seen
below in figure 6.5.
Figure 6.5 Total NO release and concentration measurements for Ni succinate over 24 hours.
As illustrated, the total NO released is almost the same as the amount initially
adsorbed. In fact, the framework releases 78.5% of its store which is much higher
than most other frameworks investigated. This is a significant result as it shows that
both Ni CPO-27 and Ni succinate release almost the same amount of NO as they
adsorb. This implies that Ni metal has a good affinity for NO, which is then easily
replaced with water when exposed to moisture.
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6.4 Ni STA-12
The vast majority of MOFs which have shown promise for gas storage and release
have used dicarboxylic acids as the organic linker. There has, however, been an
increase in research into alternative linkers for use in MOFs. One of the most heavily
researched alternative linker types is phosphonates7. The Wright group based at the
University of St Andrews have focused their efforts on synthesising MOFs using
phosphonate linkers8-9. They successfully created large pore metal phosphonate
structures in 2006 utilising two different phosphonate linkers8, N,N’–
piperazinebis(methylenephosphonic acid) and N,N’-2-
methylpiperazinebis(methylenephosphonic acid). Reactions of N,N’–
piperazinebis(methylenephosphonic acid) with nickel, cobalt and iron resulted in the
formation of a MOF known as STA-12 (St Andrews porous material-12), the
structure of which can be seen in figure 6.6. Ni STA-12 has the molecular formula
Ni2L·8H2O where L= O3PCH2NC4H8NCH2PO3. The structure consists of inorganic
chains of edge-sharing NiO5N octahedra and the resulting structure looks very
similar to that of Ni CPO-27. Indeed Ni STA-12 has CUSs upon activation of the
framework in a similar manner to that of Ni CPO-27, however as phosphonates show
higher thermal stability, Ni STA-12 is stable to a higher temperature by about 100°C.
The cobalt and iron versions of STA-12 are less thermally robust and indeed the iron
analogue collapses during dehydration8. However Ni STA-12 differs from Ni CPO-
27 in that during activation its structure changes. When initially removing the
uncoordinated (physisorbed) water molecules it retains its hexagonal honeycomb
structure. However, after treatment at 373K all the coordinated water molecules are
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removed and the structure shifts to a triclinic space group (P-1) and changes to an
elliptical shape rather than the hexagonal shape observed initially9 (see figure 6.6).
Figure 6.6 A diagram of the structure of Ni STA-12 viewed down the a-axis before and after
activation. As can be seen the structure changes during activation.
Ni STA-12 was chosen for NO adsorption measurements as it should provide a
useful comparison with Ni CPO-27 and Ni succinate. Ni STA-12 had also already
shown to be of significant interest in the storage of fuel related gases9. It has a very
similar structure visually to Ni CPO-27 and contains unsaturated Ni2+ sites when
activated, and as such was expected to show good adsorption and release of NO. A
sample of Ni STA-12 was very kindly donated by the Wright group to allow NO
experiments to be performed on this phosphonate-based MOF. Following activation
at 150°C, the NO adsorption measurements were carried out. The NO adsorption
curve can be seen in figure 6.7.
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Figure 6.7 NO adsorption isotherm for Ni STA-12 carried out at 298K.
As can be observed, a large amount of NO is adsorbed by Ni STA-12. This is not
unexpected as there should be the same number of CUSs per gram as for Ni CPO-27
and the structures are relatively similar. The theoretical adsorption of NO in Ni STA-
12 is 5.2 mmolg-1, assuming one NO per available Ni2+ site. It adsorbs 5 mmolg-1 and
when exposed to vacuum, retains about 3.5 mmolg-1, which is an indicator of
chemisorption. It is clear that the huge initial uptake of NO seen in Ni CPO-27 is not
observed in the Ni STA-12 structure.
Release experiments were also carried out on Ni STA-12. The same activation
procedure was applied (150°C under vacuum) and samples of Ni STA-12 were
exposed to 2 atm of NO. The release curves that Ni STA-12 displayed can be seen in
figure 6.8.
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Figure 6.8 NO release curves for Ni STA-12.
From figure 6.8 it can be seen that Ni STA-12 does not release its entire store of NO,
however it does release ~1.7 mmolg-1 which is about 50% of the total NO initially
adsorbed. It is also still releasing biologically significant quantities of NO after 14
hours. These results confirm that Ni is very good at binding and releasing NO in all
three of the structures investigated (Ni CPO-27, Ni succinate and Ni STA-12).
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6.5 Mn and Cu BTT
Another alternative ligand which has been used for the creation of MOFs is the
polytetrazolate-based ligand known as 1,3,5-tris(tetrazol-5-yl)benzene (BTT). This
ligand was used in the preparation of two isostructural frameworks which show
CUSs upon desolvation and display high hydrogen uptakes10-11. In 2006 Jeffrey
Long’s group produced a microporous MOF which contained unsaturated Mn2+ sites
after activation11. This activated MOF adsorbs a large amount of hydrogen and
through neutron scattering experiments it was shown that the hydrogen binds at the
exposed metal site. A Cu based isostructural analogue was also successfully
synthesised. Hydrogen storage measurements were also carried out on this version10
and it displayed an uptake of 5.7 wt% at 90 bar, which is slightly lower than the Mn
version which shows an uptake of 6.9 wt% at 90 bar.
The chemical formula for both Mn and Cu versions of this MOF is
[M(DMF)6]3[(M4Cl)3(BTT)8(H2O)12]2.42DMF.11H2O.20CH3OH where H3BTT =
1,3,5– tris(tetrazol-5-yl)benzene). The MOF’s structure is cubic, in which [M4Cl]7+
square planer units are linked via BTT3- ligands to form an anionic 3D framework
(see figure 6.9). A sodalite12 type cage structure is formed. Within this framework
water ligands occupy the sixth coordination site on each M2+. These water groups
can be removed under activation to allow access to the unsaturated Mn and Cu sites.
This framework is synthesised using DMF and therefore has to be solvent-exchanged
with methanol prior to activation to allow full activation and access to the
unsaturated metal sites. The structure shows a remarkable similarity to that of
HKUST-1 on which NO measurements have already been carried out13.
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Surface area measurements carried out on these frameworks show large BET N2
isotherms. The Mn version (when activated) displays a calculated BET surface of
2100 m2g-1 and the Cu version 1710 m2g-1. This discrepancy is due to shorter bond
lengths shown in the Cu version which contracts the unit cell parameters10.
Figure 6.9 (a) The tritopic ligand H3BTT. (b) The square-planer Mn4Cl surrounded by 8
tetrazolate rings (c) A portion of the activated MOF’s cubic structure shown down the a-axis.
Hydrogen atoms and solvent molecules are omitted for clarity.
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6.5.1 Synthesis of Mn and Cu BTT
Both versions of this MOF were synthesised. Initially the BTT ligand had to be
synthesised as it cannot be purchased through commercial vendors. Using the
methods described in the literature11,14 firstly 1,3,5-tricarbamoylbenzene then 1,3,5-
tricycanobenzene were synthesised, followed by 1,3,5-tris(2H-tetrazol-5yl)benzene
hydrochloride. Finally using the prepared linker the MOF structure could be formed.
6.5.1.1 Synthesis of 1,3,5-tricarbamoylbenzene
Following the procedure in the literature14, benzene-1,3,5-tricarbonyl trichloride was
added to concentrated ammonia solution. Once the vigorous exothermic reaction had
subsided a white precipitate formed which was then stirred for 2 hours at room
temperature. The solid was filtered, and washed with ethanol and diethyl ether before
being dried overnight in an oven at 110°C. This product was then used to form 1,3,5-
tricyanobenzene. 1,3,5-tricarbomoylbenzene is insoluble in all common solvents so
was used as prepared.
6.5.1.2 Synthesis of 1,3,5-tricyanobenzene14
A calculated amount of 1,3,5-tricarbamoylbenzene was added to DMF. Thionyl
chloride was added to the suspension over 1 hour while maintaining a temperature of
60°C. After the addition of the thionyl chloride, stirring at 60°C was maintained for a
further 6 hours in which time complete dissolution occurred. Pouring the solution
into dilute hydrochloric acid (HCl) to decompose unreacted SOCl2 resulted in a
dense white precipitate. The solid was filtered and washed with water until neutral to
pH paper and then dried at 110°C overnight. Crystallisation from a mixture of
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acetone and ethanol resulted in the product being formed as colourless needles. The
1H NMR of the product was carried out in deuterated dimethyl sulfoxide (DMSO)
and compared with the literature. The resulting spectrum can be seen in figure 6.10.
NMR [(CD3)2SO]: 1H δ 8.80 (s, 3H, o-C6H3).
Figure 6.10 1H NMR spectrum of 1,3,5-tricyanobenzene.
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6.5.1.3 1,3,5-tris(2H-tetrazol-5-yl)benzene hydrochloride11
A mixture of 1,3,5-tricyanobenzene, sodium azide and triethylamine hydrochloride
in 150 ml of toluene and 30 ml methanol was heated to reflux in a 500ml round-
bottomed flask for 3 days. After cooling to room temperature 100 ml of aqueous
sodium hydroxide (NaOH 1 molL-1) was added and the mixture was stirred for 30
minutes. The aqueous layer was then treated with 100 ml dilute HCl until a white
precipitate formed, and this was then filtered and dried before being dissolved in 1M
NaOH. The resulting clear colourless solution was titrated with ~75 ml of 1M HCl
until the pH was 4-5. The resulting white precipitate was washed with water,
methanol and acetone to yield the final product11. Again the 1H NMR spectrum was
collected using DMSO and the spectrum can be seen in figure 6.11. NMR
[(CD3)2SO]: 1H, δ 8.85 (s, 3H, o-C6H3). A 13C spectrum was also obtained and the
spectrum is in shown in figure 6.12. NMR [(CD3)2SO]: 13C, 125.72 (o-C of C6H3),
129.13 (ipso-C of C6H3) and 157.11 (C of tetrazol).
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Figure 6.11 1H NMR spectrum of 1,3,5-tris(2H-tetrazol-5-yl)benzene hydrochloride.
Figure 6.12 13C NMR spectrum of 1,3,5-tris(2H-tetrazol-5-yl)benzene hydrochloride.
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6.5.1.4 Synthesis of the framework
Both versions of the framework were synthesised in a similar manner. A metal salt
solution of Mn or Cu chloride was dissolved in methanol and added to a solution of
H3BTT.2HCl.H2O.CH3OH dissolved in DMF in the Teflon liner of an autoclave. The
pH of the slurry was adjusted to ~3 using 1M HCl. The mixture was then capped and
placed in the metal autoclave before being sealed. The Mn version was heated at
70°C and the Cu analogue was synthesised at 60°C, both for 24 hours before filtering
the resulting powder and washing with DMF and methanol.
6.5.2 Characterisation of Mn and Cu BTT
Following successful synthesis, powder XRD was employed to characterise the
synthesised Mn and Cu BTT structures. It should be noted at this point that both Mn
and Cu BTT are extremely hygroscopic. This meant that XRD measurements were
only taken over short times, rather than using overnight runs. Both Mn and Cu BTT
were run on the Phillips diffractometer for 90 minutes to prevent degradation of the
powder samples. The powder XRD patterns for Mn and Cu BTT can be seen in
figure 6.13 along with the theoretical pattern produced for Mn BTT from the cif file
using the Diamond 3.0 software. As can be seen the patterns match each other and
the theoretical pattern well, although some degradation occurs due to air exposure.
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Figure 6.13 The top graph shows the experimental powder XRD patterns of both Mn and Cu
BTT. The bottom graph illustrates the theoretical XRD pattern for Mn BTT generated using the
Diamond 3.0 software package.
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6.5.3 NO adsorption and release results for Mn and Cu BTT
Due to the hygroscopic nature of these MOFs, obtaining accurate NO adsorption and
release measurements was difficult. Indeed, following failed attempts to solvent
exchange these materials with methanol without exposure to air, it was expected that
the NO adsorption and release results would be poor. Unfortunately, NO adsorption
measurements could not be made on a solvent exchanged sample due to the
degradation shown by the samples during the solvent exchange procedures.
Nevertheless NO adsorption and release measurements were taken for both versions
of this MOF prior to solvent exchange and the results are detailed below.
The NO adsorption graph for both the Mn and Cu versions of this MOF can be seen
in figure 6.14. As explained earlier, these curves are for the samples that have not
been solvent exchanged and therefore will most likely contain DMF solvent
molecules even after activation has been carried out. The activation conditions used
were identical for each version (150°C under vacuum).
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Figure 6.14 NO adsorption curve for Mn and Cu BTT, with solvent molecules possibly still
present, carried out at 298K.
As can be seen, the Mn version adsorbs more NO compared with the Cu version.
This was not unexpected as results carried out on both frameworks for hydrogen
adsorption showed that the Mn version performed better and indeed the Mn version
shows a higher surface area10-11. The total amount of NO adsorbed is low compared
with many other frameworks investigated in this thesis for NO storage. This can be
explained by the lack of available metal sites due to guest DMF molecules still
present in the pores. In the literature the surface area almost doubled in the Mn
version (1100 to 2100 m2g-1) when the framework was solvent exchanged and then
activated. It also means that there are less CUSs available for the NO to bind to as
there are still DMF molecules present in the pores.
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Following this, partially evacuated samples were loaded with NO and placed in the
sample holder of the NO analyser to quantify the amount of NO released. The results
can be seen in the curves below.
Figure 6.15 NO release curves for the solvent filled samples of Mn and Cu BTT.
As illustrated in figure 6.15 there is very little NO released from the frameworks.
This is not surprising as if the NO was inserted into the pores the solvent molecules
would probably block the path for water molecules to diffuse into the pores in order
to replace the NO molecules at the metal sites.
A sample of each framework which had been solvent-exchanged and sealed under
argon was very kindly donated by the Long group in the U.S.A for comparison in
NO storage and release. NO release results were possible by loading the samples into
sealable vials and then into an air-tight schlenk tube using a glovebox under argon
atmosphere. The samples were then activated in the normal manner before NO
release results were obtained. The results can be seen below.
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Figure 6.16 NO release from the M BTT solvent exchanged samples from the USA.
As can be seen the amount of NO released from the Mn version of this framework
increases dramatically from ~0.04 mmolg-1 to ~0.27 mmolg-1. There is no significant
improvement noted in the Cu sample. However as was observed for HKUST-1, Cu
based MOFs do not seem to release the NO after it is bound to the metal during the
adsorption process. HKUST-1 showed similar behaviour, as it adsorbed ~3 mmolg-1
but only released 2μmog-1 of NO. As the two frameworks are relatively similar in
structure, it is not surprising that the NO release from Cu BTT is very poor.
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6.6 Summary of chapter 6
It has been shown that Ni metal provides an excellent environment for NO to bind to
and be released from. Both Ni STA-12 and Ni succinate MOFs show good
adsorption and release of NO, although not as high as Ni CPO-27. Cu based MOFs
have once again been shown to release very minimal amounts of NO as evidenced by
Cu BTT. Mn BTT shows good NO adsorption and releases about 15% of the NO
chemisorbed. This value is higher than the corresponding Mn CPO-27 which only
released 5% of the total NO initially chemisorbed. All these MOFs still display
higher NO adsorption compared with the best zeolites. Overall, the MOFs studied in
this chapter show good potential for the storage and release of NO.
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7 Formulation of MOFs for medicinal
applications
7.1 Introduction
Arising from the exceptional performance shown by MOFs in their ability to store
and controllably release NO, it is of interest to investigate the wide range of possible
therapies utilising MOFs in the area of medicine. MOFs have potential for both in
vitro and in vivo applications. Obviously the easiest applications to test for and
investigate are those using NO as a wound healing therapy due to the topological
nature of such treatment. This chapter therefore focuses on initial topological or
dermatological investigations. In addition to this, the adsorption and delivery of
drugs or pharmaceuticals is of significant interest as an application for MOFs.
Therefore, initial investigations using MOFs to store antibiotics for medicinal
purposes have also been undertaken.
7.2 Aims of chapter 7
The main aim in chapter 7 is to show the initial progress which has been made
towards implementing NO releasing MOFs in different formulations. There are many
potential methods of presenting NO-loaded MOFs in formulations and as such many
of the possibilities have been tested to see if the amount of NO released can be
controlled for the application required. The overall goal is to establish formulations
of MOFs to deliver their store of NO in a suitable manner. For example, in the form
of a bandage, or through a topically applied cream.
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7.3 In vitro applications
Due to the significant role of NO in wound healing1, one of the main aims for any
NO-releasing MOF would be its use as a therapy in accelerating wound healing
times. This has been shown to occur in patients with diabetic wounds (wounds which
have very long repair times and are extremely susceptible to infection). It has also
been demonstrated to be useful in healing second degree burns in mice2. In fact
several healing therapies have already been developed for delivering NO into a
wound3-4. However, some of these have had detrimental effects to the skin5. Our
method, employed here would only release pure NO and therefore not harm the skin.
In addition to this, because NO would be delivered directly onto the site required, it
will only be local and not systematic effects that would be observed. As all the
samples of MOFs synthesised are produced in powdered form, a suitable method for
storing powders has to be found so that they can be used in a practical formulation
which can be commercially sold in a patient friendly manner. As such numerous
different applications were tested for practicality and the ability to release the stored
NO.
7.3.1 Porous paper bags
The first method of delivery attempted was to show that a porous paper bag
containing NO-loaded MOF powder would release the same amount of NO as the
powder by itself. This was to illustrate the possibility of storing and releasing NO
from a “bandage”. A similar product known as QuikClot which utilises zeolites in a
bandage is currently available6. To test this, a number of porous papers, tea filters
and teabags were investigated. The teabags were emptied of their contents before
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being replaced with MOF sample and sealed using a heat sealer. The bags were
activated and loaded with NO, before being stored in vials. Figure 7.1 shows a NO-
loaded MOF bag. It was required that the bags be stored in vials to ensure that air
exposure to the sample was minimal.
Figure 7.1 An NO-loaded MOF bag.
The MOF chosen for this investigation was the Ni CPO-27 framework which
displayed exceptional NO storage and delivery properties as shown in chapter 4.
When being used for in vitro applications the toxicity of the nickel is of no concern,
however many people have allergies to Ni metal and that would preclude certain
patients using this formulation. Following the production of NO-loaded MOF bags,
the NO release measurements were carried out and can be seen in figure 7.2. Initial
measurements from the Ni CPO-27 loaded bag yielded the expected 7 mmolg-1,
which is equivalent to the amount released by the powdered samples. However this
amount of NO was released over almost 3 days compared with the release time of 1
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day observed for the powder by itself. This is an excellent result as it allows the
amount of NO to be controllably released over a few days as opposed to only an
initial burst of NO.
Figure 7.2 NO release profiles for a Ni CPO-27 loaded bag.
The release results suggested that there was no detrimental effect arising from the use
of porous paper. Another key requirement for any NO-releasing application is the
ability to be stored for lengthy time periods. Initial storage using a vacuum sealer
yielded results whereby the total amount of NO released decreased week by week
(figure 7.3). As can be seen, initial release from a Ni CPO-27 bag showed the
expected ~7 mmolg-1 of NO release. However subsequent release profiles show a
reduction which was attributed to the vacuum bag used not being perfectly gas tight.
Following this, air-tight glass sample vials were used to store the ready-made bags
and this resulted in no reduction in the total amount of NO being released from Ni
CPO-27 bags (figure 7.4). The slight differences in total NO released arise from
calculating the mass of MOF used in the experiment by weighing porous bag by
difference. This causes small errors in the mass of the MOF used, leading to very
slight differences in the graphs. This proves that the storage of these bags is very
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important to their successful practical application. The technology of using gas tight
foil packaging already exists and is in use in the aforementioned QuikClot products,
and it could easily be implemented for storing NO releasing bandages based on the
porous materials.
Figure 7.3 Storage of MOF bags under vacuum leads to a decrease of NO released over weeks.
Figure 7.4 NO release profiles for bags, showing that there is no loss
of NO released when stored in air-tight vials.
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Overall it has been shown that it is possible to store and release NO from MOFs in a
porous paper bag with no detrimental effect to the total NO available for release
being observed. It has also been demonstrated that it is possible to store these
“bandages” for long periods of time without any loss of total NO releasable.
7.3.2 NO releasing creams
One of the most heavily researched areas in NO releasing formulations is the use of a
NO releasing cream7. A prime example uses an acidified nitrate cream4, where
sodium nitrate and citric acid are combined leading to NO being released.
Unfortunately one of the major side-effects of this treatment is that it burns the skin5.
Another method which is currently being investigated and that would be similar to
the use of MOFs in creams is NO-releasing zeolites in creams. Research is currently
ongoing for this application, and it has been shown that zeolites display no unwanted
side effects when placed into a cream formulation5.
A variety of different creams were initially tested. Water based, paraffin based and
wax based creams were all used. The reason for this was to provide an insight into
the release of NO from a cream which promotes the replacement of NO with water
(aqua based cream) and compare it with a cream that should prevent that reaction
happening too quickly (paraffin based cream). This should delay the total release of
NO from the MOF. If this delay in NO release was possible, then a cream of this sort
could last a number of days or weeks as opposed to the number of hours shown in the
powder release experiments. The experiment was set up in the following manner. A
calculated amount of each cream was placed into a sealable vial. An amount of pre
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NO-loaded MOF was added and the two were then mixed before being sealed with a
vial cap fitted with a septum. The flowing “wet N2” line was then fed into the vial
using a needle and the output was fed through a different needle to the analyser.
Several different frameworks were investigated, Cr MIL-100 and Cr MIL-101
together with Ni and Co CPO-27. Figure 7.5 shows the release curves for Cr MIL-
101 and Cr MIL-100 with the three different creams. A sample size of 10 wt% MOF
was used in the cream mixtures.
Figure 7.5 NO release results from the Cr MIL frameworks when mixed with the various
different creams.
As can be seen, the amounts of NO released from the Cr MIL-101 structure are about
half of the amount the powder releases by itself. The same result is observed with the
Cr MIL-100 structure. The cream that allows the smallest amount of NO to be
released is the paraffin based cream. This is not unexpected as the paraffin stops
moisture entering into the MOF and therefore the NO is not being substituted for the
water molecules in the “wet N2” gas. This is a result that could be useful as it should
prolong the release of NO. However, the paraffin cream does not allow any moisture
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in at all and so does not have the desired effect. The aqua based cream shows
potential, as although it releases its NO quite quickly, it might find use as an
antibacterial delivery agent as these require an initial burst of NO8 which also
promotes wound healing.
Co and Ni CPO-27 were also investigated using the three different creams and the
results can be seen below.
Figure 7.6 NO release graphs for the Ni and Co CPO-27 frameworks in the three different
creams.
Once again, the paraffin based cream inhibits the release of NO from the mixture and
shows the poorest release of NO. The aqua based cream shows good release of NO
from the CPO-27 structures over 4 days, which is a much improved and more
promising result. The wax cream appears to produce unpredictable results as in some
release curves it shows good release, but in others it displays poor performance. One
reason for this could be the fact that the release measurements are dependent on the
mixing of the NO-loaded MOF with the pre-weighed cream in a vial. If the mixing is
inadequate then the release measurements will either follow the powder release
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profile closely or show no release at all. At the same time, as soon as the NO-loaded
MOF powder comes into contact with both air and cream, it starts to release its
gaseous content. So the mixing stage is crucial, as too long spent mixing and the
cream mixture will show poor release, but too little mixing results in the powder
release pattern being repeated. Much more work is required to achieve an optimal
formulation of cream that will both inhibit and help release NO from a framework.
Indeed even mixing different quantities of these creams in a specific ratio could
result in the desired controlled release of NO. An example could be the use of 50%
of the paraffin cream with 50% of the aqua based cream.
7.3.3 NO releasing hydrocolloids
The final formulation that has been initially investigated is the possible utilisation of
a NO-releasing hydrocolloid. Hydrocolloids are among some of the most widely
used dressings in medicine. They utilise gel forming agents and, when combined
with a polymer to produce a waterproof film or wafer, form a gel when applied to a
wound. The combination of a polymer and NO-loaded MOF together with a binder
such as cellulose could be a promising combination for use as a wound healing
antibacterial dressing. The hydrocolloids made in the laboratory used 10% cellulose,
50% poly-isobutanol (PIB) and 40% NO-loaded MOF material. Heating the PIB to
~80°C allows it to become flexible. The cellulose and the NO-loaded MOF are then
added and mixed together under an inert atmosphere resulting in the production of a
hydrocolloid with the ability to release NO over several days. For this study Ni CPO-
27 was chosen as the MOF to be used. In figure 7.7 a picture of the hydrocolloid
formed in the laboratory can be seen. Chemiluminescence measurements of NO
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release were taken from the hydrocolloid and the resulting curves are illustrated in
figure 7.8.
Figure 7.7 Photograph of a NO-loaded hydrocolloid.
Figure 7.8 NO release curves for the hydrocolloid shown against a powder sample for
comparison.
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These initial results show major potential as, although releasing ~2.5 mmolg-1 (about
half of the amount released by the powder used for comparison) it released this store
over almost 10 days, which is extremely significant. Further to this, the amount of
NO released is much higher than that which is released by powdered zeolites9-12 and
therefore merits further investigation. For a hydrocolloid to be useful it must
demonstrate that it will not leach out the toxic metal contained within the MOF
structure. To investigate this, atomic adsorption measurements were carried out to
calculate the amount of nickel leaching out of the prepared hydrocolloid. A pellet of
Ni CPO-27 was used as a comparison. The two samples were placed into PBS
(phosphate buffered saline) solution and kept at 37°C (simulating body temperature)
using a water circulator over several days. Measurements were taken to calculate the
total amount of nickel contained in the solution. Figure 7.9 shows the results for
both. As can be seen the hydrocolloid retains the Ni from the MOF significantly
better than the pellet sample of Ni CPO-27. This result confirms expectations that
when mixed with PIB the MOF will not decompose and leach out as much nickel as
the MOF by itself, due to the polymeric nature of PIB.
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Figure 7.9 Atomic adsorption measurements carried out on a prepared hydrocolloid and a Ni
CPO-27 pellet for comparison.
7.4 Testing NO release in PBS solution
The only possible initial testing which could be conducted relative to “in the body”
applications is to see how stable the frameworks are in simulated body fluid and to
monitor the amount of NO that is released from NO-loaded materials when placed in
a phosphate-buffered saline (PBS pH 7.4) solution. The flowing “wet N2” gas is only
representative of scarce water conditions, such as those situations using NO
topologically applied to skin. Using PBS is the best way to simulate physiological
conditions similar to those encountered in the body. The testing for stability in
simulated body fluid has already been carried out13 and it showed that the amount of
metal ions leaching out was minimal and the framework would have certainly
Chapter 7 Formulation of MOFs for medicinal applications
212
delivered its entire store of NO before dissolving in the solution. The NO release
measurements were carried out on a variety of frameworks. The M-CPO-27 series
and a variety of MIL frameworks were investigated and the results are reported
below. The experiment was set-up in a similar manner to the cream investigations,
using sealable vials and needle-fed gas lines. In this case the NO-loaded MOF was
placed into the vial along with a miniature stirring bar. The septum lid was then
placed on top, prior to injecting PBS through the septum into the vial, before
connecting the appropriate needles to the analyser and supply of “wet N2”.
Studies were carried out using the M-CPO-27 series using M= Co, Ni and Zn metals.
Zinc was chosen as it has no toxicological complications unlike the Co and Ni
analogues. However, the zinc version does not release the same significant amount of
NO which the Co and Ni frameworks liberate. Therefore Co and Ni CPO-27 were
also investigated to see if they still release their remarkable store of NO in a PBS
solution. The release results for the three frameworks can be seen in figure 7.10.
Initial release results using the NO-loaded powder show only a total NO release of
0.4 mmolg-1 when the PBS is injected. Follow-up experiments used pellets
constructed from 10 wt% of polytetrafluoroethylene (Teflon) combined with the
MOF. This resulted in much better total NO release measurements (3.5 mmolg-1). It
is noticeable that the half life of NO delivery is reduced from several hours under
flowing gas conditions, to only ~10 minutes when exposed to the PBS solution. The
lack of NO released from the powder samples can be rationalised by the NO being
liberated so quickly that the analyser cannot detect it. The detector only measures
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NO concentrations up to ~500 PPM. Most samples of M-CPO-27 when initially
inserted will register over this value but will quickly fall below the limit for
detection. When the Co or Ni CPO-27 powder is exposed to the PBS, it rises above
the detector limit and eventually returns below the limit. However, when over the
limit, it may be releasing much greater amounts of NO very quickly and therefore
could be releasing the expected amounts of 5-6 mmolg-1 without being registered.
The decrease in total NO liberated from the pellet samples could be attributed to the
Teflon blocking some of the pores when it is combined with the MOF in the pellet
press. The ability of these MOFs to release their entire store seems to be retained
even when placed into a buffer solution. Both versions of Zn CPO-27 show very
minimal release of NO, in fact only about one-fifth of the amount which the powder
itself releases. However, even the small amount released could still be of biological
significance as the release takes place over 30 hours and in a controlled manner.
Of most interest, however, were the iron based carboxylates of MIL-88 and MIL-100
due to studies showing that iron carboxylates pose no health risk14. Fe MIL-88-A, B,
B-2OH and B-NO2 were all run in the analyser and exposed to PBS buffer solution.
The results for Fe MIL-88-B were extremely poor as it only released 0.016 mmolg-1
of NO. Furthermore the results for Fe MIL-88-B-NO2 were inconsistent with large
variances from one experiment to the next. The results for Fe MIL-88-A and Fe
MIL-88-B-2OH are shown in figure 7.11 below. The Fe MIL-88-A sample shows a
significant increase in the amount of NO liberated compared with the powder run
under flowing “wet gas” conditions. This can be explained as studies have shown
that under PBS conditions Fe MIL-88-A decomposes, this would therefore liberate
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much more NO as the structure is collapsing. The Fe MIL-88-B-2OH also shows
improved NO release under PBS buffer conditions compared with the scarce water
conditions reported earlier. Fe MIL-100 was also tested although this experiment was
carried out using distilled water. The MIL-100 with injected water shows a lower
total release. However, it is encouraging that the release lasts longer than the powder
itself under flowing “wet gas” conditions (see concentration curve of figure 7.12).
These results show potential and merit further research for possible in vivo
applications using NO delivery therapies from MOFs.
Figure 7.10 Top left, the NO release curve for powdered samples of Ni and Co CPO-27 in PBS
buffer solution. Top right, a ten-fold increase in NO release observed using pellets of the same
MOFs. Bottom centre, shows the release curve for both versions of Zn CPO-27.
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Figure 7.11 NO deliveries from Fe MIL-88-A and Fe MIL-88-B-2OH under PBS buffer
conditions.
Figure 7.12 NO release curves for Fe MIL-100 under flowing wet gas (powder) and under aqua
conditions (in water).
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7.5 Preliminary biological investigations of NO-releasing
MOFs
As has been shown above, MOFs can release their store of NO under PBS conditions
which mimic the body’s own physiological environment. It is important however
that, when released, this store of NO promotes a relevant tissue response. As has
been shown already, NO-loaded MOFs can completely inhibit the formation of
platelet aggregation in blood20. To see the effect of an NO-loaded MOF on tissue, an
initial biological experiment was carried out21. The impact of a pressed pellet of Ni
CPO-27 (5 mg) on pre-contracted pig coronary arteries in vitro was investigated
(figure 7.13). Placement of pellets a distance of 2 mm from the vessel in the 10 mL
organ bath resulted in rapid 100% relaxation of the vessel. The pellet could be seen
to generate bubbles of gas for 10 minutes of submersion, although the relaxation
remained maximal for longer than 1 hour. In some experiments (figure 7.13), the
pellet was removed from the bath after 10 minutes and the relaxation was seen to
gradually recover. Parallel control experiments with NO-free Ni CPO-27 MOFs
failed to cause relaxation and did not generate bubbles on submersion, indicating that
NO release from the loaded MOF is responsible for the relaxing effect.
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Figure 7.13. Representative trace showing the vasodilatory effect of NO-loaded Ni CPO-27 in a
pre-contracted porcine coronary artery. A pellet (~5 mg) of NO-loaded Ni CPO-27 was placed in
the organ bath (10 mL) and removed as indicated. Within 4 minutes of the addition of the pellet,
100% relaxation was achieved, and the relaxation slowly recovered upon pellet removal. In
experiments where the pellet was left in the bath, recovery was not seen for up to 1 hour after
pellet addition.
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7.6 Antibiotic loading in Ni CPO-27
As mentioned in the introductory chapter, one of the applications that has been
targeted by chemists interested in biological therapies has been the adsorption
storage and delivery of pharmaceuticals14-16. So far the Férey group has led the way
in this niche field of MOFs. They have demonstrated that it is possible to store large
amounts of ibuprofen in MIL-10116, deliver ibuprofen from MIL-53 over an
extremely long time period15 and most recently they have demonstrated the ability of
MOFs to store and release significant amounts of both anti-AIDS and anti-cancer
drugs14. Using this work as a basis the storage of antibiotics was attempted using Ni
CPO-27. The adsorption of ibuprofen (figure 7.14) was also attempted to compare
and contrast with the amounts stored in MILs 101,100 and 53.
Ibuprofen is a well known pharmaceutical and is commonly used as an anti-
inflammatory drug17. It was introduced into the UK in 1967 and the USA in 1974
and is classed as a non-steroidal anti-inflammatory drug (NSAID). It also has
analgesic effects which are attributed to its anti-inflammatory nature. Metronidazole
(figure 7.14) is an antibiotic18-19 which is used to treat a variety of both gram-positive
and gram-negative bacteria. It is notably used to treat Clostridium difficile (C. diff) a
gram positive bacteria which is most commonly found in hospitals and nursing
homes which causes severe intestinal infection. Due to the small size and functional
groups of metronidazole, it should be readily adsorbed in Ni CPO-27.
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Figure 7.14 Drugs stored within Ni CPO-27. Ibuprofen (left) and metronidazole (right) Carbon
atoms shown as grey, oxygen as red, hydrogen as white and nitrogen as blue.
The ability to load drugs into Ni CPO-27 in combination with NO would lead to the
possibility of double functionality which would be extremely useful as a formulation.
For example, a bandage containing a MOF loaded with both NO and metronidazole
could be used to ensure that no infection occurs while the wound is being repaired
with the NO.
Testing of 1:2, 1:3 and 1:4 ratios of MOF:drug were used. A calculated amount of
Ni CPO-27 was activated and stored using the procedure described earlier. Ibuprofen
and metronidazole were added in calculated amounts to sample vials. To the sample
vial 10ml of solvent was added (dried hexane for ibuprofen and dried methanol for
metronidazole). Once the drug had fully dissolved in the solvent the dehydrated
MOF sample was added to the sample vial and the mixture was left stirring for 3
days. Using a variety of characterisation methods it was shown that the drugs had
indeed been adsorbed inside the pores of Ni CPO-27.
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7.6.1 Ibuprofen loading of Ni CPO-27
As explained earlier, samples of dehydrated MOF were exposed to a stirring solution
containing dissolved ibuprofen in hexane for 3 days. The resulting powder was
centrifuged and dried. Accurate weighing measurements before and after the
adsorption process led to estimates of how much ibuprofen had been adsorbed by the
Ni CPO-27.
There was no noticeable difference in the adsorption amounts shown between the
different ratios of MOF:ibuprofen. The average amount of ibuprofen adsorbed using
this method was observed to be 0.3973g of ibuprofen and hexane per gram of
activated MOF. This means that if the ibuprofen was interacting with the CUSs, then
30% of the metal sites available are being bound to the drug molecule. However this
value could be inaccurate as there is residual hexane still present in the framework.
To further investigate the adsorption of ibuprofen in Ni CPO-27, CHN elemental
analysis was used. Following immersion in the hexane solution containing ibuprofen,
it was expected that some residual hexane may still be present in the pores. This was
removed using an activation temperature of 100°C under vacuum. The formula of the
dehydrated structure is Ni2(C8H2O6), which has the following composition; C =
30.85% and H = 0.64%. For comparison the hydrated Ni CPO-27 structure has the
following formula and expected and calculated composition
M2(C8H2O6)(H2O)2.8H2O. Expected C = 19.56%, H = 4.48% and calculated C =
20.09%, H = 4.02%. The percentages for the ibuprofen loaded structure were shown
to be C = 38.84% and H = 3.84%. This indicates that ibuprofen has indeed been
Chapter 7 Formulation of MOFs for medicinal applications
221
adsorbed into the pores of Ni CPO-27. Using the calculated amounts of C and H it
can be estimated that the formula for the ibuprofen loaded Ni CPO-27 is
Ni2(C8H2O6).0.35(C13H18O2), thus indicating an adsorption of 0.232g ibuprofen per
gram of activated MOF.
The final method used to estimate the amount of ibuprofen incorporated into Ni
CPO-27 was TGA. The graph comparing the two samples can be seen in figure 7.15.
Figure 7.15 TGA curves of Ni CPO-27 and Ni CPO-27-IBU.
Clearly ibuprofen has been adsorbed as the TGA profile has changed considerably.
Using TGA as an estimate of ibuprofen content gives an adsorption of 0.2007g
ibuprofen per gram of activated MOF. This is taken from the loss of mass in the
region between 230 and 250°C. However TGA is not ideal for estimation of an
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organic molecule in a MOF as some of the ibuprofen may remain trapped within the
pores until the structure completely collapses.
Overall the results for the different characterisation methods for estimations of
ibuprofen content are as follows;
Figure 7.16 Table showing estimates of ibuprofen adsorption by Ni CPO-27.
As can be seen the TGA and the elemental analysis result match closely. The amount
of ibuprofen adsorbed into Ni CPO-27 when estimated from accurate weighing is
most likely to be inaccurate due to the presence of residual solvent. Indeed a close
look at the TGA curve shows that ~22% of the mass is lost before the MOF releases
the ibuprofen. If the mass changes value is decreased by 22% this results in an
estimation of ibuprofen content of 0.3g IBU per gram activated MOF. With the other
MOFs studied for ibuprofen storage the most accurate method was shown to be
elemental analysis15-16. The amount of ibuprofen actually adsorbed is comparable
with that adsorbed by MIL-5315. The amount adsorbed by MIL-100 and MIL-101
was in fact much higher. However, this is to be expected as they contain much larger
cages and pore sizes compared with Ni CPO-27. MIL-101 has pore sizes of 29Å and
Estimation of Ibuprofen content (g IBU/g activated MOF)
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34Å wide compared with only 11Å wide for Ni CPO-27. Added to this, an ibuprofen
molecule is ~10Å wide by ~5Å in height.
The testing carried out so far has not totally proved that the ibuprofen is actually in
the pores of the MOF, although it does show that something has been adsorbed. To
show that ibuprofen has indeed been adsorbed into the Ni CPO-27 pores, infrared
spectroscopy (IR) was undertaken for samples of Ni CPO-27, ibuprofen and the
ibuprofen loaded Ni CPO-27 (Ni CPO-27-IBU). The results can be seen in figure
7.17. The IR spectra show that ibuprofen has indeed been incorporated into Ni CPO-
27. Particularly with the huge increase in intensity of the υAr(C-H) bands at 3050 
cm-1 are due to the aromatic groups of the ibuprofen. Slight increases in the υ (C=O) 
and υ (C-H) at 2600 cm-1 and 1725 cm-1 are also characteristic of incorporation of the
drug into Ni CPO-27. These observations were also made for the previous MOFs
studied for ibuprofen storage15-16.
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Figure 7.17 IR graphs for Ni CPO-27 (blue), Ni CPO-27-IBU (dark yellow) and ibuprofen
(magenta). As can be seen the ibuprofen loaded Ni CPO-27 displays many of the peaks seen in
the ibuprofen sample indicating incorporation of the drug into the pores of the framework.
7.6.2 Metronidazole loading in Ni CPO-27
A similar adsorption method was used to introduce metronidazole into Ni CPO-27.
However, in this case methanol was used as the solvent as metronidazole does not
dissolve in hexane. Following careful calculations and exposure of dehydrated MOF
samples to pre-dissolved metronidazole, characterisation methods were used to
quantify the amount of metronidazole incorporated by Ni CPO-27.
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Using accurate weighing of the MOF before and after impregnation yielded an
average uptake of 0.436g of metronidazole per gram of activated MOF. However, as
explained earlier, this method is very unreliable due to the large error present in
weighing individual samples and due to residual solvent. Especially in this case as
methanol is a much less volatile solvent compared with hexane. Indeed it is also
possible that some methanol may still reside in the pores of Ni CPO-27. However, it
does give an indication that metronidazole has indeed been adsorbed.
The next characterisation method utilised was CHN elemental analysis, using the
calculated and expected ratios of both the hydrated and activated samples of Ni CPO-
27 as a comparison. The results obtained were as follows: C = 31.98%, H = 3.66%
and N = 3.46%. This result shows clearly that metronidazole has been adsorbed as
metronidazole contains 3 nitrogen atoms per molecule, whereas Ni CPO-27 does not
contain any nitrogen atoms. Calculating the amount of metronidazole present using
these ratios gives a formula of Ni2(C8H2O6).0.3(C6H9N3O3). This results in an
estimation of 0.165g of metronidazole for 1g of activated MOF.
The final characterisation method was TGA. A sample of metronidazole-loaded Ni
CPO-27 (Ni CPO-27-METRO) was run and the graph produced is shown in figure
7.18.
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Figure 7.18 TGA curves of Ni-CPO-27 and Ni CPO-27-METRO.
It is much more difficult to observe at exactly which point the metronidazole is
released from the framework. However, attempts to remove the excess methanol and
retain the metronidazole showed that at 100°C under vacuum all the metronidazole is
released. This would indicate that the metronidazole is released in the TGA curve
between 100 and 170°C, which indicates a mass loss of 11.337%. This gives an
estimate of metronidazole adsorption of 0.11337g of metronidazole per gram of
activated Ni CPO-27. As with the TGA for the ibuprofen-loaded material, this value
underestimates the actual value as some of the drug may remain trapped in the pores
until the structure collapses at 250°C.
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The overall results can be seen in figure 7.19. Once again the most reliable estimate
of metronidazole content of Ni CPO-27 is given by the elemental analysis.
Figure 7.19 Table showing the estimated adsorption values of metronidazole in Ni CPO-27.
Again the estimation of metronidazole content using mass changes and accurate
weighing is inaccurate due to solvent content. Unfortunately the solvent is released at
the same time as the drug. This also means that the TGA estimation is inaccurate for
this reason as well as residual metronidazole content.
Finally IR measurements were taken to show that the metronidazole had indeed been
adsorbed into the pores. Figure 7.20 shows the IR spectra for the dehydrated Ni
CPO-27, the metronidazole-loaded Ni CPO-27 and the metronidazole by itself.
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Figure 7.20 IR spectra for the three samples.
As shown above it is very hard to see peaks present in the Ni CPO-27-METRO
sample which are representative of metronidazole. Unfortunately, many of the most
obvious peaks in the metronidazole overlap with peaks already present in the Ni
CPO-27. For example the imidazole ring peak of metronidazole is observed at 800
cm-1. The most obvious peak which is missing from the Ni CPO-27-METRO sample
is the υ(C-H) from the imidazole ring at 3100 cm-1. Clearly the IR result is
inconclusive and further characterisation would be necessary such as solid state
NMR to prove that metronidazole had indeed been adsorbed.
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7.6.3 NO adsorption in ibuprofen-loaded Ni CPO-27
As mentioned earlier, the storage of both NO and drugs within MOFs would provide
potential for double functionality. To this end initial NO adsorption experiments
were carried out on a sample of ibuprofen-loaded Ni CPO-27 to see if it was possible
to store any NO within the framework as well as the already stored anti-
inflammatory. Activation of the sample was carried out at 80°C to avoid removing
the ibuprofen. The NO adsorption graph can be seen in figure 7.21. It illustrates that
it is indeed possible to store both NO and ibuprofen within the same framework. The
sample irreversibly stores ~3.3 mmolg-1 of NO which is a strong indicator that the
NO is binding to the CUSs available as the ibuprofen would be expected to interact
with the linker.
Figure 7.21 Experimental NO adsorption isotherm of ibuprofen-loaded Ni CPO-27 carried out
at 298K.
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A significant result is that the first point in the adsorption curve which is responsible
for the vast majority of the NO stored in both Ni CPO-27 and ibuprofen loaded Ni
CPO-27 takes significantly longer to reach equilibrium in the ibuprofen loaded
sample compared with the bare framework. Figure 7.22 displays the adsorption of
NO over time. It is clear from this graph that the ibuprofen delays the NO from
accessing the pores and in particular the CUSs.
Figure 7.22 A graph showing the difference in time for equilibrium to occur for the first NO
adsorption point between the ibuprofen-loaded Ni CPO-27 and the bare framework Ni CPO-27.
This result shows major potential for further research to be conducted in this area. If
it takes a long time for the NO to enter into the pores and attach to the vacant metal
site perhaps the NO release curve will display a longer release time.
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7.6 Summary of chapter 7
In summary it has been shown in this chapter that MOFs present significant potential
for medicinal applications. A wide variety of applications could be available for NO-
loaded MOFs. The major drawbacks with regard to the use of MOFs as delivery
agents of biologically significant gases (such as NO) and drugs is the dermatological
testing required using humans and the study of possible toxicity of the MOFs, which
are both necessary before any commercial application can be fully realised.
Nevertheless, these initial tests show that MOFs are of significant interest for use in
many medicinal applications. Testing has been carried out using porous paper bags
and it has been shown that porous paper does not cause any detrimental value to the
total NO available from MOFs. Initial studies using different cream formulations
have been attempted and have shown mixed results. Further investigation into the
optimal formulation for the release of NO from a cream is required. More promising
are the results from NO-loaded MOF based hydrocolloids which illustrate very good
release of NO and initially demonstrate good stability in PBS when stored at body
temperatures (37°C). Initial biological experiments of NO-containing MOFs have
shown great promise for NO-releasing formulations. A porcine artery is shown to
completely relax when exposed to NO-loaded Ni CPO-27 and only contracts once
the NO-loaded MOF is either removed or has completely released its entire store of
NO. Finally, initial studies into the storing of pharmaceuticals have shown that it is
possible to store both anti-inflammatory and antibiotic drugs within MOFs. There is
tremendous potential for the use of MOFs as drug delivery agents and much more
research needs to be carried out into this particular area of MOF research.
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8 Conclusions and Further Work
8.1 Conclusions
The overall aim of this project was to investigate MOFs which contained open metal
sites when activated and examine if they could store and controllably release
biologically significant quantities of NO. There are many conclusions that can be
drawn from the work carried out in this thesis. However, most importantly, it has
been shown that MOFs can be used to store and release significant amounts of NO
for medical applications. However, the performance of the different MOFs studied
varies considerably.
It has been shown that nickel based frameworks (Ni CPO-27, Ni succinate and Ni
STA-12) in particular show a remarkable ability not only to store large quantities of
NO but also controllably release the majority, if not all of its store resulting in an
almost perfect gas storage and release material. So far only one cobalt framework has
been investigated (Co CPO-27) but it has also shown almost perfect storage and
releaseability of NO. Other analogues of M-CPO-27 (Zn, Mg and Mn) exhibit very
good adsorption, but poor release by comparison. This behaviour is also noted in the
Fe based frameworks investigated (Fe MIL-88s). Further to this, the results gained
from Cu based MOFs show good adsorption but extremely poor release. A table
detailing the various NO adsorption and release totals investigated in this thesis can
be seen in figure 8.1. While the number of frameworks studied is small, it is striking
from figure 8.1 that the nickel and cobalt-based MOFs release considerably more NO
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than all the others. The question arises – is there something particularly suitable
about these metals?
Figure 8.1 A table containing all the NO adsorption and release data for the MOFs investigated
in this thesis.
It was noted in chapter 4 that the two materials which performed the best over the
whole NO adsorption-release cycle were also the two easiest to activate. The theory
presented was that the mechanism of the release reaction probably involved a
transition state that was structurally similar to the dehydrated material. Given that the
other two nickel compounds studied in this thesis also show good NO release, can
this be explained by looking at the basic chemistry of Ni?
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Undergraduate chemistry texts suggest that 18e- complexes of transition elements are
the most stable. Simple counting of electrons would therefore suggest that the 5
coordinate dehydrated present in activated Ni CPO-27 should be relatively stable as
it contains a total of 18e- (see figure 8.2). Therefore one would expect any reaction
where the transition state has a similar structure to the dehydrated phase to proceed
relatively well. This may partly explain why all the nickel materials perform well in
these studies. Additionally it partly explains why the cobalt analogue of CPO-27 also
performs well and potentially why the manganese version performs poorly too.
These changes are the most likely explanation as the coordination environment is
constrained and so other possible environments that could be observed in the solution
state are not seen in the solid. The simple electron counting method is not
particularly applicable to a d10 ion like Zn2+, but there is clearly no gain in stability
for the uncoordinated ion.
All of the iron-based MOFs studied in this thesis display reasonable uptakes of NO
but poor overall release - the question is why?
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Figure 8.2 A diagram showing the dehydration and NO loading mechanism combined with a
table showing the total number of electrons in the complex (assuming one electron donated from
the bent NO molecule)
The case of iron is more complex as there is the possibility of redox chemistry at the
metal. This was seen in chapter 5 where, when activated, a “self-reduction”
hydrolysis reaction occurs in iron zeolites, which leads to a majority of Fe2+ and
some unchanged Fe3+. This “self-reduction” reaction is likely to be present in the
MIL MOFs studied in this thesis and indeed a majority of Fe2+ is observed when the
material studied is activated (see in-situ IR on Fe MIL-100 chapter 5). This
complication makes any straightforward theories based on simple electron counting
even less likely to provide the complete answer.
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However, looking at iron in terms of the 18 rule, it can be seen that Fe2+ has 6 d
electrons and combined with the 12 electrons from the surrounding oxygen atoms,
gives a total of 18 e- (from figure 8.2). It can be deduced from this that there is no
extra stability from crystal field stabilisation energy (CFSE) to help the dehydrated
state as the most favourable state is the hydrated structure. Following NO adsorption
the iron complex has a total of 17 e-, which is probably more stable than the
dehydrated complex and therefore it is unlikely to go back to the dehydrated state
and replace the NO for a water molecule. A similar case is also observed for Mn
where the hydrated structure has 17 e- and the dehydrated structure only has 15 e-.
Therefore, when the activated material is exposed to NO, it appears to irreversibly
bind to the metal. The in-situ IR also showed that when NO-loaded materials are
exposed to water, the vast majority of NO stays bound or is involved in the possible
formation of N2O. This is explained by the NO-loaded complex structure being
relatively more stable compared with the intermediate “dehydrated structure” that
would be evoked if the water were indeed to replace the NO.
However the 18e- doesn’t necessarily apply in this situation as it more properly
applies to classical metal complexes, although it might give an insight as to why
certain metals perform better in the activation-storage-delivery cycle for NO.
Another key factor which would strongly influence the ability of MOFs to release
bound NO, is the way in which the NO has bound to the metal. NO can bind in two
ways to transition metals, either linearly or in a bent fashion. As was shown in
chapter 4, the Co and Ni versions of M-CPO-27 bind NO in a bent manner. This
means that there is no π backbonding and therefore the bond will be weaker 
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compared to the linearly bound NO which will form π bonds with the metal centre. 
This weaker bond is important as it allows the water to replace the NO in the
mechanism described at the end of chapter 4. A diagram showing the two possible
binding modes is shown below.
Figure 8.3 Two possible binding modes for NO with transition metals.
If the manganese, zinc and magnesium versions were to bind NO in a linear way then
this might explain why good adsorption of NO is seen but poor release. The linear
bond is much stronger and therefore it will be much harder for the water to replace
the NO. It might also be the same for the Fe MIL compounds investigated. Further
powder X-ray diffraction studies of the NO-loaded materials (Mn, Zn, Mg CPO-27
and Fe MILs) using a synchrotron source should show if the NO binds to the metals
in a linear or a bent fashion or a combination of both leading to poor release values
for NO.
As mentioned before, the iron atom situation is made more complicated by the “self-
reduction” reaction that takes place in zeolites and could be occurring in the MIL
materials too. The reduction of Fe3+ to Fe2+ is never 100% successful so even after
extensive thermal treatments under vacuum some residual Fe3+ will remain. This will
bind the NO, but very weakly as described in chapter 5. However the Fe2+ seems to
M N O·· M N
O····
··
·· ··
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strongly bind NO even when exposed to water, indicating that the amount of NO
which can be recovered from an NO-loaded MOF will be less than the expected total.
Also in chapter 5 it was shown that when exposed to water, N2O is produced
meaning that the situation is made more complex due to the interactions taking place
between different iron environments. It is for this reason that Fe-based zeolites have
been heavily investigated for use as deNOX catalysts for use in car exhausts where
NO is reduced to N2 in the presence of water at elevated temperatures1.
The case of Cu based MOFs, is separate as it forms completely different structures,
many of which contain Cu-Cu dimers. However, it is not difficult to imagine that a
similar situation could be observed in these structures. Indeed Cu, has also been
heavily researched for its redox properties and its use as a deNOX catalyst2. Cu2+
readily reduces to Cu+ under similar “self-reduction” (hydrolysis) conditions to iron
and therefore this could be an added complication for MOFs storing NO as the Cu2+
could be reduced and therefore irreversibly bind to the NO. This is evident from the
extremely small amounts of NO released from the two Cu MOFs investigated so far.
This explanation, combined with the theory put forward in chapter 4 and the in-situ
IR studies conducted on Fe MIL-100 in chapter 5, is a potential explanation as to
why certain metals show greater affinity for NO compared with others.
Further conclusions can be drawn regarding the formulations of MOFs for medicinal
applications. The total NO released from differing formulations is still remarkable
and merits further research. It has been shown that the delivery of NO from MOFs in
a variety of different formulations is possible and that there can be advantages to
Chapter 8 Conclusions and Further Work
241
utilising different delivery methods for different applications. For example, utilising
a hydrocolloid it is possible to deliver very significant quantities of NO for up to 10
days, whereas using porous bags or bandages this time can be reduced to a number of
hours. NO-loaded MOF formulations can therefore be tailor-made to the desired
application and this is a huge advantage for commercialisation. It has also been
initially demonstrated that it is possible to produce MOFs with double functionality
as both pharmaceutical products and NO can be stored in MOFs at the same time.
This thesis has shown the enormous potential that MOFs have as gas storage
materials, in particularly with regard to the storage of the biologically significant gas
NO. It can be concluded that MOFs range from being exceptional to poor in their
behaviour towards NO, which as mentioned previously gives a wide range of
delivery rates and amounts. For example Ni CPO-27 delivers 7 mmolg-1 of NO3 and
this is 7000 times as much as HKUST-14. This means that MOFs can be tailored
towards different applications depending on the amount of NO required and over
what time period. Much more research needs to be carried out regarding the
formulation and the toxicology of these materials before bringing any products to
market, however there is great potential has been shown for the use of MOFs in the
delivery of NO for many applications.
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8.2 Further Work
In this thesis great promise has been shown for the use of MOFs as delivery vehicles
of biologically significant molecules, in particular, the wound healing gas NO. Initial
studies concerning the use of MOFs in storing pharmaceuticals have also been
presented.
However there are several investigations which still need to be carried out to fully
understand the chemical processes occurring inside the pores of MOFs during the
activation, storage and controlled release of gas and possibly other drugs as well.
The first and most logical investigation should be the synthesis and full
characterisation (including NO storage and release isotherms) of Fe CPO-27 which
has been published recently5. Not only would the NO storage and release results be
of interest as a comparison with the other analogues of the M-CPO-27 series, but
comparison with the Fe based MIL structures would be of significant interest too. It
would also help to confirm the theory put forward in the Conclusions section. In Fe
CPO-27 there would be no redox chemistry present as the iron complex is fully Fe2+
and therefore eliminates any redox complication. A direct comparison can therefore
be made with the Ni and Co versions.
Secondly, it is of significant interest to understand the reasons why the release of NO
from Zn, Mg and Mn CPO-27 is poor in comparison with the Ni and Co versions. If
the reasons for this poor release can be understood, then possibly a method can be
found to increase the delivery of NO and therefore these much less toxic analogues
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could also find potential uses in formulations. In-situ IR experiments would be
helpful in understanding which reactions are occurring at the metal and to see if the
NO is staying bound to the metal despite the presence of water. Calorimetric
experiments would also be useful as they should give strong indicators about the
relative strength of the metal-NO bond.
Further alternative synthesis of such frameworks should be carried out to see if they
can possibly be successfully synthesised using cheaper methods. HKUST-1 has been
successfully synthesised using an electrochemical process which also gives the
optimised surface area for this MOF6. If it is possible to synthesise versions of the
M-CPO-27 series then it might be feasible to increase the NO storage and release
from the Zn, Mg and Mn versions. Alternatively if it were possible to synthesise the
Ni and Co structures at room temperature, like the Zn version7, then this would help
cut costs for the industrial production of these MOFs, if they are to be used in
formulations for applications.
There are also a number of improvements which could be made to make these
experiments much more accurate. The first of which would be the calculation of total
adsorption of NO volumetrically and use this to calculate surface areas of activated
MOFs. At the moment all calculations are made gravimetrically and are subject to
mass changes which makes the calculations much more inaccurate than if NO
isotherms were calculated volumetrically utilising a similar apparatus as that used for
N2 adsorption.
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It would also be an improvement if the activation conditions used in the loading of
MOF samples for release experiments matched those in the NO adsorption
experiments. The NO adsorption utilises a diffusion pump which allows high
vacuums to be generated, this currently is not used in the loading mechanism. It
would not be too difficult to match the conditions exactly, therefore achieving more
accurate release results.
However the investigations that need be carried out in the immediate future are
dermatological and biological experiments to see if the MOFs that store NO are
acceptable as NO delivery agents. Testing has been carried out using NO-loaded
zeolites and has been shown to be extremely effective against a number of different
bacteria and also non-destructive to the skin when placed in cream8-9. The zinc
version of M-CPO-27 would also be of significant interest as bare zinc zeolites show
anti-bacterial properties and suppress the growth of further bacteria. Therefore the
NO-loaded Zn CPO-27 could also have double functionality against bacteria in a
similar way to Zn zeolite-A. Similar experiments using M-CPO-27 or MIL MOFs
need to be carried out and also need to show advantageous results for MOFs to
continue to be considered of use as NO delivery agents.
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